Healthcare Realty Trust (HR) 10-K 1 Mar 23 2022 FY Annual report Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2022	Feb. 24, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-35568
Entity Registrant Name	HEALTHCARE REALTY TRUST INCORPORATED
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	20-4738467
Entity Address, Address Line One	3310 West End Avenue
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Nashville
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37203
City Area Code	615
Local Phone Number	269-8175
Title of 12(b) Security	Class A Common Stock, $0.01 par value per share
Trading Symbol	HR
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 6,374,706,546
Entity Common Stock, Shares Outstanding		380,779,861
Documents Incorporated by Reference	Portions of the Registrant’s definitive Proxy Statement relating to the Annual Meeting of Stockholders to be held on June 5, 2023 are incorporated by reference into Part III of this Report .
Entity Central Index Key	0001360604
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2022
Audit Information [Abstract]
Auditor Name	BDO USA, LLP
Auditor Location	Nashville, TN
Auditor Firm ID	243

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Real estate properties
Land	$ 1,439,798	$ 387,918
Buildings and improvements	11,332,037	4,337,641
Lease intangibles	959,998	120,478
Personal property	11,907	11,761
Investment in financing receivables, net	120,236	186,745
Financing lease right-of-use assets	83,824	31,576
Construction in progress	35,560	3,974
Land held for development	74,265	24,849
Total real estate investments	14,057,625	5,104,942
Less accumulated depreciation	(1,645,271)	(1,338,743)
Total real estate investments, net	12,412,354	3,766,199
Cash and cash equivalents	60,961	13,175
Assets held for sale, net	18,893	57
Operating lease right-of-use assets	336,983	128,386
Investments in unconsolidated joint ventures	327,248	161,942
Goodwill	223,202	3,487
Other assets, net	469,990	185,673
Total assets	13,849,631	4,258,919
Liabilities
Notes and bonds payable	5,351,827	1,801,325
Accounts payable and accrued liabilities	244,033	86,108
Liabilities of properties held for sale	437	294
Operating lease liabilities	279,895	96,138
Financing lease liabilities	72,939	22,551
Other liabilities	218,668	67,387
Total liabilities	6,167,799	2,073,803
Commitments and contingencies (See Footnote 15)
Redeemable non-controlling interests	2,014	0
Stockholders' equity
Preferred stock, $0.01 par value; 200,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.01 par value; 1,000,000 shares authorized; 380,590 and 150,457 shares issued and outstanding at December 31, 2022 and 2021, respectively.	3,806	1,505
Additional paid-in capital	9,587,637	3,972,917
Accumulated other comprehensive income (loss)	2,140	(9,981)
Cumulative net income attributable to common stockholders	1,307,055	1,266,158
Cumulative dividends	(3,329,562)	(3,045,483)
Total stockholders’ equity	7,571,076	2,185,116
Non-controlling interest	108,742	0
Total equity	7,679,818	2,185,116
Total liabilities, redeemable non-controlling interests, and stockholders' equity	$ 13,849,631	$ 4,258,919

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	200,000,000	200,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, issued (in shares)	380,590,000	150,457,000
Common stock, outstanding (in shares)	380,590,000	150,457,000
Lease intangibles	$ 959,998	$ 120,478

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues
Rental income	$ 907,451	$ 520,334	$ 492,262
Interest income	11,480	4,192	0
Other operating	13,706	10,291	7,367
Total Revenue	932,637	534,817	499,629
Expenses
Property operating	344,038	212,273	196,514
General and administrative	52,734	34,152	30,704
Acquisition and pursuit costs	3,229	3,930	2,561
Merger-related costs	103,380	0	0
Depreciation and amortization	453,082	202,714	190,435
Total expenses	956,463	453,069	420,214
Other income (expense)
Gain on sales of real estate properties	270,271	55,940	70,361
Interest expense	(146,691)	(53,124)	(56,174)
Loss on extinguishment of debt	(2,401)	0	(21,503)
Impairment of real estate properties	(54,427)	(17,101)	0
Equity loss recognized during the period	(687)	(795)	(463)
Interest and other (expense) income, net	(1,546)	(9)	559
Total other income (expense)	64,519	(15,089)	(7,220)
Net income	40,693	66,659	72,195
Net loss attributable to non-controlling interests	204	0	0
Net income attributable to common stockholders	$ 40,897	$ 66,659	$ 72,195
Basic and diluted earnings per share:
Basic earnings per common share (in dollars per share)	$ 0.15	$ 0.45	$ 0.52
Diluted earnings per common share (in dollars per share)	$ 0.15	$ 0.45	$ 0.52
Weighted average number of shares outstanding, basic and diluted:
Weighted average common shares outstanding - basic (in shares)	252,356,203	142,637,166	133,930,145
Weighted average common shares outstanding - diluted (in shares)	253,873,321	142,710,228	134,006,940
Revenue, Product and Service [Extensible List]	Service [Member]	Service [Member]

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net income	$ 40,693	$ 66,659	$ 72,195
Interest rate swaps
Reclassification adjustment for losses included in net income (interest expense)	1,527	4,472	3,472
Gains (losses) arising during the period on interest rate swaps and treasury rate locks	10,630
Net current-period other comprehensive income	12,157	7,851	(11,657)
Comprehensive income	52,850	74,510	60,538
Less: Comprehensive loss attributable to non-controlling interests	168
Comprehensive income attributable to common stockholders	53,018	74,510	60,538
Interest Rate Swaps
Interest rate swaps
Gains (losses) arising during the period on interest rate swaps and treasury rate locks	10,630	3,379	(10,862)
Treasury Rate Locks
Interest rate swaps
Gains (losses) arising during the period on interest rate swaps and treasury rate locks	$ 0	$ 0	$ (4,267)

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Cumulative Net Income	Cumulative Dividends	Total Stockholders’ Equity	Non- controlling Interests
Beginning Balance at Dec. 31, 2019	$ 1,900,009	$ 0	$ 1,347	$ 3,485,003	$ (6,175)	$ 1,127,304	$ (2,707,470)	$ 1,900,009	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net of costs	142,170		47	142,123				142,170
Common stock redemption	(1,706)		(1)	(1,705)				(1,706)
Share-based compensation	9,922		2	9,920				9,922
Net income	72,195					72,195		72,195
Reclassification adjustments for losses included in net income (interest expense)	3,472
Gains (Losses) arising during the period on interest rate swaps and treasury locks	(11,657)				(11,657)			(11,657)
Dividends to common stockholders ($1.24 per share)	(162,557)						(162,557)	(162,557)
Ending Balance at Dec. 31, 2020	1,948,376	0	1,395	3,635,341	(17,832)	1,199,499	(2,870,027)	1,948,376	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net of costs	331,042		109	330,933				331,042
Common stock redemption	(4,085)		(1)	(4,084)				(4,085)
Share-based compensation	10,729		2	10,727				10,729
Net income	66,659					66,659		66,659
Reclassification adjustments for losses included in net income (interest expense)	4,472
Gains (Losses) arising during the period on interest rate swaps and treasury locks	7,851				7,851			7,851
Dividends to common stockholders ($1.24 per share)	(175,456)						(175,456)	(175,456)
Ending Balance at Dec. 31, 2021	2,185,116	0	1,505	3,972,917	(9,981)	1,266,158	(3,045,483)	2,185,116	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net of costs	22,907		6	22,901				22,907
Merger consideration transferred	5,687,165		2,289	5,574,174				5,576,463	110,702
Common stock redemption	(2,792)		(1)	(2,791)				(2,792)
Share-based compensation	20,346		7	20,339				20,346
Redemption of non-controlling interest	0			97				97	(97)
Net income	40,693					40,897		40,897	(204)
Reclassification adjustments for losses included in net income (interest expense)	1,527				1,531			1,531	(4)
Gains (Losses) arising during the period on interest rate swaps and treasury locks	10,630				10,590			10,590	40
Dividends to common stockholders ($1.24 per share)	(285,774)						(284,079)	(284,079)	(1,695)
Ending Balance at Dec. 31, 2022	$ 7,679,818	$ 0	$ 3,806	$ 9,587,637	$ 2,140	$ 1,307,055	$ (3,329,562)	$ 7,571,076	$ 108,742

Consolidated Statements of Eq_2

Consolidated Statements of Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Stockholders' Equity [Abstract]
Dividend per share to common stockholders (in dollars per share)	$ 1.24	$ 1.21	$ 1.20

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
OPERATING ACTIVITIES
Net income	$ 40,693	$ 66,659	$ 72,195
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	453,082	202,714	190,435
Other amortization	24,695	3,793	4,381
Share-based compensation	20,346	10,729	9,922
Amortization of straight-line rent receivable (lessor)	(23,498)	(5,801)	(3,735)
Amortization of straight-line rent on operating leases (lessee)	3,374	1,498	1,490
Gain on sales of real estate properties	(270,271)	(55,940)	(70,361)
Loss on extinguishment of debt	2,401	0	21,503
Impairment of real estate properties	54,427	17,101	0
Equity loss from unconsolidated joint ventures	687	795	463
Distributions from unconsolidated joint ventures	1,881	0	193
Proceeds from disposition of sales-type lease properties	0	0	244,454
Non-cash interest from financing and real estate notes receivable	(2,257)	(391)	0
Changes in operating assets and liabilities:
Other assets, including right-of-use-assets	(26,098)	(11,436)	(727)
Accounts payable and accrued liabilities	24,191	(839)	4,555
Other liabilities	(30,906)	3,747	(4,679)
Net cash provided by operating activities	272,747	232,629	470,089
INVESTING ACTIVITIES
Acquisitions of real estate	(402,529)	(365,943)	(397,349)
Development of real estate	(37,862)	(4,029)	(3,089)
Additional long-lived assets	(163,544)	(100,689)	(93,963)
Funding of mortgages and notes receivable	(23,325)	0	0
Investments in unconsolidated joint ventures	(99,967)	(89,600)	(65,663)
Investment in financing receivable	(1,002)	(186,433)	0
Proceeds from sales of real estate properties and additional long-lived assets	1,201,068	184,221	4,898
Proceeds from notes receivable repayments	1,688	0	0
Cash assumed in Merger, including restricted cash for special dividend payment	1,159,837	0
Net cash provided by (used in) investing activities	1,634,364	(562,473)	(555,166)
FINANCING ACTIVITIES
Net borrowings/(repayments) on unsecured credit facility	40,000	210,000	(293,000)
Borrowings on term loans	666,500	0	150,000
Repayment on term loan	(1,141,500)	0	0
Borrowings of notes and bonds payable	0	0	596,562
Repayments of notes and bonds payable	(20,042)	(24,557)	(47,845)
Redemption of notes and bonds payable	(2,184)	0	(270,386)
Dividends paid	(283,713)	(175,456)	(162,557)
Special dividend paid in relation to the Merger	(1,123,648)	0	0
Net proceeds from issuance of common stock	22,902	331,119	142,000
Common stock redemptions	(3,192)	(3,803)	(1,436)
Distributions to non-controlling interest of limited partners	(1,695)	0	0
Settlement of treasury rate locks	0	0	(4,267)
Debt issuance and assumption costs	(12,753)	(405)	(5,931)
Payments made on finance leases	0	(9,182)	(3,417)
Net cash (used in) provided by financing activities	(1,859,325)	327,716	99,723
Increase (decrease) in cash and cash equivalents	47,786	(2,128)	14,646
Cash and cash equivalents cash at beginning of period	13,175	15,303	657
Cash and cash equivalents at end of period	60,961	13,175	15,303
Supplemental Cash Flow Information
Interest paid	112,692	49,443	52,787
Mortgage notes payable assumed upon acquisition (adjusted to fair value)	0	11,790	36,536
Invoices accrued for construction, tenant improvements and other capitalized costs	48,292	17,655	14,935
Capitalized interest	1,410	221	1,142
Real estate notes receivable assumed in Merger (adjusted to fair value)	74,819	0	0
Unsecured credit facility and term loans assumed in Merger (adjusted to fair value)	1,758,650	0	0
Senior notes assumed in Merger (adjusted to fair value)	2,232,650	0	0
Consideration transferred in relation to the Merger	$ 5,576,463	$ 0	$ 0

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business Overview Healthcare Realty Trust Incorporated (the “Company”) is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. See Note 2 below for a discussion of the Merger between Legacy HR and Legacy HTA. The Company had gross investments of approximately $14.1 billion in 688 real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development, and corporate property as of December 31, 2022. The Company’s 688 real estate properties are located in 35 states and total approximately 40.3 million square feet. In addition, the Company had a weighted average ownership interest of approximately 48% in 33 real estate properties held in joint ventures. See Note 5 below for more details regarding the Company's joint ventures. Square footage and property count disclosures in these Notes to the Company's Consolidated Financial Statements are unaudited. Principles of Consolidation The Company’s Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). Accounting Standards Codification Topic 810 broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity’s economic performance or (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE’s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Consolidated Financial Statements. The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis. For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. Healthcare Realty Holdings, L.P. (formally known as Healthcare Trust of America Holdings, LP) (the "OP") is 98.9% owned by the Company. Holders of operating partnership units (“OP Units”) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of December 31, 2022 there were approximately 4.0 million, or 1.1%, of OP Units issued and outstanding held by non-controlling interest holders. Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP. As of December 31, 2022, the Company had three consolidated VIEs in addition to the OP where it is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures. Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate: (dollars in thousands) DECEMBER 31, 2022 Assets: Net real estate investments $ 46,322 Cash and cash equivalents 3,645 Receivables and other assets 2,385 Total assets $ 52,352 Liabilities: Accrued expenses and other liabilities $ 12,214 Total equity 40,138 Total liabilities and equity $ 52,352 As of December 31, 2022, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture. The Company does not have the power or economics to direct the activities of the VIEs on a stand-alone basis, therefore it was determined that the Company was not the primary beneficiary. Therefore, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method. See below for additional information regarding the Company's unconsolidated VIEs: ORIGINATION DATE LOCATION SOURCE CARRYING AMOUNT MAXIMUM EXPOSURE TO LOSS 2021 Houston, TX 1 Note receivable $ 29,753 $ 31,150 2021 Charlotte, NC 1 Note receivable 5,984 6,000 2022 Texas 2 Equity method 23,219 23,219 1 Assumed mortgage note receivable in connection with the Merger. 2 Includes investments in six properties. As of December 31, 2022, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities. See Note 5 for more details regarding the Company's unconsolidated joint ventures. Use of Estimates in the Consolidated Financial Statements Preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates and assumptions. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, impairments, collectability of tenant receivables, and fair value measurements, as applicable. Reclassifications Certain reclassifications have been made on the Company's prior year Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Consolidated Balance Sheets. Segment Reporting The Company owns, leases, acquires, manages, finances, develops and redevelops outpatient and other healthcare-related properties. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single reportable segment. Real Estate Properties Real estate properties are recorded at cost or at fair value if acquired in a transaction that is a business combination under Accounting Standards Codification Topic 805, Business Combinations . Cost or fair value at the time of acquisition is allocated among land, buildings, tenant improvements, lease and other intangibles, and personal property as applicable. During 2022 and 2021, the Company eliminated against accumulated depreciation approximately $19.6 million and $16.3 million, respectively, of fully amortized real estate intangibles that were initially recorded as a component of certain real estate acquisitions. Also during 2022 and 2021, approximately $4.1 million and $9.9 million, respectively, of fully depreciated tenant and capital improvements that were no longer in service were eliminated against accumulated depreciation. In addition, during 2021, the Company eliminated against accumulated depreciation approximately $7.1 million of a fully depreciated building that is being demolished and redeveloped. Depreciation expense of real estate properties for the three years ended December 31, 2022, 2021 and 2020 was $320.8 million, $170.0 million and $162.4 million, respectively. Depreciation and amortization of real estate assets in place as of December 31, 2022, is provided for on a straight-line basis over the asset’s estimated useful life: Land improvements 2.0 to 39.0 years Buildings and improvements 3.0 to 49.0 years Lease intangibles (including ground lease intangibles) 1.2 to 99.0 years Personal property 3.0 to 20.0 years The Company capitalizes direct costs, including costs such as construction costs and professional services, and indirect costs, including capitalized interest and overhead costs, associated with the development and construction of real estate assets while substantive activities are ongoing to prepare the assets for their intended use. Capitalized interest cost is calculated using the weighted average interest rate of the Company's unsecured debt or the interest rate on project specific debt, if applicable. The Company continues to capitalize interest on the unoccupied portion of the properties in stabilization for up to one year after the buildings have been placed into service, at which time the capitalization of interest must cease. Land Held for Development Land held for development includes parcels of land owned by the Company, upon which the Company intends to develop and own outpatient healthcare facilities. The Company's land held for development included twenty parcels as of December 31, 2022 and seven parcels as of December 31, 2021. The Company’s investments in land held for development totaled approximately $74.3 million as of December 31, 2022 and $24.8 million as of December 31, 2021. The current land that is held for development is located adjacent to certain of the Company's existing medical office buildings in California, Colorado, Connecticut, Florida, Georgia, Massachusetts, New York, North Carolina, Tennessee, Texas and Washington. Asset Impairment The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants. In addition, the Company reviews for possible impairment, those assets subject to purchase options and those impacted by casualty losses, such as tornadoes and hurricanes. A property value is considered impaired only if management's estimate of current and projected (undiscounted and unleveraged) operating cash flows of the property is less than the net carrying value of the property. These estimates of future cash flows include only those that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the property based on its estimated remaining useful life. These estimates, including the useful life determination which can be affected by any potential sale of the property, are based on management's assumptions about its use of the property. Therefore, significant judgment is involved in estimating the current and projected cash flows. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property or the estimated fair value less costs to sell the property. Acquisitions of Real Estate Properties with In-Place Leases The Company's acquisitions of real estate properties typically do not meet the definition of a business and are accounted for as asset acquisitions. Acquisitions of real estate properties with in-place leases are accounted for at relative fair value. When a building with in-place leases is acquired, the cost of the acquisition must be allocated between the tangible real estate assets "as-if-vacant" and the intangible real estate assets related to in-place leases based on their estimated fair values. Land fair value is estimated by using an assessment of comparable transactions and other relevant data. The Company considers whether any of the in-place lease rental rates are above- or below-market. An asset (if the actual rental rate is above-market) or a liability (if the actual rental rate is below-market) is calculated and recorded in an amount equal to the present value of the future cash flows that represent the difference between the actual lease rate and the estimated market rate. If an in-place lease is identified as a below-market rental rate, the Company would also evaluate any renewal options associated with that lease to determine if the intangible should include those periods. The values related to above- or below-market in-place lease intangibles are amortized over the remaining term of the leases upon acquisition to rental income where the Company is the lessor and to property operating expense where the Company is the lessee. The Company also estimates an absorption period, which can vary by property, assuming the building is vacant and must be leased up to the actual level of occupancy when acquired. During that absorption period, the owner would incur direct costs, such as tenant improvements, and would suffer lost rental income. Likewise, the owner would have acquired a measurable asset in that, assuming the building was vacant, certain fixed costs would be avoided because the actual in-place lessees would reimburse a certain portion of fixed costs through expense reimbursements during the absorption period. All of these intangible assets (above- or below-market lease, tenant improvement costs avoided, leasing costs avoided, rental income lost, and expenses recovered through in-place lessee reimbursements) are estimated and recorded in amounts equal to the present value of estimated future cash flows. The actual purchase price is allocated based on the various relative asset fair values described above. The building and tenant improvement components of the purchase price are depreciated over the estimated useful life of the building or the weighted average remaining term of the in-place leases. The at-market, in-place lease intangibles are amortized to depreciation and amortization expense over the weighted average remaining term of the leases, and customer relationship assets are amortized to depreciation amortization expense over terms applicable to each acquisition. Any goodwill recorded through a business combination would be reviewed for impairment at least annually and is not amortized. See Note 9 for more details on the Company’s intangible assets. Fair Value Measurements Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements. A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: • Level 1 – quoted prices for identical instruments in active markets; • Level 2 – quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Executed purchase and sale agreements, that are binding agreements, are categorized as level one inputs. Brokerage estimates, letters of intent, or unexecuted purchase and sale agreements are considered to be level three as they are nonbinding in nature. Fair Value of Derivative Financial Instruments Derivative financial instruments are recorded at fair value on the Company's Consolidated Balance Sheets as other assets or other liabilities. The valuation of derivative instruments requires the Company to make estimates and judgments that affect the fair value of the instruments. Fair values of derivatives are estimated by pricing models that consider the forward yield curves and discount rates. The fair value of the Company's forward starting interest rate swap contracts are estimated by pricing models that consider foreign trade rates and discount rates. Such amounts and the recognition of such amounts are subject to significant estimates that may change in the future. For derivatives designated in qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive income (loss). Gains and losses are reclassified from accumulated other comprehensive income (loss) into earnings once the underlying hedged transaction is recognized in earnings. As of December 31, 2022 and 2021, the Company had $2.1 million recorded in accumulated other comprehensive income and $10.0 million recorded in accumulated other comprehensive loss, respectively, related to forward starting interest rate swaps entered into and settled during 2015 and 2020 and a hedge of the Company's variable rate debt. See Note 11 for additional information. Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. Restricted cash includes cash held in escrow in connection with proceeds from the sales of certain real estate properties. The Company did not have any restricted cash for the years ended December 31, 2022 or 2021. Cash and cash equivalents are held in bank accounts and overnight investments. The Company maintains its bank deposits with large financial institutions in amounts that often exceed federally-insured limits. The Company has not experienced any losses in such accounts. Goodwill and Other Intangible Assets Goodwill and intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present. Identifiable intangible assets of the Company are comprised of enterprise goodwill, in-place lease intangible assets, customer relationship intangible assets, and debt issuance costs. In-place lease and customer relationship intangible assets are amortized on a straight-line basis over the applicable lives of the assets. Debt issuance costs are amortized over the term of the debt instrument on the effective interest method or the straight-line method when the effective interest method is not applicable. Goodwill is not amortized but is evaluated annually as of December 31 for impairment. The Company's goodwill asset increased to $223.2 million in 2022 as a result of the Merger. The 2022 impairment evaluation indicated that no impairment had occurred with respect to the Company's goodwill asset. See Note 9 for more detail on the Company’s intangible assets. Contingent Liabilities From time to time, the Company may be subject to loss contingencies arising from legal proceedings and similar matters. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or underinsured damages. The Company continually monitors any matters that may present a contingent liability, and, on a quarterly basis, management reviews the Company’s reserves and accruals in relation to each of them, adjusting provisions as necessary in view of changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be reasonably estimated. Changes in estimates regarding the exposure to a contingent loss are reflected as adjustments to the related liability in the periods when they occur. Because of uncertainties inherent in the estimation of contingent liabilities, it is possible that the Company’s provision for contingent losses could change materially in the near term. To the extent that any significant losses, in addition to amounts recognized, are at least reasonably possible, such amounts will be disclosed in the notes to the Consolidated Financial Statements. Share-Based Compensation The Company has various employee and director share-based awards outstanding. These awards include non-vested common stock and options to purchase common stock granted to employees pursuant to the Company's Amended and Restated 2006 Incentive Plan, dated April 29, 2021 ("Incentive Plan"), which replaced the Company's 2015 Stock Incentive Plan (the "Legacy HR Stock Incentive Plan") following the Merger. References to the Incentive Plan include issuances under the Incentive Plan and the Legacy HR Stock Incentive Plan. Legacy HR's 2000 Employee Stock Purchase Plan (the "Legacy HR Employee Stock Purchase Plan") was terminated during 2022 and all outstanding options will expire by 2024. No new options will be issued under this plan. The Company recognizes share-based payments to employees and directors in the Consolidated Statements of Income on a straight-line basis over the requisite service period based on the fair value of the award on the measurement date. The Company recognizes the impact of forfeitures as they occur. See Note 13 for details on the Company’s share-based awards. Accumulated Other Comprehensive Income (Loss) Certain items must be included in comprehensive income, including items such as foreign currency translation adjustments, minimum pension liability adjustments, changes in the fair value of derivative instruments and unrealized gains or losses on available-for-sale securities. As of December 31, 2022, the Company’s accumulated other comprehensive income (loss) consists of the loss for changes in the fair value of active derivatives designated as cash flow hedges and the loss on the unamortized settlement of forward starting swaps and treasury hedges. See Note 11 for more details on the Company's derivative financial instruments. Revenue from Contracts with Customers (Topic 606) The Company recognizes certain revenue under the core principle of Topic 606. This requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. Revenue that is accounted for under Topic 606 is segregated on the Company’s Consolidated Statements of Income in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income. Below is a detail of the amounts by category: YEAR ENDED DECEMBER 31, Dollars in thousands 2022 2021 2020 Type of Revenue Parking income $ 8,513 $ 7,859 $ 6,720 Management fee income 4,668 2,049 343 Miscellaneous 525 383 304 $ 13,706 $ 10,291 $ 7,367 The Company’s three major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time and the Company recognizes revenue monthly based on this principle. In most cases, the revenue is due and payable on a monthly basis. The Company had a receivable balance of $1.5 million and $1.4 million for the years ended December 31, 2022 and 2021, respectively. Management fee income includes property management services provided to third parties and certain of the properties in the Company's unconsolidated joint ventures and is generally calculated, accrued and billed monthly based on a percentage of cash collections of tenant receivables for the month or a stated amount per square foot. Management fee income also includes amounts paid to the Company for its asset management services for certain of its unconsolidated joint ventures. Internal management fee income, where the Company manages its owned properties, is eliminated in consolidation. Rental Income Rental income related to non-cancelable operating leases is recognized as earned over the life of the lease agreements on a straight-line basis. The Company's lease agreements generally include provisions for stated annual increases or increases based on a Consumer Price Index ("CPI"). Rental income from properties under multi-tenant office lease arrangements and rental income from properties with single-tenant lease arrangements are included in rental income on the Company's Consolidated Statements of Income. For lessors, the new standard requires a lessor to classify leases as either sales-type, direct-financing or operating. A lease will be treated as a sale if it is considered to transfer control of the underlying asset to the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control. Otherwise, the lease is treated as an operating lease. Nonlease components, such as common area maintenance, are generally accounted for under Topic 606 and separated from the lease payments. However, the Company elected the lessor practical expedient allowing the Company to not separate these components when certain conditions are met. The combined component is accounted for under Accounting Standards Codification, Topic 842. The components of rental income are as follows: YEAR ENDED DECEMBER 31, Dollars in thousands 2022 2021 2020 Property operating income $ 883,953 $ 514,533 $ 488,527 Straight-line rent 23,498 5,801 3,735 Rental income $ 907,451 $ 520,334 $ 492,262 Federal Income Taxes The Company believes it has qualified to be taxed as a REIT and intends at all times to continue to qualify as a REIT under Sections 856 through 860 of the Internal Revenue Code. The Company must distribute at least 90% per annum of its real estate investment trust taxable income to its stockholders and meet other requirements to continue to qualify as a real estate investment trust. As a REIT, the Company is generally not subject to federal income tax on net income it distributes to its stockholders, but may be subject to certain state and local taxes and fees. See Note 16 for further discussion. If HR fails to qualify as a REIT in any taxable year, it will be subject to U.S. federal income taxes on its taxable income and will not be permitted to qualify for treatment as a REIT for U.S. federal income tax purposes for four years following the year during which the qualification is lost unless the IRS grants it relief under certain statutory provisions. Such event could have a material adverse effect on its business, financial condition, results of operations and net cash available for dividend distributions to its stockholders. HR conducts substantially all of its operations through the OP. As a partnership, the OP generally is not liable for federal income taxes. The income and loss from the operations of the OP is included in the tax returns of its partners, including HR, who are responsible for reporting their allocable share of the partnership income and loss. Accordingly no provision for income tax has been made in the accompanying consolidated financial statements. The Company classifies interest and penalties related to uncertain tax positions, if any, in the Consolidated Financial Statements as a component of general and administrative expenses. No such amounts were recognized during the three years ended December 31, 2022. Federal tax returns for the years 2019, 2020, 2021 and 2022 are currently subject to examination by taxing authorities. State Income Taxes The Company must pay certain state income taxes and the provisions for such taxes are generally included in general and administrative expense on the Company’s Consolidated Statements of Income. See Note 16 for further discussion. Sales and Use Taxes The Company must pay sales and use taxes to certain state tax authorities based on rents collected from tenants in properties located in those states. The Company is generally reimbursed for these taxes by the tenant. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis in rental income in the Company’s Consolidated Statements of Income. Assets Held for Sale Long-lived assets held for sale are reported at the lower of their carrying amount or their fair value less estimated cost to sell. Further, depreciation of these assets ceases at the time the assets are classified as held for sale. Losses resulting from the sale of such properties are characterized as impairment losses in the Consolidated Statements of Income. See Note 6 for more detail on assets held for sale. Earnings per Share The Company uses the two-class method of computing net earnings per common share. Earnings per common share is calculated by considering share-based payment awards that contain nonforfeitable rights to dividends or dividend equivalents as participating securities. Undistributed earnings (excess net income over dividend payments) are allocated on a pro rata basis to common shareholders and restricted shareholders. Undistributed losses (dividends in excess of net income) do not get allocated to restricted stockholders as they do not have the contractual obligation to share in losses. The amount of undistributed losses that applies to the restricted stockholders is allocated to the common stockholders. Basic earnings per common share is calculated using weighted average shares outstanding less issued and outstanding non-vested shares of common stock. Diluted earnings per common share is calculated using weighted average shares outstanding plus the dilutive effect of the outstanding stock options from the Legacy HR Employee Stock Purchase Plan using the treasury stock method and the average stock price during the period. Additionally, net income (loss) allocated to OP units has been included in the numerator and common stock related to redeemable OP units have been included in the denominator for the purpose of computing diluted earnings per share. See Note 14 for the calculations of earnings per share. Redeemable Non-Controlling Interests The Compan

Merger with HTA

Merger with HTA	12 Months Ended
	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Merger with HTA	Merger with HTA On July 20, 2022 (the “Closing Date”), pursuant to the Agreement and Plan of Merger dated as of February 28, 2022 (the “Merger Agreement”), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (“Legacy HR”), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (“Legacy HTA”), the OP, and HR Acquisition 2, LLC, a Maryland limited liability company (“Merger Sub”), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the “Merger”). On the Closing Date, each outstanding share of Legacy HR common stock, $0.01 par value per share (the “Legacy HR Common Stock”), was cancelled and converted into the right to receive one share of Legacy HTA class A common stock at a fixed ratio of 1.00 to 1.00. Per the terms of the Merger Agreement, Legacy HTA declared a special dividend of $4.82 (the “Special Dividend”) for each outstanding share of Legacy HTA class A common stock, $0.01 par value per share ( the “Legacy HTA Common Stock”), and the OP declared a corresponding distribution to the holders of its partnership units, payable to Legacy HTA stockholders and OP unitholders of record on July 19, 2022. Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to HRTI, LLC and Legacy HTA changed its name to “Healthcare Realty Trust Incorporated”. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP such that Legacy HR became a wholly-owned subsidiary of the OP. The Company operates under the name “Healthcare Realty Trust Incorporated” and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange (the “NYSE”) under the ticker symbol “HR”. For accounting purposes, the Merger was treated as a “reverse acquisition” in which Legacy HTA was considered the legal acquirer and Legacy HR was considered the accounting acquirer based on various factors, including, but not limited to: (i) the composition of the board of directors of the consolidated Company, (ii) the composition of senior management of the consolidated Company, and (iii) the premium transferred to the Legacy HTA stockholders. As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company. The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, which requires, among other things, the assets acquired, the liabilities assumed and non-controlling interests, if any, to be recognized at their acquisition date fair value. The implied consideration transferred on the Closing Date is as follows: Dollars in thousands, except for per share data Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (a) 228,520,990 Exchange ratio 1.00 Implied shares of Legacy HR Common Stock issued 228,520,990 Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (b) $ 24.37 Value of implied Legacy HR Common Stock issued $ 5,569,057 Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services (c) 7,406 Consideration transferred $ 5,576,463 (a) Includes 228,520,990 shares of Legacy HTA Common Stock as of July 20, 2022. The number of shares of HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 HTA fractional shares that were paid in cash less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares and units were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 per share of HTA Common Stock. (b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022. (c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services. Preliminary Purchase Price Allocation The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: Dollars in thousands PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE MEASUREMENT PERIOD ADJUSTMENTS PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE ASSETS Real estate investments Land $ 985,926 $ 6,775 $ 992,701 Buildings and improvements 6,960,418 (83,662) 6,876,756 Lease intangible assets (a) 831,920 1,230 833,150 Financing lease right-of-use assets 9,874 3,146 13,020 Construction in progress 10,071 (6,744) 3,327 Land held for development 46,538 — 46,538 Total real estate investments $ 8,844,747 $ (79,255) $ 8,765,492 Assets held for sale, net 707,442 (7,946) 699,496 Investments in unconsolidated joint ventures 67,892 — 67,892 Cash and cash equivalents 26,034 11,403 37,437 Restricted cash 1,123,647 (1,247) 1,122,400 Operating lease right-of-use assets 198,261 17,786 216,047 Other assets, net (b) (c) 209,163 (3,840) 205,323 Total assets acquired $ 11,177,186 $ (63,099) $ 11,114,087 LIABILITIES Notes and bonds payable $ 3,991,300 $ — $ 3,991,300 Accounts payable and accrued liabilities 1,227,570 17,374 1,244,944 Liabilities of assets held for sale 28,677 (3,939) 24,738 Operating lease liabilities 173,948 10,173 184,121 Financing lease liabilities 10,720 (855) 9,865 Other liabilities 203,210 (11,541) 191,669 Total liabilities assumed $ 5,635,425 $ 11,212 $ 5,646,637 Net identifiable assets acquired $ 5,541,761 $ (74,311) $ 5,467,450 Non-controlling interest $ 110,702 $ — $ 110,702 Goodwill $ 145,404 $ 74,311 $ 219,715 (a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years. (b) Includes $15.9 million of contractual accounts receivable, which approximates fair value. (c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date. The measurement period adjustments recorded during the year ended December 31, 2022 primarily resulted from updated valuations related to the Company’s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $74.3 million. As of December 31, 2022, the Company had not finalized the determination of fair value of certain tangible and intangible assets acquired and liabilities assumed, including, but not limited to real estate assets and liabilities, notes receivables and goodwill. As such, the assessment of fair value of assets acquired and liabilities assumed is preliminary and was based on information that was available at the time the Consolidated Financial Statements were prepared. The finalization of the purchase accounting assessment could result in material changes in the Company’s determination of the fair value of assets acquired and liabilities assumed, which will be recorded as measurement period adjustments in the period in which they are identified, up to one year from the Closing Date. A preliminary estimate of approximately $219.7 million has been allocated to goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The recognized goodwill is attributable to expected synergies and benefits arising from the Merger, including anticipated general and administrative cost savings and potential economies of scale benefits in both tenant and vendor relationships following the closing of the Merger. None of the goodwill recognized is expected to be deductible for tax purposes. Merger related Costs In conjunction with the Merger, the Company incurred Merger-related costs of $103.4 million during the year ended December 31, 2022, which were included within Merger-related costs in results of operations. The Merger-related costs primarily consist of legal, consulting, banking services, and other Merger-related costs. Unaudited Pro Forma Financial Information The Consolidated Statement of Income for the year ended December 31, 2022 includes $351.8 million of revenues and $79.3 million of net loss associated with the results of operations of Legacy HTA from the Merger closing date to December 31, 2022. The following unaudited pro forma information presents a summary of our Consolidated Statements of Income for the years ended December 31, 2022 and 2021, as if the Merger had occurred on January 1, 2021. Adjustments in the pro forma financial information include but are not limited to the following: (i) additional depreciation and amortization expense related to the acquired tangible and intangible assets, (ii) additional interest expense on transaction-related borrowings, including assumed debt in connection with the Merger, (iii) additional rental income related to the assumed above and below-market leases, and straight-line rent and (iv) Merger-related costs and other one-time, non-recurring costs. The pro forma financial information excludes adjustments for estimated cost synergies or other effects of the integration of the Merger. The following pro forma financial information is not necessarily indicative of the results of operations had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including, but not limited to, differences between the assumptions used to prepare the pro forma information, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses. YEAR ENDED Dollars in thousands 2022 2021 Total revenues $ 1,391,096 $ 1,316,743 Net income $ 130,445 $ (78,990)

Property Investments

Property Investments	12 Months Ended
	Dec. 31, 2022
Real Estate Investment Property, Net [Abstract]
Property Investments	Property Investments The Company invests in healthcare-related properties located throughout the United States. The Company provides management, leasing, development and redevelopment services, and capital for the construction of new facilities as well as for the acquisition of existing properties. The following table summarizes the Company’s consolidated investments at December 31, 2022. Dollars in thousands NUMBER OF PROPERTIES LAND BUILDINGS AND IMPROVEMENTS LEASE INTANGIBLES PERSONAL PROPERTY TOTAL ACCUMULATED DEPRECIATION Dallas, TX 45 $ 95,010 $ 1,116,725 $ 77,589 $ 551 $ 1,289,875 $ (202,031) Seattle, WA 29 64,295 623,166 13,444 726 701,631 (164,423) Los Angeles, CA 23 98,524 460,780 31,790 453 591,547 (129,663) Boston, MA 18 128,904 396,002 63,134 — 588,040 (13,513) Charlotte, NC 32 35,402 450,076 29,839 105 515,422 (95,363) Houston, TX 34 85,389 633,474 64,045 57 782,965 (63,486) Miami, FL 23 72,364 400,839 46,355 105 519,663 (52,920) Atlanta, GA 28 49,379 437,312 36,170 95 522,956 (63,773) Tampa, FL 20 31,533 377,455 36,838 33 445,859 (18,991) Denver, CO 33 76,698 497,235 45,854 609 620,396 (65,123) Raleigh, NC 27 56,620 363,359 37,446 9 457,434 (15,566) Phoenix, AZ 35 20,262 430,396 37,097 425 488,180 (30,281) Chicago, IL 7 32,374 266,672 20,608 81 319,735 (28,243) Indianapolis, IN 36 52,180 265,070 32,739 13 350,002 (19,705) Hartford, CT 30 43,326 204,049 31,803 — 279,178 (8,015) Nashville, TN 12 43,348 346,312 10,205 1,424 401,289 (92,720) New York, NY 14 64,402 167,819 26,430 — 258,651 (4,771) Austin, TX 13 27,064 271,692 18,568 142 317,466 (40,363) Orlando, FL 8 20,708 180,694 21,581 1 222,984 (11,654) Memphis, TN 11 13,901 184,540 4,211 317 202,969 (60,624) Other (51 markets) 210 326,262 3,256,027 273,568 1,223 3,857,080 (457,572) 688 1,437,945 11,329,694 959,314 6,369 13,733,322 (1,638,800) Construction in progress — — — — 35,560 — Land held for development — — — — — 74,265 (1,183) Financing lease right-of-use assets — — — — — 83,824 — Investment in financing receivables, net — — — — — 120,236 — Corporate property 1 — 1,853 2,343 684 5,538 10,418 (5,288) Total real estate investments 688 $ 1,439,798 $ 11,332,037 $ 959,998 $ 11,907 $ 14,057,625 $ (1,645,271) 1 Includes a 15,014 square foot building located in Charleston, South Carolina that is used as one of the Company's corporate offices.

Leases

Leases	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Leases	Leases Lessor Accounting Under ASC 842 The Company’s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide for fixed rent renewal terms in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company’s portfolio of single-tenant leases generally requires the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property. The Company records these expenses on a net basis, with the exception of property taxes. Property taxes are recorded on a gross basis as a lessor cost in which the tenant reimburses the Company. The Company generally expects that collectability is probable at lease commencement. If the assessment of collectability changes after the lease commencement date and Rental income is not considered probable, Rental income is recognized on a cash basis and all previously recognized uncollectible Rental income is reversed in the period in which it is determined not to be probable of collection. In addition to the lease-specific collectability assessment performed under Topic 842, the Company may also apply a general reserve ("provision for bad debt"), as a reduction to Rental income, for its portfolio of operating lease receivables. The Company's leases typically have escalators that are either based on a stated percentage or an index such as CPI (consumer price index). In addition, most of the Company's leases include nonlease components such as reimbursement of operating expenses as additional rent or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the year ended December 31, 2022 was $907.5 million. Future minimum lease payments under the non-cancelable operating leases, excluding any reimbursements, as of December 31, 2022 are as follows: In thousands 2023 $ 928,516 2024 814,132 2025 701,659 2026 603,051 2027 500,645 2028 and thereafter 1,633,847 $ 5,181,850 Revenue Concentrations The Company’s real estate portfolio is leased to a diverse tenant base. The Company did not have any customers that account for 10% or more of the Company's revenues for the years ended December 31, 2022, 2021 and 2020. Purchase Option Provisions Certain of the Company’s leases include purchase option provisions. The provisions vary by agreement but generally allow the lessee to purchase the property covered by the agreement at fair market value or an amount equal to the Company’s gross investment. The Company expects that the purchase price from its purchase options will be greater than its net investment in the properties at the time of potential exercise by the lessee. The Company had investments of approximately $100.4 million in five real estate properties as of December 31, 2022 that were subject to purchase options that were exercisable. Lessee Accounting Under ASC 842 As of December 31, 2022, the Company was obligated, as the lessee, under operating and finance lease agreements consisting primarily of the Company’s ground leases. Contracts evaluated and treated as leases are those that convey the right to control the use of identified assets for a period of time in exchange for consideration. ASC 842 requires the recording of these leases based on the aggregate future cash flows, discounted utilizing the implicit rate in the lease, or, if not readily determinable, based upon the lessee's incremental borrowing rate, to which the Company utilizes market inputs that are both similar to the Company's credit profile and corresponding term of the leases. As of December 31, 2022, the Company had 242 properties totaling 17.8 million square feet that were held under ground leases. Some of the ground leases renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company’s ground leases are generally either stated or based on the Consumer Price Index. The Company had 75 prepaid ground leases as of December 31, 2022. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $1.1 million for the year ended December 31, 2022 and $0.6 million for the years ended December 31, 2021 and 2020. The Company’s future lease payments (primarily for its 167 non-prepaid ground leases) as of December 31, 2022 were as follows: In thousands OPERATING FINANCING 2023 $ 15,641 $ 2,140 2024 $ 15,227 $ 2,182 2025 $ 14,814 $ 2,218 2026 $ 14,852 $ 2,255 2027 $ 14,921 $ 2,294 2028 and thereafter $ 939,165 $ 396,398 Total undiscounted lease payments $ 1,014,620 $ 407,487 Discount $ (734,725) $ (334,548) Lease liabilities $ 279,895 $ 72,939 The following table provides details of the Company's total lease expense for the year ended December 31, 2022: In thousands YEAR ENDED YEAR ENDED Operating lease cost Operating lease expense $ 12,699 $ 4,765 Variable lease expense 4,529 3,929 Finance lease cost Amortization of right-of-use assets 1,288 388 Interest on lease liabilities 2,876 1,032 Total lease expense $ 21,392 $ 10,114 Other information Operating cash flows outflows related to operating leases $ 12,816 $ 7,706 Operating cash flows outflows related to financing leases $ 1,838 $ 809 Financing cash flows outflows related to financing leases $ — $ 9,182 Right-of-use assets obtained in exchange for new finance lease liabilities $ 53,765 $ 3,827 Right-of-use assets obtained in exchange for new operating lease liabilities $ 216,047 $ 8,298 Weighted-average remaining lease term (excluding renewal options) - operating leases 47.5 47.6 Weighted-average remaining lease term (excluding renewal options) -finance leases 58.9 62.1 Weighted-average discount rate - operating leases 5.8 % 5.6 % Weighted-average discount rate - finance leases 5.0 % 5.3 %
Leases	Leases Lessor Accounting Under ASC 842 The Company’s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide for fixed rent renewal terms in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company’s portfolio of single-tenant leases generally requires the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property. The Company records these expenses on a net basis, with the exception of property taxes. Property taxes are recorded on a gross basis as a lessor cost in which the tenant reimburses the Company. The Company generally expects that collectability is probable at lease commencement. If the assessment of collectability changes after the lease commencement date and Rental income is not considered probable, Rental income is recognized on a cash basis and all previously recognized uncollectible Rental income is reversed in the period in which it is determined not to be probable of collection. In addition to the lease-specific collectability assessment performed under Topic 842, the Company may also apply a general reserve ("provision for bad debt"), as a reduction to Rental income, for its portfolio of operating lease receivables. The Company's leases typically have escalators that are either based on a stated percentage or an index such as CPI (consumer price index). In addition, most of the Company's leases include nonlease components such as reimbursement of operating expenses as additional rent or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the year ended December 31, 2022 was $907.5 million. Future minimum lease payments under the non-cancelable operating leases, excluding any reimbursements, as of December 31, 2022 are as follows: In thousands 2023 $ 928,516 2024 814,132 2025 701,659 2026 603,051 2027 500,645 2028 and thereafter 1,633,847 $ 5,181,850 Revenue Concentrations The Company’s real estate portfolio is leased to a diverse tenant base. The Company did not have any customers that account for 10% or more of the Company's revenues for the years ended December 31, 2022, 2021 and 2020. Purchase Option Provisions Certain of the Company’s leases include purchase option provisions. The provisions vary by agreement but generally allow the lessee to purchase the property covered by the agreement at fair market value or an amount equal to the Company’s gross investment. The Company expects that the purchase price from its purchase options will be greater than its net investment in the properties at the time of potential exercise by the lessee. The Company had investments of approximately $100.4 million in five real estate properties as of December 31, 2022 that were subject to purchase options that were exercisable. Lessee Accounting Under ASC 842 As of December 31, 2022, the Company was obligated, as the lessee, under operating and finance lease agreements consisting primarily of the Company’s ground leases. Contracts evaluated and treated as leases are those that convey the right to control the use of identified assets for a period of time in exchange for consideration. ASC 842 requires the recording of these leases based on the aggregate future cash flows, discounted utilizing the implicit rate in the lease, or, if not readily determinable, based upon the lessee's incremental borrowing rate, to which the Company utilizes market inputs that are both similar to the Company's credit profile and corresponding term of the leases. As of December 31, 2022, the Company had 242 properties totaling 17.8 million square feet that were held under ground leases. Some of the ground leases renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company’s ground leases are generally either stated or based on the Consumer Price Index. The Company had 75 prepaid ground leases as of December 31, 2022. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $1.1 million for the year ended December 31, 2022 and $0.6 million for the years ended December 31, 2021 and 2020. The Company’s future lease payments (primarily for its 167 non-prepaid ground leases) as of December 31, 2022 were as follows: In thousands OPERATING FINANCING 2023 $ 15,641 $ 2,140 2024 $ 15,227 $ 2,182 2025 $ 14,814 $ 2,218 2026 $ 14,852 $ 2,255 2027 $ 14,921 $ 2,294 2028 and thereafter $ 939,165 $ 396,398 Total undiscounted lease payments $ 1,014,620 $ 407,487 Discount $ (734,725) $ (334,548) Lease liabilities $ 279,895 $ 72,939 The following table provides details of the Company's total lease expense for the year ended December 31, 2022: In thousands YEAR ENDED YEAR ENDED Operating lease cost Operating lease expense $ 12,699 $ 4,765 Variable lease expense 4,529 3,929 Finance lease cost Amortization of right-of-use assets 1,288 388 Interest on lease liabilities 2,876 1,032 Total lease expense $ 21,392 $ 10,114 Other information Operating cash flows outflows related to operating leases $ 12,816 $ 7,706 Operating cash flows outflows related to financing leases $ 1,838 $ 809 Financing cash flows outflows related to financing leases $ — $ 9,182 Right-of-use assets obtained in exchange for new finance lease liabilities $ 53,765 $ 3,827 Right-of-use assets obtained in exchange for new operating lease liabilities $ 216,047 $ 8,298 Weighted-average remaining lease term (excluding renewal options) - operating leases 47.5 47.6 Weighted-average remaining lease term (excluding renewal options) -finance leases 58.9 62.1 Weighted-average discount rate - operating leases 5.8 % 5.6 % Weighted-average discount rate - finance leases 5.0 % 5.3 %

Acquisitions, Dispositions and

Acquisitions, Dispositions and Mortgage Repayments	12 Months Ended
	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions, Dispositions and Mortgage Repayments	Acquisitions, Dispositions and Mortgage Repayments 2022 Acquisitions The following table details the Company's acquisitions, exclusive of the Merger, for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE CASH 2 REAL OTHER 3 SQUARE FOOTAGE Dallas, TX 4 MOB 2/11/22 $ 8,175 $ 8,185 $ 8,202 $ (17) 18,000 San Francisco, CA 5 MOB 3/7/22 114,000 112,986 108,687 4,299 166,396 Atlanta, GA MOB 4/7/22 6,912 7,054 7,178 (124) 21,535 Denver, CO MOB 4/13/22 6,320 5,254 5,269 (15) 12,207 Colorado Springs, CO 6 MOB 4/13/22 13,680 13,686 13,701 (15) 25,800 Seattle, WA MOB 4/28/22 8,350 8,334 8,370 (36) 13,256 Houston, TX MOB 4/28/22 36,250 36,299 36,816 (517) 76,781 Los Angeles, CA MOB 4/29/22 35,000 35,242 25,400 9,842 34,282 Oklahoma City, OK MOB 4/29/22 11,100 11,259 11,334 (75) 34,944 Raleigh, NC 5 MOB 5/31/22 27,500 26,710 27,127 (417) 85,113 Tampa. FL 6 MOB 6/9/22 18,650 18,619 18,212 407 55,788 Seattle, WA MOB 8/1/22 4,850 4,806 4,882 (76) 10,593 Raleigh, NC MOB 8/9/22 3,783 3,878 3,932 (54) 11,345 Jacksonville, FL MOB 8/9/22 18,195 18,508 18,583 (75) 34,133 Atlanta, GA MOB 8/10/22 11,800 11,525 12,038 (513) 43,496 Denver, CO MOB 8/11/22 14,800 13,902 13,918 (16) 34,785 Raleigh, NC MOB 8/18/22 11,375 10,670 10,547 123 31,318 Nashville, TN MOB 9/15/22 21,000 20,764 20,572 192 61,932 Austin, TX MOB 9/29/22 5,450 5,449 5,572 (123) 15,000 Jacksonville, FL 4 MOB 10/12/22 3,600 3,530 3,609 (79) 6,200 Houston, TX MOB 11/21/22 5,500 5,469 5,513 (44) 28,369 Austin, TX 7 MOB 12/28/22 888 890 889 1 2,219 Denver, CO MOB 12/28/22 16,400 16,170 16,467 (297) 39,692 $ 403,578 $ 399,189 $ 386,818 $ 12,371 863,184 1 MOB = medical office building. 2 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Represents a single-tenant property. 5 Includes three properties. 6 Includes two properties. 7 The Company acquired additional ownership interests in an existing building bringing the Company's ownership to 71.4%. The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2022 as of the acquisition date: ESTIMATED ESTIMATED Building $ 250.7 14.0 - 38.0 Land 76.1 — Land Improvements 11.2 5.0 - 14.0 Intangibles At-market lease intangibles 48.8 1.5 - 13.4 Above-market lease intangibles (lessor) 15.9 1.3 - 15.6 Below-market lease intangibles (lessor) (2.2) 1.3 - 19.3 Below-market lease intangibles (lessee) 1.2 13.1 Other assets acquired 0.4 Accounts payable, accrued liabilities and other liabilities assumed (2.9) Total cash paid $ 399.2 Unconsolidated Joint Ventures As of December 31, 2022, the Company had a weighted average ownership interest of approximately 48% in 33 real estate properties held in joint ventures. 2022 Acquisitions The following table details the joint venture acquisitions for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE CASH 2 REAL OTHER 3 SQUARE FOOTAGE San Francisco, CA 4 MOB 3/7/22 $ 67,175 $ 66,789 $ 65,179 $ 1,610 110,865 Los Angeles, CA 5 MOB 3/7/22 33,800 32,384 32,390 (6) 103,259 $ 100,975 $ 99,173 $ 97,569 $ 1,604 214,124 1 MOB = medical office building. 2 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Includes three properties. 5 Includes two properties. The Company's investment in and loss recognized for the years ended December 31, 2022 and 2021 related to its joint ventures accounted for under the equity method are shown in the table below: DECEMBER 31, Dollars in millions 2022 2021 Investments in unconsolidated joint ventures, beginning of period $ 161.9 $ 73.1 New investments during the period 1 167.9 89.6 Equity loss recognized during the period (0.7) (0.8) Owner distributions (1.9) — Investments in unconsolidated joint ventures, end of period $ 327.2 $ 161.9 1 For the year ended December 31, 2022, this included unconsolidated joint ventures acquired as part of the Merger, as well as investments in two joint ventures representing a 20% and 40% ownership interest in portfolios in Los Angeles, California and Dallas, Texas, respectively. Also, see 2022 Real Estate Asset Dispositions below for additional information. 2021 Acquisitions The following table details the Company's acquisitions for the year ended December 31, 2021: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE 2 MORTGAGES ASSUMED 3 CASH 4 REAL ESTATE 2 OTHER 5 SQUARE FOOTAGE San Diego, CA 6 MOB 1/7/21 $ 17,150 $ — $ 17,182 $ 17,182 $ — 22,461 Dallas, TX 8 MOB 2/1/21 22,515 — 22,299 22,641 (342) 121,709 Atlanta, GA 8 MOB 2/17/21 9,800 — 10,027 10,073 (46) 44,567 Washington, D.C. MOB 3/3/21 12,750 — 12,709 12,658 51 26,496 Houston, TX MOB 5/14/21 13,500 — 12,986 13,379 (393) 45,393 San Diego, CA 6,7 MOB 5/28/21 102,650 — 103,984 104,629 (645) 160,394 Greensboro, NC MOB 6/28/21 9,390 — 9,475 10,047 (572) 25,168 Baltimore, MD MOB 6/29/21 14,600 — 14,357 14,437 (80) 33,316 Denver, CO 9 MOB 7/16/21 70,426 — 69,151 65,100 4,051 259,555 Greensboro, NC 6 MOB 7/19/21 6,400 — 6,374 6,514 (140) 18,119 Colorado Springs, CO MOB 7/27/21 33,400 — 32,738 33,241 (503) 69,526 Birmingham, AL MOB 8/19/21 9,250 — 9,355 9,388 (33) 29,942 Raleigh, NC MOB 9/20/21 5,780 — 5,821 5,810 11 18,280 Denver, CO MOB 9/22/21 20,250 — 19,630 19,405 225 83,604 Raleigh, NC MOB 9/30/21 10,000 — 9,921 9,874 47 29,178 Denver, CO MOB 11/15/21 7,700 — 7,383 7,431 (48) 18,599 Denver, CO MOB 11/18/21 22,400 — 22,343 22,422 (79) 30,185 Columbus, OH 10 MOB 12/1/21 16,275 — 15,970 7,365 8,605 71,930 Nashville, TN MOB 12/2/21 11,300 — 11,245 11,263 (18) 34,908 Colorado Springs, CO MOB 12/20/21 10,575 — 10,541 11,009 (468) 44,166 Columbus, OH 8 MOB 12/28/21 9,525 — 9,521 9,601 (80) 28,962 Los Angeles, CA MOB 12/28/21 20,500 (11,000) 9,396 20,316 80 56,762 Nashville, TN 11 MOB 12/29/21 19,775 — 19,833 19,982 (149) 85,590 Austin, TX MOB 12/29/21 20,500 — 20,696 20,741 (45) 62,548 Atlanta, GA MOB 12/30/21 4,900 — 4,772 4,419 353 11,840 Nashville, TN 12 MOB 12/30/21 54,000 — 53,923 54,072 (149) 74,489 Nashville, TN 12 MOB 12/30/21 20,500 — 19,833 19,825 8 32,454 $ 575,811 $ (11,000) $ 561,465 $ 562,824 $ 9,641 1,540,141 1 MOB = medical office building. 2 Includes investments in financing receivables and an $8.9 million right-of-use asset related to the Columbus, Ohio transaction. 3 The mortgages assumed in the acquisitions do not reflect the fair value adjustments totaling $0.8 million in aggregate recorded by the Company upon acquisition (included in Other). 4 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 5 Includes other assets acquired, liabilities assumed, intangibles, and fair value mortgage adjustments recognized at acquisition. 6 Represents a single-tenant property. 7 The Company acquired a single-tenant net lease property in San Diego, CA in a sale-leaseback transaction which was accounted for as a financing arrangement as required under ASC 842, Leases. 8 Includes two properties. 9 Includes three properties. 10 This sale-leaseback transaction was a multi-tenant lease property. A portion of the transaction totaling $7.4 million was accounted for as a financing receivable and the remaining $8.9 million was accounted for as an imputed lease arrangement. See Note 1 to the Consolidated Financial Statements accompanying this report for more information. 11 Includes purchase of an adjoining 2.7 acre land parcel that will be held for development. 12 This sale-leaseback transaction was a multi-tenant lease property which was accounted for as a financing arrangement as required under ASC 842, Leases. The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2021 as of the acquisition date: ESTIMATED ESTIMATED Building $ 275.1 18.0 - 44.0 Investment in financing receivables, net 185.9 0.5 - 34.0 Financing lease right of use assets 1 8.9 15.0 - 34.0 Land 34.1 — Land Improvements 8.9 6.0 - 16.0 Intangibles At-market lease intangibles 58.8 2.6 - 16.6 Above-market lease intangibles (lessor) 3.4 1.9 - 8.1 Below-market lease intangibles (lessor) (1.4) 3.1 - 21.8 Above-market lease intangibles (lessee) (0.3) 36.7 - 64.5 Below-market lease intangibles (lessee) 4.7 45.4 Mortgage notes payable assumed, including fair value adjustments (11.8) Other assets acquired 0.8 Accounts payable, accrued liabilities and other liabilities assumed (5.6) Total cash paid $ 561.5 1 The Company acquired a building in Columbus, Ohio in a sale lease back transaction totaling $16.3 million, in which $8.9 million was recorded as an imputed lease arrangement and the remaining $7.4 million was recorded as an investment in financing receivables. Unconsolidated Joint Ventures The following table details the joint venture acquisitions for the year ended December 31, 2021: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE CASH 2 REAL OTHER 3 SQUARE FOOTAGE Denver, CO MOB 3/30/21 $ 14,375 $ 14,056 $ 14,550 $ (494) 59,359 Colorado Springs, CO MOB 4/1/21 7,200 7,288 7,347 (59) 27,510 Los Angeles, CA MOB 4/8/21 31,335 30,179 30,642 (463) 57,573 San Antonio, TX MOB 4/30/21 13,600 13,412 13,656 (244) 45,000 Los Angeles, CA MOB 5/10/21 24,600 24,259 24,147 112 73,078 Colorado Springs, CO 4 MOB 7/27/21 9,133 9,137 9,135 2 23,956 Denver, CO MOB 10/21/21 23,000 22,638 23,021 (383) 57,257 San Antonio, TX 5 MOB 12/10/21 42,300 41,892 42,190 (298) 117,597 San Antonio, TX MOB 12/29/21 6,094 6,218 6,308 (90) 22,381 San Antonio, TX MOB 12/29/21 8,850 8,915 8,866 49 30,542 $ 180,487 $ 177,994 $ 179,862 $ (1,868) 514,253 1 MOB = medical office building. 2 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Includes purchase of an adjoining 3.0 acre land parcel. 5 Includes three properties. 2022 Real Estate Asset Dispositions The following table details the Company's dispositions for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE DISPOSED SALES PRICE CLOSING ADJUSTMENTS NET PROCEEDS NET REAL ESTATE INVESTMENT OTHER 2 GAIN/ SQUARE FOOTAGE Loveland, CO 3, 4 MOB 2/24/22 $ 84,950 $ (45) $ 84,905 $ 40,095 $ 4 $ 44,806 150,291 San Antonio, TX 3 MOB 4/15/22 25,500 (2,272) 23,228 14,381 284 8,563 201,523 GA, FL, PA 5, 11 MOB 7/29/22 133,100 (8,109) 124,991 124,991 — — 316,739 GA, FL, TX 7, 11 MOB 8/4/22 160,917 (5,893) 155,024 151,819 3,205 — 343,545 Los Angeles, CA 5, 9, 11 MOB 8/5/22 134,845 (3,102) 131,743 131,332 411 — 283,780 Dallas, TX 7, 10, 11 MOB 8/30/22 114,290 (682) 113,608 113,608 — — 189,385 Indianapolis, IN 6, 12 MOB 8/31/22 238,845 (5,846) 232,999 84,767 4,324 143,908 506,406 Dallas, TX 3 MOB 10/4/22 104,025 (5,883) 98,142 38,872 6,436 52,834 291,328 Houston, TX MOB 10/21/22 32,000 (280) 31,720 10,762 744 20,214 134,910 College Station, TX MOB 11/10/22 49,177 (3,755) 45,422 44,918 475 28 122,942 El Paso, TX MOB 12/22/22 55,326 (4,002) 51,324 56,427 (1,897) (3,205) 110,465 Atlanta, GA 8 MOB 12/22/22 91,243 (4,326) 86,917 109,051 235 (22,369) 348,416 St. Louis, MO MOB 12/28/22 18,000 (1,471) 16,529 18,340 4 (1,815) 69,394 $ 1,242,218 $ (45,666) $ 1,196,552 $ 939,363 $ 14,225 $ 242,964 3,069,124 1 MOB = medical office building 2 Includes straight-line rent receivables, leasing commissions and lease inducements. 3 Includes two properties. 4 The Company deferred the tax gain through a 1031 exchange and reinvested the proceeds. 5 Includes four properties. 6 Includes five properties. 7 Includes six properties. 8 Includes nine properties. 9 Values and square feet are represented at 100%. The Company retained a 20% ownership interest in the joint venture with an unrelated third party that purchased these properties. 10 Values and square feet are represented at 100%. The Company retained a 40% ownership interest in the joint venture with an unrelated third party that purchased these properties. 11 These properties were acquired as part of the Merger and were included as assets held for sale in the purchase price allocation. 12 Two of the five properties included in this portfolio were acquired in the Merger and were included as assets held for sale in the purchase price allocation. Subsequent Dispositions On January 13, 2023, the Company disposed of two medical office buildings, one in Tampa, Florida and one in Miami, Florida, with a combined total of 224,037 square feet for an aggregate purchase price of $93.3 million. On January 30, 2023, the Company disposed of a 36,691 square foot medical office building in Dallas, Texas, for a purchase price of $19.2 million. The Company retained a 40% ownership interest in the joint venture that purchased this property. On February 10, 2023, the Company disposed of a 6,500 square foot medical office building in St. Louis, Missouri for a purchase price of $0.4 million. 2021 Real Estate Asset Dispositions The following table details the Company's dispositions for the year ended December 31, 2021: Dollars in thousands TYPE 1 DATE DISPOSED SALES PRICE CLOSING ADJUSTMENTS NET PROCEEDS NET REAL ESTATE INVESTMENT OTHER 2 GAIN/ SQUARE FOOTAGE Los Angeles, CA 3 MOB 3/11/21 $ 26,000 $ (555) $ 25,445 $ 6,046 $ 509 $ 18,890 73,906 Atlanta, GA MOB 4/12/21 8,050 (272) 7,778 5,675 151 1,952 19,732 Richmond, VA MOB 5/18/21 52,000 (314) 51,686 29,414 3,270 19,002 142,856 Gadsden, AL 4 MOB 5/19/21 5,500 (280) 5,220 5,914 175 (869) 120,192 Dallas, TX 5 MOB 7/9/21 23,000 (1,117) 21,883 18,733 1,966 1,184 190,160 Chicago, IL MOB 10/28/21 13,300 (388) 12,912 23,213 706 (11,007) 95,436 Des Moines, IA 6 MOB 12/8/21 47,000 (901) 46,099 32,312 1,037 12,750 132,617 Aberdeen, SD MOB 12/22/21 12,750 (299) 12,451 10,337 — 2,114 58,285 Dallas, TX MOB 12/23/21 800 (103) 697 712 167 (182) 13,818 $ 188,400 $ (4,229) $ 184,171 $ 132,356 $ 7,981 $ 43,834 847,002 1 MOB = medical office building 2 Includes straight-line rent receivables, leasing commissions and lease inducements. 3 Includes two properties sold to a single purchaser in two transactions which closed on March 5 and March 11, 2021. 4 Includes three properties. 5 Includes four properties and a land parcel sold under a single purchase agreement.

Held for Sale

Held for Sale	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Held for Sale	Held for Sale Assets and liabilities of properties sold or classified as held for sale are separately identified on the Company’s Consolidated Balance Sheets. As of December 31, 2022 the Company had one property classified as held for sale, and as of December 31, 2021 the Company had no real estate properties classified as held for sale. The table below reflects the assets and liabilities classified as held for sale as of December 31, 2022 and 2021. DECEMBER 31, Dollars in thousands 2022 2021 Balance Sheet data Land $ 1,700 $ — Buildings and improvements 15,164 — Lease intangibles 1,986 — 18,850 — Accumulated depreciation — — Real estate assets held for sale, net 18,850 — Other assets, net 43 57 Assets held for sale, net $ 18,893 $ 57 Accounts payable and accrued liabilities $ 282 $ 169 Other liabilities 155 125 Liabilities of properties held for sale $ 437 $ 294

Impairment Charges

Impairment Charges	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Impairment Charges	Impairment Charges An asset is impaired when undiscounted cash flows expected to be generated by the asset are less than the carrying value of the asset. The Company must assess the potential for impairment of its long-lived assets, including real estate properties, whenever events occur or there is a change in circumstances, such as the sale of a property or the decision to sell a property, that indicate that the recorded value might not be fully recoverable. The Company recorded impairment charges on 12 properties sold and three additional properties associated with completed or planned disposition activity for the year ended December 31, 2022 totaling $54.4 million. The Company

Other Assets and Liabilities

Other Assets and Liabilities	12 Months Ended
	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets and Liabilities	Other Assets and Liabilities Other Assets Other assets consist primarily of intangible assets, prepaid assets, real estate notes receivable, straight-line rent receivables, accounts receivable, additional long-lived assets and interest rate swaps. Items included in "Other assets, net" on the Company’s Consolidated Balance Sheets as of December 31, 2022 and 2021 are detailed in the table below: Dollars in thousands December 31, 2022 December 31, 2021 Real estate notes receivable, net $ 99,643 $ — Straight-line rent receivables 88,868 70,784 Prepaid assets 81,900 58,618 Above-market intangible assets, net 80,720 4,966 Accounts receivable, net 1 47,498 14,072 Additional long-lived assets, net 21,446 20,048 Interest rate swap assets 14,512 — Other receivables, net 7,169 — Investment in securities (2) 6,011 — Debt issuance costs, net 5,977 1,813 Project costs 4,337 5,129 Net investment in lease 1,828 — Customer relationship intangible assets, net 1,120 1,174 Other 8,961 9,069 $ 469,990 $ 185,673 1 This amount is net of allowance for doubtful accounts of $4.0 million 2 This amount represents the value of the Company's preferred stock investment in a data analytics platform. Accounts Payable and Accrued Liabilities The following table provides details of the items included in "Accounts payable and accrued liabilities" on the Company's Consolidated Balance Sheets as of December 31, 2022 and 2021: Dollars in thousands December 31, 2022 December 31, 2021 Accrued property taxes $ 78,185 $ 35,295 Accounts payable and capital expenditures 57,352 17,036 Accrued interest 50,037 12,060 Other operating accruals 58,459 21,717 $ 244,033 $ 86,108 Other Liabilities The following table provides details of the items included in "Other liabilities" on the Company's Consolidated Balance Sheets as of December 31, 2022 and 2021: Dollars in thousands December 31, 2022 December 31, 2021 Below-market intangible liabilities, net $ 97,935 $ 4,931 Deferred revenue 87,325 45,130 Security deposits 28,521 11,116 Interest rate swap liability 4,269 5,917 Other 618 293 $ 218,668 $ 67,387

Intangible Assets and Liabiliti

Intangible Assets and Liabilities	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Liabilities	Intangible Assets and Liabilities The Company has several types of intangible assets and liabilities included in its Consolidated Balance Sheets, including goodwill, debt issuance costs, above-, below-, and at-market lease intangibles, and customer relationship intangibles. For additional detail on the Company's debt issuance costs, see Note 10 to the Consolidated Financial Statements. The Company’s intangible assets and liabilities, including assets held for sale and excluding certain debt issuance costs, as of December 31, 2022 and 2021 consisted of the following: GROSS BALANCE ACCUMULATED AMORTIZATION WEIGHTED AVG. BALANCE SHEET CLASSIFICATION Dollars in millions 2022 2021 2022 2021 Goodwill $ 223.2 $ 3.5 $ — $ — N/A Goodwill Credit facility debt issuance costs 6.9 5.1 0.9 3.3 2.9 Other assets, net Above-market lease intangibles (lessor) 91.5 7.0 10.7 2.0 5.3 Other assets, net Customer relationship intangibles (lessor) 2.1 2.1 1.0 0.9 20.6 Other assets, net Below-market lease intangibles (lessor) (112.5) (10.1) (14.6) (5.1) 5.7 Other liabilities At-market lease intangibles 1,067.4 213.0 188.3 77.5 5.2 Real estate properties $ 1,278.6 $ 220.6 $ 186.3 $ 78.6 5.3 For the years ended December 31, 2022 and 2021, the Company recognized approximately $133.6 million and $33.7 million of intangible amortization, respectively. The following table represents expected amortization over the next five years of the Company’s intangible assets and liabilities in place as of December 31, 2022: Dollars in millions FUTURE AMORTIZATION OF INTANGIBLES, NET 2023 $ 233.8 2024 197.9 2025 151.1 2026 97.6 2027 64.3

Notes and Bonds Payable

Notes and Bonds Payable	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Notes and Bonds Payable	Notes and Bonds Payable DECEMBER 31, MATURITY DATES CONTRACTUAL INTEREST RATES EFFECTIVE INTEREST RATES PRINCIPAL PAYMENTS INTEREST PAYMENTS Dollars in thousands 2022 2021 $700M Unsecured Credit Facility $ — $ 210,000 5/23 LIBOR + 0.90% N/A At maturity Monthly $1.5B Unsecured Credit Facility 385,000 — 10/25 SOFR + 0.95% 5.27 % At maturity Monthly $350M Unsecured Term Loan 1 349,114 — 7/23 SOFR + 1.05% 5.17 % At maturity Monthly $200M Unsecured Term Loan 1 199,670 199,460 5/24 SOFR + 1.05% 5.17 % At maturity Monthly $150M Unsecured Term Loan 1 149,495 149,376 6/26 SOFR + 1.05% 5.17 % At maturity Monthly $300M Unsecured Term Loan 1 299,936 — 10/25 SOFR + 1.05% 5.17 % At maturity Monthly $200M Unsecured Term Loan 1 199,362 — 7/27 SOFR + 1.05% 5.17 % At maturity Monthly $300M Unsecured Term Loan 1 297,869 — 1/28 SOFR + 1.05% 5.17 % At maturity Monthly Senior Notes due 2025 1 249,115 249,040 5/25 3.88 % 4.12 % At maturity Semi-annual Senior Notes due 2026 1 571,587 — 8/26 3.50 % 4.94 % At maturity Semi-annual Senior Notes due 2027 1 479,553 — 7/27 3.75 % 4.76 % At maturity Semi-annual Senior Notes due 2028 1 296,852 296,612 1/28 3.63 % 3.85 % At maturity Semi-annual Senior Notes due 2030 1 565,402 — 2/30 3.10 % 5.30 % At maturity Semi-annual Senior Notes due 2030 1 296,385 296,813 3/30 2.40 % 2.72 % At maturity Semi-annual Senior Notes due 2031 1 295,547 295,374 3/31 2.05 % 2.25 % At maturity Semi-annual Senior Notes due 2031 1 632,693 — 3/31 2.00 % 5.13 % At maturity Semi-annual Mortgage notes payable 2 84,247 104,650 8/23-12/26 3.31%-4.77% 3.42%-4.84% Monthly Monthly $ 5,351,827 $ 1,801,325 1 Balances are shown net of discounts and unamortized issuance costs. 2 Balances are shown net of discounts and unamortized issuance costs and include premiums. The Company’s various debt agreements contain certain representations, warranties, and financial and other covenants customary in such loan agreements. Among other things, these provisions require the Company to maintain certain financial ratios and impose certain limits on the Company’s ability to incur indebtedness and create liens or encumbrances. As of December 31, 2022, the Company was in compliance with its financial covenant provisions under its various debt instruments. Exchange Offer In connection with the Merger, the OP offered to exchange all validly tendered and accepted notes of each series previously issued by Legacy HR (the “Old HR Notes”) for (i) up to $250,000,000 of 3.875% Senior Notes due 2025 (the “2025 Notes”), (ii) up to $300,000,000 of 3.625% Senior Notes due 2028 (the “2028 Notes”), (iii) up to $300,000,000 of 2.400% Senior Notes due 2030 (the “2030 Notes”) and (iv) up to $300,000,000 of 2.050% Senior Notes due 2031 to be issued by the OP (the “2031 Notes” and, collectively, the “New HR Notes”) and solicited consents from holders of the Old HR Notes to amend the indenture governing the Old HR Notes to eliminate substantially all of the restrictive covenants in such indenture (the “Exchange Offers”). Legacy HTA guaranteed the New HR Notes pursuant to (i) a guarantee of the 2025 Notes, (ii) a guarantee of the 2028 Notes, (iii) a guarantee of the 2030 Notes, and (iv) a guarantee of the 2031 Notes, each dated July 22, 2022. Legacy HTA and the OP filed a registration statement on Form S-4 (File No. 333-265593) relating to the issuance of the New HR Notes with the Securities and Exchange Commission (the “SEC”) on June 14, 2022, which was declared effective by the SEC on June 28, 2022. The following sets forth the results of the Exchange Offers: Series of Old HR Notes Tenders and Consents Received as of the Expiration Date Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes 3.875 % Senior Notes due 2025 $235,016,000 94.01 % 3.625 % Senior Notes due 2028 $290,246,000 96.75 % 2.400 % Senior Notes due 2030 $297,507,000 99.17 % 2.050 % Senior Notes due 2031 $298,858,000 99.62 % Senior Notes Assumed with the Merger In connection with the Merger, the Company assumed senior notes ("Legacy Senior Notes") that were originated on various dates prior to the date of the Merger by the OP (formerly, Healthcare Trust of America Holdings, LP). These notes are all fully and unconditionally guaranteed by the Company and have semi-annual payment requirements. In addition, the Legacy Senior Notes carry customary restrictive financial covenants, including limitations on our ability to incur additional indebtedness and requirements to maintain a pool of unencumbered assets. In addition, the corresponding indentures provide for the ability to redeem the Legacy Senior Notes, subject to certain "make whole" call provisions. The Legacy Senior Notes assumed by the Company consist of the following: COUPON PRINCIPAL OUTSTANDING AS OF Dollars in thousands FACE VALUE 12/31/2022 12/31/2021 Senior Notes due 2026 3.50% $ 600,000 $ 600,000 $ — Senior Notes due 2027 3.75% 500,000 500,000 — Senior Notes due 2030 3.10% 650,000 650,000 — Senior Notes due 2031 2.00% 800,000 800,000 — $ 2,550,000 $ 2,550,000 $ — The following table reconciles the Company’s aggregate Senior notes principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2022 and 2021 DECEMBER 31, Dollars in thousands 2022 2021 Senior notes principal balance $ 3,699,500 $ 1,150,000 Unaccreted discount (304,919) (4,730) Debt issuance costs (7,447) (7,431) Senior notes carrying amount $ 3,387,134 $ 1,137,839 Credit Facilities The Unsecured Credit Facility restructured the parties’ existing bank facilities and added additional borrowing capacities for the Company following the Merger. The OP is the borrower under the Unsecured Credit Facility (in such capacity, the “Borrower”). • Legacy HR’s existing $700.0 million revolving credit facility under the Amended and Restated Credit Agreement, dated as of May 31, 2019 (as amended, restated, replaced, supplemented, or otherwise modified from time to time prior to July 20, 2022, the “Existing HR Revolving Credit Agreement”), by and among Legacy HR, the lenders party thereto from time to time and their assignees, as lenders, and Wells Fargo Bank, National Association, as the administrative agent (the “WF Administrative Agent”), was terminated, all outstanding obligations in respect thereof were deemed paid in full and all commitments thereunder were permanently reduced to zero and terminated. • Legacy HR’s existing $200.0 million term loan facility and existing $150.0 million term loan facility under the Amended and Restated Term Loan Agreement, dated as of May 31, 2019 (as amended, restated, replaced, supplemented, or otherwise modified from time to time prior to July 20, 2022, the “Existing HR Term Loan Agreement”), by and among Legacy HR, the lenders party thereto from time to time and their assignees, as lenders, and the WF Administrative Agent, in each, case, were deemed continued and assumed by the Borrower under the Credit Facility, and the Existing HR Term Loan Agreement was terminated. ◦ The existing $200.0 million term loan facility was amended to: (a) conform to the terms of the Borrower’s other term loan facilities under the Credit Facility; (b) include two one-year extension options, resulting in a latest final maturity in May 2026; and (c) reprice to align with the pricing for the Borrower’s other term loan facilities under the Credit Facility; and ◦ The existing $150.0 million term loan facility was amended to conform to the terms of the Borrower’s other term loan facilities under the Credit Facility, and the existing maturity in June 2026 remains unchanged under the Credit Facility. • Legacy HTA’s and the OP’s existing $1.0 billion revolving credit facility was upsized to $1.5 billion (the “Revolver”) pursuant to the Credit Facility. The Revolver currently matures in October 2025, and the Credit Facility adds an additional one-year extension option for the Revolver, for a total of two one-year extension options. • Legacy HTA’s and the OP’s existing $300.0 million term loan facility was deemed continued pursuant to the Credit Facility and was amended to conform to the terms of the Borrower’s other term loan facilities under the Credit Facility. The existing maturity in October 2025 remains unchanged under the Credit Facility. • Legacy HTA’s and the OP’s existing $200.0 million term loan facility was deemed continued pursuant to the Credit Facility and was amended to (a) conform to the terms of the Borrower’s other term loan facilities under the Credit Facility; (b) extend the maturity from January 2024 to July 20, 2027; and (c) reprice to align with the pricing for the Borrower’s other term loan facilities under the Credit Facility. • The Credit Facility provides for a new $350.0 million delayed-draw term loan facility that is available to be drawn for 12 months after July 20, 2022 and has an initial maturity date of July 20, 2023, with two one-year extension options. As of December 31, 2022, the $350.0 million Credit Facility was drawn in full. The terms of any delayed draw term loans funded thereunder conform to the terms of the Borrower’s other term loan facilities under the Credit Facility, and the pricing for such delayed draw term loans aligns with the pricing for the Borrower’s other term loan facilities under the Credit Facility. • The Credit Facility provides for a new $300.0 million term loan facility that was funded on July 20, 2022 and has a maturity date of January 20, 2028, with no extension options. The terms of such term loan facility conform to the terms of the Borrower’s other term loan facilities under the Credit Facility, and the pricing for such term loan facility aligns with the pricing for the Borrower’s other term loan facilities under the Credit Facility. The following table reconciles the Company’s aggregate term loan principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2022 and 2021. DECEMBER 31, Dollars in thousands 2022 2021 Term loan principal balances $ 1,500,000 $ 350,000 Debt issuance costs (4,554) (1,164) Term Loans carrying amount $ 1,495,446 $ 348,836 $1.125 billion Asset Sale Term Loan The Company completed its draw of the $1.125 billion asset sale term loan on July 19, 2022. The principal balance was fully repaid on December 30, 2022. Mortgage Notes Payable The following table reconciles the Company’s aggregate mortgage notes principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2022 and 2021. DECEMBER 31, Dollars in thousands 2022 2021 Mortgage notes payable principal balance $ 84,122 $ 103,664 Unamortized premium 486 1,720 Unaccreted discount (38) (83) Debt issuance costs (323) (651) Mortgage notes payable carrying amount $ 84,247 $ 104,650 Mortgage Activity On February 18, 2022, the Company repaid in full a mortgage note payable bearing interest at a rate of 4.70% that encumbered a 56,762 square foot property in California. The aggregate payoff price of $12.6 million consisted of outstanding principal of $11.0 million and a "make-whole" amount of approximately $1.6 million. The unamortized premium of $0.8 million and the unamortized cost on this note of $0.1 million were written off upon payoff. On February 24, 2022, the Company repaid in full a mortgage note payable bearing interest at a rate of 6.17% that encumbered a 80,153 square foot property in Colorado, in conjunction with the disposition of the property. The aggregate payoff price of $6.4 million consisted of outstanding principal of $5.8 million and a "make-whole" amount of approximately $0.6 million. The unamortized premium of $0.1 million was written off upon payoff. The following table details the Company’s mortgage notes payable, with related collateral. ORIGINAL BALANCE EFFECTIVE INTEREST RATE 10 MATURITY COLLATERAL 11 PRINCIPAL AND INTEREST PAYMENTS 9 INVESTMENT IN COLLATERAL BALANCE Dollars in millions 2022 2022 2021 Commercial Bank 1 15.0 5.25 % 4/27 MOB Monthly/20-yr amort. — — 6.1 Life Insurance Co. 2 11.0 3.64 % 5/27 MOB Monthly/10-yr amort. — — 11.6 Life Insurance Co. 3 12.3 3.86 % 8/23 MOB Monthly/7-yr amort. 25.9 10.0 10.3 Life Insurance Co. 4 9.0 4.84 % 12/23 MOB,OFC Monthly/10-yr amort. 24.5 6.8 7.1 Life Insurance Co. 5 13.3 4.13 % 1/24 MOB Monthly/10-yr amort. 22.5 11.7 12.0 Life Insurance Co. 6 6.8 3.96 % 2/24 MOB Monthly/7-yr amort. 14.7 5.8 6.0 Financial Services 7 9.7 4.32 % 9/24 MOB Monthly/10-yr amort. 16.6 7.5 7.8 Life Insurance Co. 8 16.5 3.43 % 12/25 MOB,OFC Monthly/7-yr amort. 39.1 16.2 16.7 Financial Services 11.5 3.71 % 1/26 MOB Monthly/10-yr amort. 40.5 8.3 8.7 Life Insurance Co. 19.2 4.08 % 12/26 MOB Monthly/10-yr amort. 44.5 17.9 18.4 $ 228.3 $ 84.2 $ 104.7 1 The Company repaid this loan at the time of disposal in February 2022. 2 The Company repaid this loan in February 2022. The Company's unencumbered gross investment was $20.6 million at December 31, 2022. 3 The unaccreted portion of the $0.2 million discount recorded on this note upon acquisition is included in the balance above. 4 The unamortized portion of the $0.1 million premium recorded on this note upon acquisition is included in the balance above. 5 The unamortized portion of the $0.8 million premium recorded on this note upon acquisition is included in the balance above. 6 The unamortized portion of the $0.2 million premium recorded on this note upon acquisition is included in the balance above. 7 The unamortized portion of the $0.1 million premium recorded on this note upon acquisition is included in the balance above. 8 The unamortized portion of the $0.7 million premium recorded on this note upon acquisition is included in the balance above. 9 Payable in monthly installments of principal and interest with the final payment due at maturity (unless otherwise noted). 10 The contractual interest rates for the eight outstanding mortgage notes ranged from 3.3% to 4.8% as of December 31, 2022. 11 MOB-Medical office building; OFC-Office Other Long-Term Debt Information Future maturities of the Company’s notes and bonds payable as of December 31, 2022 were as follows: Dollars in thousands PRINCIPAL MATURITIES NET ACCRETION/ AMORTIZATION 1 DEBT ISSUANCE COSTS 2 NOTES AND % 2023 $ 368,880 $ (38,805) $ (3,258) $ 326,817 6.1 % 2024 225,352 (40,922) (2,211) 182,219 3.4 % 2025 951,250 (43,193) (1,851) 906,206 16.9 % 2026 773,640 (41,798) (1,636) 730,206 13.6 % 2027 700,000 (36,192) (1,518) 662,290 12.4 % 2028 and thereafter 2,649,500 (103,561) (1,850) 2,544,089 47.6 % $ 5,668,622 $ (304,471) $ (12,324) $ 5,351,827 100.0 % 1 Includes discount accretion and premium amortization related to the Company’s Senior Notes and six mortgage notes payable. 2 Excludes approximately $6.0 million in debt issuance costs related to the Company's Unsecured Credit Facility included in other assets, net.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During 2022, 2021 and 2020, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income (loss) and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income (loss) related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. During 2020, the Company entered into two treasury rate locks totaling $75.0 million and $40.0 million, respectively. The treasury rate locks were settled for an aggregate amount of $4.3 million concurrent with the Company's issuance of its Senior Notes due 2030. The settlement will be amortized over the 10-year term of the notes. As of December 31, 2022, the Company had interest rate derivatives that were designated as cash flow hedges of interest rate risk. The table below presents the notional value and weighted average rates of the Company's derivative financial instruments as of December 31, 2022 and 2021: NOTIONAL VALUE AS OF WEIGHTED AVERAGE RATE EXPIRATION DATE DECEMBER 31, 2022 January 31, 2023 $ 300,000 1.42 % January 15, 2024 200,000 1.21 % May 1, 2026 100,000 2.15 % December 1, 2026 150,000 3.84 % June 1, 2027 150,000 4.13 % December 1, 2027 250,000 3.79 % $ 1,150,000 2.63 % On February 16, 2023, the Company entered into a swap transaction with a notional amount of $50.0 million and a fixed rate of 4.16%. The swap agreement has an effective date of March 1, 2023 and a termination date of June 1, 2026. Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the Consolidated Balance Sheets as of December 31, 2022 and 2021. AS OF DECEMBER 31, 2022 AS OF DECEMBER 31, 2021 Dollars in thousands BALANCE SHEET LOCATION FAIR BALANCE SHEET LOCATION FAIR Derivatives designated as hedging instruments Interest rate swaps 2017 Other liabilities $ (420) Interest rate swaps 2018 Other liabilities (976) Interest rate swaps 2019 Other Assets $ 13,603 Other liabilities (4,521) Interest rate swaps 2022 Other Assets 909 — Interest rate swaps 2022 Other Liabilities (4,269) — Total derivatives designated as hedging instruments $ 10,243 $ (5,917) Tabular Disclosure of the Effect of Fair Value and Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) The table below presents the effect of cash flow hedge accounting on Accumulated other comprehensive income (loss) as of December 31, 2022 related to the Company's outstanding interest rate swaps. AMOUNT OF GAIN/(LOSS) RECOGNIZED IN OCI AMOUNT OF (GAIN)/LOSS RECLASSIFIED Dollars in thousands 2022 2022 2021 Interest rate swaps 2017 $ 302 Interest expense $ 118 $ 527 Interest rate swaps 2018 616 Interest expense 361 1,194 Interest rate swaps 2019 12,964 Interest expense 563 2,157 Interest rate swaps 2022 (3,252) Interest expense (109) — Settled treasury hedges — Interest expense 426 426 Settled interest rate swaps — Interest expense 168 168 $ 10,630 Total interest expense $ 1,527 $ 4,472 The Company estimates that an additional $10.3 million will be reclassified from accumulated other comprehensive loss as a net decrease to interest expense over the next 12 months. Tabular Disclosure Offsetting Derivatives The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company's derivatives as of December 31, 2022. The net amounts of derivative liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative liabilities are presented on the Company's Consolidated Balance Sheets. Offsetting of Derivative Assets GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF ASSETS GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ 14,512 $ — $ 14,512 $ (4,269) $ — $ 10,243 Offsetting of Derivative Liabilities GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF LIABILITIES GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ (4,269) $ — $ (4,269) $ 4,269 $ — $ — Credit-risk-related Contingent Features The Company has agreements with each of its derivative counterparties that contain a provision where the Company could be declared in default on its derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to the Company's default on the indebtedness. The Company has agreements with each of its derivative counterparties that contain a provision where if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligations. As of December 31, 2022, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was $2.1 million. As of December 31, 2022, the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value of $2.1 million.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock The Company had no preferred shares outstanding and had common shares outstanding for the three years ended December 31, 2022, 2021, and 2020 as follows: YEAR ENDED DECEMBER 31, 2022 2021 2020 Balance, beginning of year 150,457,433 139,487,375 134,706,154 Issuance of common stock 229,618,304 10,899,301 4,637,445 Non-vested share-based awards, net of withheld shares and forfeitures 514,157 70,757 143,776 Balance, end of year 380,589,894 150,457,433 139,487,375 At-The-Market Equity Offering Program The Company has in place an ATM equity offering program to sell shares of the Company’s common stock from time to time in at-the-market sales transactions. The Company has equity distribution agreements with various sales agents with respect to the ATM offering program of common stock with an aggregate sales amount of up to $750.0 million. As of December 31, 2022, $750.0 million remained available for issuance under the current ATM offering program. The Company's previous ATM agreements involving Legacy HR are no longer in effect following the Merger on July 20, 2022. The following table details the Company's at-the-market activity, including any forward transactions: WEIGHTED AVERAGE SALE PRICE SHARES PRICED SHARES SETTLED SHARES REMAINING TO BE SETTLED NET PROCEEDS 2021 $ 31.09 9,763,680 10,859,539 727,400 $ 330.3 2022 $ 31.73 — 727,400 — $ 22.3 Dividends Declared During 2022, the Company declared and paid common stock dividends aggregating $1.24 per share ($0.31 per share per quarter). On February 24, 2023, the Company declared a quarterly common stock dividend in the amount of $0.31 per share payable on March 21, 2023 to stockholders of record on March 7, 2023. Authorization to Repurchase Common Stock On August 2, 2022, the Company’s Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company’s common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints, and other customary conditions. The Company is not obligated under this authorization to repurchase any specific number of shares. This authorization supersedes all previous stock repurchase authorizations. As of the date of these Consolidated Financial Statements, the Company has not repurchased any shares of its common stock under this authorization. Accumulated Other Comprehensive Income During the year ended December 31, 2020, the Company entered into two treasury rate locks that were settled for an aggregate amount of $4.3 million concurrent with the Company’s issuance of its Senior Notes due 2030. This amount will be reclassified out of accumulated other comprehensive over the 10-year term of the notes. The Company continues to amortize the 2015 settlement of forward-starting interest rate swaps. This amount will be reclassified out of accumulated other comprehensive income impacting net income over the 10-year term of the associated senior note issuance. See Note 11 for more information regarding the Company's derivative instruments. The following table represents the changes in accumulated other comprehensive income (loss) during the years ended December 31, 2022 and 2021: INTEREST RATE SWAPS Dollars in thousands 2022 2021 Beginning balance $ (9,981) $ (17,832) Other comprehensive loss before reclassifications 1,531 4,472 Amounts reclassified from accumulated other comprehensive income 10,590 3,379 Net current-period other comprehensive income 12,121 7,851 Ending balance $ 2,140 $ (9,981) The following table represents the details regarding the reclassifications from accumulated other comprehensive income (loss) during the year ended December 31, 2022 (dollars in thousands): DETAILS ABOUT ACCUMULATED OTHER COMPREHENSIVE AMOUNT RECLASSIFIED AFFECTED LINE ITEM Amounts reclassified from accumulated other comprehensive income (loss) related to settled interest rate swaps $ 594 Interest Expense Amounts reclassified from accumulated other comprehensive income (loss) related to current interest rate swaps 937 Interest Expense $ 1,531

Stock and Other Incentive Plans

Stock and Other Incentive Plans	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock and Other Incentive Plans	Stock and Other Incentive Plans Stock Incentive Plan The Legacy HR stockholders approved the Legacy HR Incentive Plan, which authorized the Company to issue 3,500,000 shares of common stock to its employees and directors. The Legacy HR Incentive Plan was replaced as of the merger date by the Incentive Plan. As of December 31, 2022 and 2021, the Company had issued a total of 3,417,696 and 2,386,822 restricted shares under the Incentive Plan and the Legacy HR Incentive Plan, respectively. Unvested awards under the Legacy HR Incentive Plan were assumed according to their existing terms by the Company in connection with the Merger. Non-vested shares issued under the Legacy HR Incentive Plan are generally subject to fixed vesting periods varying from three $13.9 million , $10.4 million and $9.7 million, respectively. The following table represents expected amortization of the Company's non-vested shares issued as of December 31, 2022: Dollars in millions FUTURE AMORTIZATION 2023 $ 12.0 2024 10.0 2025 8.3 2026 5.5 2027 0.4 2028 and thereafter 0.1 Total $ 36.3 Executive Incentive Plan The Compensation Committee has adopted an executive incentive plan pursuant to the Incentive Plan (the "Executive Incentive Plan") to provide specific award criteria with respect to incentive awards made under the Incentive Plan subject to the discretion of the Compensation Committee. Under the terms of the Executive Incentive Plan, the Company's named executive officers, and certain other members of senior management, may earn incentive awards in the form of cash, non-vested stock, restricted stock units ("RSUs"), and units in the OP ("OP Units"). For 2022, 2021 and 2020, compensation expense, included in general and administrative expense, resulting from the amortization of the Executive Incentive Plan non-vested share and RSU grants to officers was approximately $9.8 million , $6.6 million, and $5.9 million, respectively. Details of equity awards that have been issued under this plan are as follows: • On January 3, 2022, the Company granted non-vested stock awards to its named executive officers, and certain other members of senior management and employees, with a grant date fair value of $7.9 million, which consisted of an aggregate of 249,689 non-vested shares with a five-year vesting period, which will result in an annual compensation expense of $1.6 million for each of 2023, 2024, 2025 and 2026. • On January 3, 2022, the Company granted RSUs to its named executive officers, and certain other members of senior management and officers, with a grant date fair value of $9.7 million, which consisted of an aggregate 294,932 RSUs with a three-year performance period and a total five-year vesting period, which will result in an annual compensation expense of $1.9 million for each of 2023, 2024, 2025, and 2026. • On February 22, 2022, the Company granted a performance-based award to its named executive officers, senior vice presidents, and first vice presidents with a grant date fair value of $3.9 million, which consisted of an aggregate of 126,930 non-vested shares with a five-year vesting period, which will result in an annual compensation expense of $0.8 million for 2023, 2024, 2025 and 2026, and $0.1 million for 2027. • On December 12, 2022, the Company granted non-vested stock awards to its named executive officers in view of efforts with respect to the merger transaction and integration of the two companies, with a grant date fair value of $2.7 million, which consisted of an aggregate of 140,809 non-vested shares with a three-year vesting period, which will result in an compensation expense of $0.9 million for 2023, 2024 and 2025. • On January 4, 2023, the Company granted non-vested stock awards to its named executive officers, senior vice presidents, and first vice presidents with a grant date fair value of $4.1 million, which consisted of an aggregate of 205,264 shares with a ratable five-year vesting period, which will result in an annual compensation expense of $0.8 million for 2023, 2024, 2025, 2026 and 2027. • On January 4, 2023, the Company granted 627,547 in OP units to named executive officers with a three-year performance period and ratable vestings of 50% in year four and 50% in year five. The expense will be recognized on the straight-line basis over the five-year vesting period. • On January 4, 2023, the Company granted RSUs to certain of its non-executive senior officers consisting of an aggregate of 165,174 RSUs with ratable vestings of 50% in year four and 50% in year five. The expense will be recognized on the straight-line basis over the five-year vesting period Approximately 43% of the RSUs vest based on two market performance conditions. Relative and absolute total shareholder return ("TSR") awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $30.56 for the absolute TSR component and $41.30 for the relative TSR component for the January 2022 grant using the following assumptions: Volatility 30.0 % Dividend Assumption Accrued Expected term in years 3 years Risk-free rate 1.02 % Stock price (per share) $31.68 The remaining 57% of the RSUs vest upon certain operating performance conditions. With respect to the operating performance conditions of the January grant, the grant date fair value was $31.68 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January 2022 RSUs was $33.04 per share. Long-Term Incentive Program In the first quarter of 2022, the Company granted a performance-based award to certain non-executive officers under the Long-term Incentive Program adopted under the Legacy HR Incentive Plan (the "LTIP") totaling approximately $0.6 million, which was granted in the form of 19,204 non-vested shares. In the first quarter of 2021, the Company granted a performance-based award to certain non-executive officers under the LTIP totaling approximately $0.6 million, which was granted in the form of 19,679 non-vested shares. The shares have vesting periods ranging from one For 2022, 2021 and 2020, compensation expense resulting from the amortization of non-vested share grants to officers was approximately $0.9 million , $1.0 million, and $1.1 million, respectively. Salary Deferral Plan The Company's salary deferral plan allows certain of its officers to elect to defer up to 50% of their base salary in the form of non-vested shares subject to long-term vesting. The number of shares will be increased through a Company match depending on the length of the vesting period selected by the officer. The officer's vesting period choices are: three years for a 30% match; five years for a 50% match; and eight years for a 100% match. During 2022, 2021 and 2020, the Company issued 17,381 shares, 21,396 shares and 17,570 shares, respectively, to its officers through the salary deferral plan. For 2022, 2021 and 2020, compensation expense resulting from the amortization of non-vested share grants to officers was approximately $0.9 million for each year , respectively. Non-employee Directors Incentive Plan The Company issues non-vested shares to its non-employee directors under the Incentive Plan. The directors’ shares have a one-year vesting period and are subject to forfeiture prior to such date upon termination of the director’s service, at no cost to the Company. For each of the years 2022, 2021 and 2020, compensation expense resulting from the amortization of non-vested share grants to directors was approximately $1.5 million , $1.2 million, and $1.0 million, respectively. • On May 13, 2022, the Company granted a non-vested stock award to eight of its directors, with a grant date fair value of $0.8 million, which consisted of an aggregate of 26,840 non-vested shares, with a one-year vesting period. • On August 2, 2022, the Company granted non-vested stock awards to twelve of its directors, with a grant date fair value of $1.8 million, which consisted of an aggregate of 70,816 non-vested shares, with a vesting period between one Other Grants The Company issued three one-time non-vested share grants related to executive management transition in 2016. For 2022, 2021 and 2020, compensation expense resulting from the amortization of these non-vested share grants to officers was approximately $0.8 million , $0.7 million, and $0.8 million, respectively. In 2022, the Company made discretionary awards of 5,806 shares of non-vested stock to three employees. A summary of the activity under the Incentive Plans and related information for the three years in the period ended December 31, 2022 follows: YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2022 2021 2020 Share-based awards, beginning of year 1,562,028 1,766,061 1,754,066 Granted 657,475 203,701 197,999 Vested (418,949) (404,777) (186,004) Forfeited (5,426) (2,957) — Share-based awards, end of year 1,795,128 1,562,028 1,766,061 Weighted-average grant date fair value of Share-based awards, beginning of year $ 31.10 $ 30.51 $ 29.82 Share-based awards granted during the year $ 28.11 $ 30.86 $ 30.33 Share-based awards vested during the year $ 31.52 $ 28.38 $ 23.82 Stock-based awards forfeited during the year $ 31.48 $ 33.04 $ — Share-based awards, end of year $ 29.91 $ 31.10 $ 30.51 Grant date fair value of shares granted during the year $ 18,480 $ 6,286 $ 6,006 The vesting periods for the non-vested shares granted during 2022 ranged from one eight years with a weighted-average amortization period remaining as of December 31, 2022 of approximately 4.3 years . During 2022, 2021 and 2020, the Company withheld 137,892 s hares, 129,987 shares and 54,223 shares, respectively, of common stock from its officers to pay estimated withholding taxes related to the vesting of shares. 401(k) Plan The Company maintains a 401(k) plan that allows eligible employees to defer salary, subject to certain limitations imposed by the Internal Revenue Code. The Company provides a matching contribution of up to 3% of each eligible employee’s salary, subject to certain limitations. The Company’s matching contributions were approximately $1.2 million for the year ended December 31, 2022, $0.7 million for 2021 and $0.6 million for 2020. Employee Stock Purchase Plan The outstanding options relate only to the Legacy HR Employee Stock Purchase Plan, which was terminated in November 2022. No new options will be issued under the Legacy HR Employee Stock Purchase Plan and existing options will expire in March 2024. During the years ended December 31, 2022, 2021 and 2020, the Company recognized in general and administrative expenses approximately $0.4 million, $0.4 million, and $0.3 million, respectively, of compensation expense related to the annual grant of options to its employees to purchase shares under the Legacy HR Employee Stock Purchase Plan. Cash received from employees upon exercising options under the Legacy HR Employee Stock Purchase Plan was approximately $0.4 million for the year ended December 31, 2022, $0.8 million for the year ended December 31, 2021, and $0.7 million for the year ended December 31, 2020. A summary of the Legacy HR Employee Stock Purchase Plan activity and related information for the three years in the period ended December 31, 2022 is as follows: YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2022 2021 2020 Options outstanding, beginning of year 348,514 341,647 332,659 Granted 255,960 253,200 212,716 Exercised (20,246) (30,281) (21,713) Forfeited (102,619) (71,630) (42,221) Expired (140,633) (144,422) (139,794) Options outstanding and exercisable, end of year 340,976 348,514 341,647 Weighted-average exercise price of Options outstanding, beginning of year $ 25.38 $ 24.70 $ 25.59 Options granted during the year $ 26.89 $ 25.16 $ 28.36 Options exercised during the year $ 20.97 $ 25.03 $ 24.10 Options forfeited during the year $ 21.88 $ 25.45 $ 25.29 Options expired during the year $ 23.36 $ 24.17 $ 23.74 Options outstanding, end of year $ 16.38 $ 25.38 $ 24.70 Weighted-average fair value of options granted during the year (calculated as of the grant date) $ 9.91 $ 9.05 $ 8.06 Intrinsic value of options exercised during the year $ 75 $ 165 $ 101 Intrinsic value of options outstanding and exercisable (calculated as of December 31) $ 985 $ 1,997 $ 1,673 Exercise prices of options outstanding (calculated as of December 31) $ 16.38 $ 25.91 $ 24.70 Weighted-average contractual life of outstanding options (calculated as of December 31, in years) 0.8 0.8 0.8 The fair values for these options were estimated at the date of grant using a Black-Scholes options pricing model with the weighted-average assumptions for the options granted during the period noted in the following table. The risk-free interest rate was based on the U.S. Treasury constant maturity-nominal two-year rate whose maturity is nearest to the date of the expiration of the latest option outstanding and exercisable; the expected dividend yield was based on the expected dividends of the current year as a percentage of the average stock price of the prior year; the expected life of each option was estimated using the historical exercise behavior of employees; expected volatility was based on historical volatility of the Company’s common stock; and expected forfeitures were based on historical forfeiture rates within the look-back period. 2022 2021 2020 Risk-free interest rates 0.73 % 0.13 % 1.58 % Expected dividend yields 3.97 % 4.11 % 3.69 % Expected life (in years) 1.44 1.43 1.43 Expected volatility 49.0 % 48.2 % 28.6 % Expected forfeiture rates 85 % 85 % 85 %

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. The Company used the treasury method to determine the dilution from the forward equity agreements during the period of time prior to settlement. The number of weighted-average shares outstanding used in the computation of earnings per common share for the year ended December 31, 2021 included the effect from the assumed issuance of 0.7 million shares of common stock pursuant to the settlement of the forward equity agreements at the contractual price, less the assumed repurchase of the common stock at the average market price using the proceeds of approximately $23.1 million, adjusted for costs to borrow. For the year ended December 31, 2021, 1,682 weighted-average incremental shares of common stock were excluded from the computation of weighted-average common shares outstanding - diluted, as the impact was anti-dilutive. As of and for the year ended December 31, 2022, these forward equity agreements settled and consequently, the Company did not have any remaining shares subject to unsettled forward sale agreements. The table below sets forth the computation of basic and diluted earnings per common share for the three years in the period ended December 31, 2022. YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2022 2021 2020 Weighted average common shares outstanding Weighted average common shares outstanding 254,296,810 144,411,835 135,666,503 Non-vested shares (1,940,607) (1,774,669) (1,736,358) Weighted average common shares outstanding - basic 252,356,203 142,637,166 133,930,145 Weighted average common shares outstanding - basic 252,356,203 142,637,166 133,930,145 Dilutive effect of forward equity shares — — 6,283 Dilutive effect of OP Units 1,451,599 — — Dilutive effect of employee stock purchase plan 65,519 73,062 70,512 Weighted average common shares outstanding - diluted 253,873,321 142,710,228 134,006,940 Net income attributable to common stockholders $ 40,897 $ 66,659 $ 72,195 Dividends paid on nonvested share-based awards (2,437) (2,154) (2,083) Net income applicable to common stockholders - basic $ 38,460 $ 64,505 $ 70,112 Net income attributable to OP Units 81 — — Net income applicable to common stockholders - diluted $ 38,541 $ 64,505 $ 70,112 Basic earnings per common share - net income $ 0.15 $ 0.45 $ 0.52 Diluted earnings per common share - net income $ 0.15 $ 0.45 $ 0.52

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Re/development Activity During the year ended December 31, 2022, the Company funded $60.8 million toward development and redevelopment of properties. Tenant Improvements The Company may provide a tenant improvement allowance in new or renewal leases for the purpose of refurbishing or renovating tenant space. As of December 31, 2022, the Company had commitments of approximately $195.1 million that are expected to be spent on tenant improvements throughout the portfolio, excluding development properties currently under construction. Land Held for Development Land held for development includes parcels of land owned by the Company, upon which the Company intends to develop and own outpatient healthcare facilities. The Company's land held for development included twenty parcels as of December 31, 2022 and seven parcels as of December 31, 2021. The Company’s investments in land held for development totaled approximately $74.3 million as of December 31, 2022 and $24.8 million as of December 31, 2021. The current land held for development is located adjacent to certain of the Company's existing medical office buildings in New York, Massachusetts, California, Connecticut, Florida, North Carolina, Texas, Tennessee, Georgia, Washington, and Colorado. Security Deposits and Letters of Credit As of December 31, 2022, the Company held approximately $32.1 million in letters of credit and security deposits for the benefit of the Company in the event the obligated tenant fails to perform under the terms of its respective lease. Generally, the Company may, at its discretion and upon notification to the tenant, draw upon these instruments if there are any defaults under the leases.

Other Data

Other Data	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Other Data	Other Data Taxable Income (unaudited) The Company has elected to be taxed as a REIT, as defined under the Internal Revenue Code. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement that it currently distribute at least 90% of its taxable income to its stockholders. As a REIT, the Company generally will not be subject to federal income tax on taxable income it distributes currently to its stockholders. Accordingly, no provision for federal income taxes has been made in the accompanying Consolidated Financial Statements. If the Company fails to qualify as a REIT for any taxable year, then it will be subject to federal income taxes at regular corporate rates, including any applicable alternative minimum tax, and may not be able to qualify as a REIT for four subsequent taxable years. Even if the Company qualifies as a REIT, it may be subject to certain state and local taxes on its income and property and to federal income and excise tax on its undistributed taxable income. Earnings and profits (as defined under the Internal Revenue Code), the current and accumulated amounts of which determine the taxability of distributions to stockholders, vary from net income attributable to common stockholders and taxable income because of different depreciation recovery periods, depreciation methods, and other items. While Legacy HR was considered the accounting acquirer in the Merger for GAAP purposes, Legacy HR’s separate tax existence ceased with the Merger and Legacy HTA continues as the tax successor. On a tax basis, the Company’s gross real estate assets totaled approximately $13.0 billion as of December 31, 2022. As of December 31, 2021 and 2020 gross real estate assets on a tax basis were $5.0 billion and $4.7 billion for Legacy HR and $8.2 billion and $7.9 billion for Legacy HTA, respectively. Characterization of Distributions (unaudited) Distributions in excess of earnings and profits generally constitute a return of capital. The following table gives the characterization of the distributions on the Company’s common stock for the three years ended December 31, 2022. For the three years ended December 31, 2022, there were no preferred shares outstanding. As such, no dividends were distributed related to preferred shares for those periods. YEAR ENDED DECEMBER 31, 2022 2021 2020 PER SHARE PER SHARE PER SHARE Tax Treatment of Dividends Pre-Merger Healthcare Trust of America Ordinary income 1 $ 0.5862 $ 0.7920 $ 0.6976 Return of capital 4.0162 0.4930 0.5582 Capital gain 1.2216 — 0.0092 Common stock distributions $ 5.8240 $ 1.2850 $ 1.2650 Tax Treatment of Dividends Pre-Merger Healthcare Realty Ordinary income 1 $ 0.2655 $ 0.7500 $ 0.7738 Return of capital 0.5555 0.3600 0.1084 Capital gain — 0.0964 0.3178 Common stock distributions $ 0.8210 $ 1.2064 $ 1.2000 Tax Treatment of Dividends Post-Merger Healthcare Realty Ordinary income 1 $ 0.0422 $ — $ — Return of capital 0.2889 — — Capital gain 0.0879 — — Common stock distributions $ 0.4190 $ — $ — 1 Reporting year ordinary income is also Code Section 199A eligible per the The Tax Cut and Jobs Act of 2017. State Income Taxes The Company must pay certain state income taxes, which are typically included in general and administrative expense on the Company’s Consolidated Statements of Income. The State of Texas gross margins tax on gross receipts from operations is disclosed in the table below as an income tax because it is considered such by the Securities and Exchange Commission. State income tax expense and state income tax payments for the three years ended December 31, 2022 are detailed in the table below: YEAR ENDED DECEMBER 31, Dollars in thousands 2022 2021 2020 State income tax expense Texas gross margins tax $ 1,693 $ 564 $ 546 Other 151 8 8 Total state income tax expense $ 1,844 $ 572 $ 554 State income tax payments, net of refunds and collections $ 1,834 $ 560 $ 557

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value. • Cash, cash equivalents and restricted cash - The carrying amount approximates fair value. • Borrowings under the Unsecured Credit Facility, Unsecured Term Loan due 2024 and Unsecured Term Loan due 2026 - The carrying amount approximates fair value because the borrowings are based on variable market interest rates. • Senior unsecured notes payable - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company’s current interest rates for similar types of borrowing arrangements. • Mortgage notes payable - The fair value is estimated using cash flow analyses, based on the Company’s current interest rates for similar types of borrowing arrangements. • Interest rate swap agreements - Interest rate swap agreements are recorded in other assets on the Company's Consolidated Balance Sheets at fair value. Fair value, using level 2 inputs, is estimated by utilizing pricing models that consider forward yield curves and discount rates. The table below details the fair value and carrying values for our other financial instruments as of December 31, 2022 and 2021. December 31, 2022 December 31, 2021 Dollars in millions CARRYING VALUE FAIR VALUE CARRYING VALUE FAIR VALUE Notes and bonds payable 1, 2 $ 5,351.8 $ 5,149.6 $ 1,801.3 $ 1,797.4 Real estate notes receivable 1 $ 99.6 $ 99.6 $ — $ — 1 Level 2 – model-derived valuations in which significant inputs and significant value drivers are observable in active markets. 2 Fair value for senior notes includes accrued interest as of December 31, 2022.

Related-Party Transactions

Related-Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related-Party Transactions	Related-Party TransactionsIn the ordinary course of conducting its business, the Company enters into agreements with affiliates in relation to the management and leasing of its real estate assets, including real estate assets owned through joint ventures.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Valuation and Qualifying Accounts	Schedule II – Valuation and Qualifying Accounts for the years ended December 31, 2022, 2021 and 2020 Dollars in thousands ADDITIONS AND DEDUCTIONS DESCRIPTION BALANCE CHARGED/(CREDITED) TO COSTS AND EXPENSES CHARGED UNCOLLECTIBLE ACCOUNTS WRITTEN-OFF BALANCE 2022 Accounts receivable allowance $ 654 $ 3,306 $ — $ 6 $ 3,954 2021 Accounts receivable allowance $ 604 $ 72 $ — $ 22 $ 654 2020 Accounts receivable allowance $ 418 $ 207 $ — $ 21 $ 604

Schedule III - Real Estate and

Schedule III - Real Estate and Accumulated Depreciation	12 Months Ended
	Dec. 31, 2022
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]
Real Estate and Accumulated Depreciation	Schedule III – Real Estate and Accumulated Depreciation as of December 31, 2022 Dollars in thousands LAND 1 BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1 MARKET NUMBER OF PROP. INITIAL INVESTMENT COST CAPITALIZED subsequent to acquisition TOTAL INITIAL INVESTMENT COST CAPITALIZED subsequent to acquisition TOTAL PERSONAL PROPERTY 2, 3, 5 1, 3 ACCUMULATED DEPRECIATION 4 ENCUMBRANCES 5 DATE CONST. Dallas, TX 45 $ 95,647 $ 1,063 $ 96,710 $ 1,081,969 $ 129,495 $ 1,211,464 $ 551 $ 1,308,725 $ 202,031 $ — 2003-2022 1974-2021 Seattle, WA 29 59,412 4,883 64,295 558,280 78,330 636,610 726 701,631 164,423 — 2008-2022 1974-2018 Los Angeles, CA 23 95,360 3,164 98,524 436,629 55,941 492,570 453 591,547 129,663 38,373 1993-2022 1959-2018 Boston, MA 18 128,904 — 128,904 456,963 2,173 459,136 — 588,040 13,513 — 2022 1860-2019 Charlotte, NC 32 35,366 36 35,402 454,299 25,616 479,915 105 515,422 95,363 — 2008-2022 1961-2018 Houston, TX 34 82,539 2,850 85,389 669,553 27,966 697,519 57 782,965 63,486 — 1993-2022 1974-2018 Miami, FL 23 72,304 60 72,364 429,781 17,413 447,194 105 519,663 52,920 — 1994-2022 1954-2021 Atlanta, GA 28 45,220 4,159 49,379 463,963 9,519 473,482 95 522,956 63,773 15,778 2017-2022 1960-2014 Tampa, FL 20 30,790 743 31,533 419,354 (5,061) 414,293 33 445,859 18,991 — 1994-2022 1954-2015 Denver, CO 33 70,478 6,220 76,698 491,881 51,208 543,089 609 620,396 65,123 6,818 2010-2022 1942-2020 Raleigh, NC 27 52,954 3,666 56,620 394,574 6,231 400,805 9 457,434 15,566 — 2019-2022 1977-2020 Phoenix, AZ 35 20,257 5 20,262 448,657 18,836 467,493 425 488,180 30,281 — 2007-2022 1971-2006 Chicago, IL 7 32,374 — 32,374 271,285 15,995 287,280 81 319,735 28,243 — 2004-2022 1970-2017 Indianapolis, IN 36 52,180 — 52,180 292,372 5,437 297,809 13 350,002 19,705 — 2019-2022 1988-2013 Hartford, CT 30 43,326 — 43,326 234,702 1,150 235,852 — 279,178 8,015 — 2022 1955-2017 Nashville, TN 12 41,291 2,057 43,348 272,122 84,395 356,517 1,424 401,289 92,720 — 2004-2022 1976-2021 New York, NY 14 64,402 — 64,402 192,029 2,220 194,249 — 258,651 4,771 — 2022 1920-2014 Austin, TX 13 25,718 1,346 27,064 261,585 28,675 290,260 142 317,466 40,363 — 2007-2022 1972-2015 Orlando, FL 8 20,698 10 20,708 198,719 3,556 202,275 1 222,984 11,654 — 1998-2022 1988-2009 Memphis, TN 11 12,811 1,090 13,901 118,426 70,325 188,751 317 202,969 60,624 — 1999-2022 1982-2021 Other (51 markets) 210 315,986 10,276 326,262 3,324,552 205,043 3,529,595 1,223 3,857,080 457,572 23,728 1993-2022 Total real estate 688 1,398,017 41,628 1,439,645 11,471,695 834,463 12,306,158 6,369 13,752,172 1,638,800 84,697 Land held for develop. — 74,265 — 74,265 — — — — 74,265 1,183 — Construction in Progress — — — — 35,560 — 35,560 — 35,560 — — Corporate property — 1,853 — 1,853 1,787 1,240 3,027 5,538 10,418 5,288 — Financing lease right-of-use assets — — — — — — — — 83,824 — — Investment in financing receivables, net — — — — — — — — 120,236 — — Total properties 688 1,474,135 $ 41,628 $ 1,515,763 $ 11,509,042 $ 835,703 $ 12,344,745 $ 11,907 $ 14,076,475 $ 1,645,271 $ 84,697 1 Includes one asset held for sale at 12/31/22 of approximately $18.9 million. 2 Total properties as of December 31, 2022 have an estimated aggregate total cost of $13.0 billion for federal income tax purposes. 3 Depreciation is provided for on a straight-line basis on buildings and improvements over 3.0 to 49.0 years, lease intangibles over 1.2 to 99.0 years, personal property over 3.0 to 20.0 years, and land improvements over 2.0 to 39.0 years. 4 Includes unamortized premium of $0.5 million and unaccreted discount of $38 thousand and debt issuance costs of $0.3 million as of December 31, 2022. 5 Includes merger of Healthcare Trust of America, Inc. buildings, acquired in 2022. 6 Rollforward of Total Property and Accumulated Depreciation, including assets held for sale, for the year ended December 31, 2022, 2021 and 2020 follows: YEAR ENDED DEC. 31, 2022 YEAR ENDED DEC. 31, 2021 YEAR ENDED DEC. 31, 2020 Dollars in thousands TOTAL PROPERTY ACCUMULATED DEPRECIATION TOTAL PROPERTY ACCUMULATED DEPRECIATION TOTAL PROPERTY ACCUMULATED DEPRECIATION Beginning balance $ 5,104,942 $ 1,338,743 $ 4,670,226 $ 1,249,679 $ 4,359,993 $ 1,121,102 Additions during the period Real estate acquired 9,780,070 241,285 374,912 7,668 430,205 8,313 Other improvements 219,783 205,703 103,035 191,875 80,462 178,636 Land held for development 49,416 — 2,021 — 2,579 282 Construction in progress 31,586 — 3,974 — — — Investment in financing receivable, net (66,509) — 186,745 — — — Financing lease right-of-use assets, net 52,249 — 11,909 — 19,667 — Corporate Properties 3,640 236 — — — — Retirement/dispositions Real estate (1,098,702) (140,696) (247,880) (110,479) (222,680) (58,654) Ending balance $ 14,076,475 $ 1,645,271 $ 5,104,942 $ 1,338,743 $ 4,670,226 $ 1,249,679

Schedule IV - Mortgage Loans on

Schedule IV - Mortgage Loans on Real Estate Assets	12 Months Ended
	Dec. 31, 2022
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
Schedule IV - Mortgage Loans on Real Estate Assets	Schedule IV – Mortgage Loans on Real Estate Assets as of December 31, 2022 Dollars in thousands Final Maturity Date Payment Terms Prior Liens Face Amount Carrying Amount Principal Amount of Loans Subject to Delinquent Principal or Interest Mortgage loan on real estate located in: Texas 7.00 % 12/31/2023 (1) $ — $ 31,150 $ 30,552 $ — Florida 6.00 % 2/27/2026 (2) $ — 13,062 12,988 — Mezzanine loans on real estate located in: Texas 8.00 % 6/24/2024 (3) — 54,119 51,052 — North Carolina 8.00 % 12/22/2024 (4) — 6,000 5,493 — Total real estate notes receivable $ — $ 104,331 $ 100,085 $ — Accrued interest receivable — — 758 — Deferred fee — — (1,200) — Total real estate notes receivable, net $ — $ 104,331 $ 99,643 $ — 1 Twelve-month prefunded interest reserve, with principal sum and interest on unpaid principal due on the maturity date. 2 Construction loan up to $65 million with periodic disbursements. Interest only payments due with principal and any unpaid interest due on the maturity date. 3 Interest is accrued and funded utilizing interest reserves, funded through payment-in-kind interest, until such time the interest reserve is fully funded. Thereafter, interest only payments due with principal and any unpaid interest due on the maturity date. 4 Capitalized interest through maturity, with outstanding principal and accrued interest due on the maturity date. The following shows changes in the carrying amounts of mortgage loans on real estate assets during the years ended December 31, 2022, 2021 and 2020: Year Ended December 31, 2022 2021 2020 Balance as of the beginning of the year $ — $ — $ — Additions: Fair value real estate notes assumed 74,819 — — New real estate notes 23,325 — — Capitalized interest 1,499 — — Accretion of fees and other items — — — Deductions: Collection of real estate loans — — — Deferred fees and other items — — — Balance as of the end of the year $ 99,643 $ — $ — All other schedules for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are omitted because they are not required under the related instructions or are not applicable, or because the required information is shown in the consolidated financial statements or notes thereto.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Business Overview	Business OverviewHealthcare Realty Trust Incorporated (the “Company”) is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. See Note 2 below for a discussion of the Merger between Legacy HR and Legacy HTA. The Company had gross investments of approximately $14.1 billion in 688 real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development, and corporate property as of December 31, 2022. The Company’s 688 real estate properties are located in 35 states and total approximately 40.3 million square feet. In addition, the Company had a weighted average ownership interest of approximately 48% in 33 real estate properties held in joint ventures.
Principles of Consolidation	Principles of Consolidation The Company’s Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). Accounting Standards Codification Topic 810 broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity’s economic performance or (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE’s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Consolidated Financial Statements. The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis. For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. Healthcare Realty Holdings, L.P. (formally known as Healthcare Trust of America Holdings, LP) (the "OP") is 98.9% owned by the Company. Holders of operating partnership units (“OP Units”) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of December 31, 2022 there were approximately 4.0 million, or 1.1%, of OP Units issued and outstanding held by non-controlling interest holders. Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP. As of December 31, 2022, the Company had three consolidated VIEs in addition to the OP where it is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures. Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate: (dollars in thousands) DECEMBER 31, 2022 Assets: Net real estate investments $ 46,322 Cash and cash equivalents 3,645 Receivables and other assets 2,385 Total assets $ 52,352 Liabilities: Accrued expenses and other liabilities $ 12,214 Total equity 40,138 Total liabilities and equity $ 52,352 As of December 31, 2022, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture. The Company does not have the power or economics to direct the activities of the VIEs on a stand-alone basis, therefore it was determined that the Company was not the primary beneficiary. Therefore, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method. See below for additional information regarding the Company's unconsolidated VIEs: ORIGINATION DATE LOCATION SOURCE CARRYING AMOUNT MAXIMUM EXPOSURE TO LOSS 2021 Houston, TX 1 Note receivable $ 29,753 $ 31,150 2021 Charlotte, NC 1 Note receivable 5,984 6,000 2022 Texas 2 Equity method 23,219 23,219 1 Assumed mortgage note receivable in connection with the Merger. 2 Includes investments in six properties.
Use of Estimates in the Consolidated Financial Statements	Use of Estimates in the Consolidated Financial Statements Preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates and assumptions. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, impairments, collectability of tenant receivables, and fair value measurements, as applicable.
Reclassifications	Reclassifications Certain reclassifications have been made on the Company's prior year Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Consolidated Balance Sheets.
Segment Reporting	Segment Reporting The Company owns, leases, acquires, manages, finances, develops and redevelops outpatient and other healthcare-related properties. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single reportable segment.
Real Estate Properties	Real Estate Properties Real estate properties are recorded at cost or at fair value if acquired in a transaction that is a business combination under Accounting Standards Codification Topic 805, Business Combinations . Cost or fair value at the time of acquisition is allocated among land, buildings, tenant improvements, lease and other intangibles, and personal property as applicable. During 2022 and 2021, the Company eliminated against accumulated depreciation approximately $19.6 million and $16.3 million, respectively, of fully amortized real estate intangibles that were initially recorded as a component of certain real estate acquisitions. Also during 2022 and 2021, approximately $4.1 million and $9.9 million, respectively, of fully depreciated tenant and capital improvements that were no longer in service were eliminated against accumulated depreciation. In addition, during 2021, the Company eliminated against accumulated depreciation approximately $7.1 million of a fully depreciated building that is being demolished and redeveloped. Depreciation expense of real estate properties for the three years ended December 31, 2022, 2021 and 2020 was $320.8 million, $170.0 million and $162.4 million, respectively. Depreciation and amortization of real estate assets in place as of December 31, 2022, is provided for on a straight-line basis over the asset’s estimated useful life: Land improvements 2.0 to 39.0 years Buildings and improvements 3.0 to 49.0 years Lease intangibles (including ground lease intangibles) 1.2 to 99.0 years Personal property 3.0 to 20.0 years The Company capitalizes direct costs, including costs such as construction costs and professional services, and indirect costs, including capitalized interest and overhead costs, associated with the development and construction of real estate assets while substantive activities are ongoing to prepare the assets for their intended use. Capitalized interest cost is calculated using the weighted average interest rate of the Company's unsecured debt or the interest rate on project specific debt, if applicable. The Company continues to capitalize interest on the unoccupied portion of the properties in stabilization for up to one year after the buildings have been placed into service, at which time the capitalization of interest must cease.
Land Held for Development	Land Held for DevelopmentLand held for development includes parcels of land owned by the Company, upon which the Company intends to develop and own outpatient healthcare facilities.
Asset Impairment	Asset Impairment The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants. In addition, the Company reviews for possible impairment, those assets subject to purchase options and those impacted by casualty losses, such as tornadoes and hurricanes. A property value is considered impaired only if management's estimate of current and projected (undiscounted and unleveraged) operating cash flows of the property is less than the net carrying value of the property. These estimates of future cash flows include only those that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the property based on its estimated remaining useful life. These estimates, including the useful life determination which can be affected by any potential sale of the property, are based on management's assumptions about its use of the property. Therefore, significant judgment is involved in estimating the current and projected cash flows. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property or the estimated fair value less costs to sell the property.
Acquisitions of Real Estate Properties with In-Place Leases	Acquisitions of Real Estate Properties with In-Place Leases The Company's acquisitions of real estate properties typically do not meet the definition of a business and are accounted for as asset acquisitions. Acquisitions of real estate properties with in-place leases are accounted for at relative fair value. When a building with in-place leases is acquired, the cost of the acquisition must be allocated between the tangible real estate assets "as-if-vacant" and the intangible real estate assets related to in-place leases based on their estimated fair values. Land fair value is estimated by using an assessment of comparable transactions and other relevant data. The Company considers whether any of the in-place lease rental rates are above- or below-market. An asset (if the actual rental rate is above-market) or a liability (if the actual rental rate is below-market) is calculated and recorded in an amount equal to the present value of the future cash flows that represent the difference between the actual lease rate and the estimated market rate. If an in-place lease is identified as a below-market rental rate, the Company would also evaluate any renewal options associated with that lease to determine if the intangible should include those periods. The values related to above- or below-market in-place lease intangibles are amortized over the remaining term of the leases upon acquisition to rental income where the Company is the lessor and to property operating expense where the Company is the lessee. The Company also estimates an absorption period, which can vary by property, assuming the building is vacant and must be leased up to the actual level of occupancy when acquired. During that absorption period, the owner would incur direct costs, such as tenant improvements, and would suffer lost rental income. Likewise, the owner would have acquired a measurable asset in that, assuming the building was vacant, certain fixed costs would be avoided because the actual in-place lessees would reimburse a certain portion of fixed costs through expense reimbursements during the absorption period. All of these intangible assets (above- or below-market lease, tenant improvement costs avoided, leasing costs avoided, rental income lost, and expenses recovered through in-place lessee reimbursements) are estimated and recorded in amounts equal to the present value of estimated future cash flows. The actual purchase price is allocated based on the various relative asset fair values described above. The building and tenant improvement components of the purchase price are depreciated over the estimated useful life of the building or the weighted average remaining term of the in-place leases. The at-market, in-place lease intangibles are amortized to depreciation and amortization expense over the weighted average remaining term of the leases, and customer relationship assets are amortized to depreciation amortization expense over terms applicable to each acquisition. Any goodwill recorded through a business combination would be reviewed for impairment at least annually and is not amortized.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements. A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: • Level 1 – quoted prices for identical instruments in active markets; • Level 2 – quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Executed purchase and sale agreements, that are binding agreements, are categorized as level one inputs. Brokerage estimates, letters of intent, or unexecuted purchase and sale agreements are considered to be level three as they are nonbinding in nature.
Fair Value of Derivative Financial Instruments	Fair Value of Derivative Financial InstrumentsDerivative financial instruments are recorded at fair value on the Company's Consolidated Balance Sheets as other assets or other liabilities. The valuation of derivative instruments requires the Company to make estimates and judgments that affect the fair value of the instruments. Fair values of derivatives are estimated by pricing models that consider the forward yield curves and discount rates. The fair value of the Company's forward starting interest rate swap contracts are estimated by pricing models that consider foreign trade rates and discount rates. Such amounts and the recognition of such amounts are subject to significant estimates that may change in the future. For derivatives designated in qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive income (loss). Gains and losses are reclassified from accumulated other comprehensive income (loss) into earnings once the underlying hedged transaction is recognized in earnings. As of December 31, 2022 and 2021, the Company had $2.1 million recorded in accumulated other comprehensive income and $10.0 million recorded in accumulated other comprehensive loss, respectively, related to forward starting interest rate swaps entered into and settled during 2015 and 2020 and a hedge of the Company's variable rate debt.
Cash, Cash Equivalents and Restricted Cash	Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. Restricted cash includes cash held in escrow in connection with proceeds from the sales of certain real estate properties. The Company did not have any restricted cash for the years ended December 31, 2022 or 2021. Cash and cash equivalents are held in bank accounts and overnight investments. The Company maintains its bank deposits with large financial institutions in amounts that often exceed federally-insured limits. The Company has not experienced any losses in such accounts.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill and intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present. Identifiable intangible assets of the Company are comprised of enterprise goodwill, in-place lease intangible assets, customer relationship intangible assets, and debt issuance costs. In-place lease and customer relationship intangible assets are amortized on a straight-line basis over the applicable lives of the assets. Debt issuance costs are amortized
Contingent Liabilities	Contingent Liabilities From time to time, the Company may be subject to loss contingencies arising from legal proceedings and similar matters. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or underinsured damages. The Company continually monitors any matters that may present a contingent liability, and, on a quarterly basis, management reviews the Company’s reserves and accruals in relation to each of them, adjusting provisions as necessary in view of changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be reasonably estimated. Changes in estimates regarding the exposure to a contingent loss are reflected as adjustments to the related liability in the periods when they occur. Because of uncertainties inherent in the estimation of contingent liabilities, it is possible that the Company’s provision for contingent losses could change materially in the near term. To the extent that any significant losses, in addition to amounts recognized, are at least reasonably possible, such amounts will be disclosed in the notes to the Consolidated Financial Statements.
Stock-based Compensation	Share-Based CompensationThe Company has various employee and director share-based awards outstanding. These awards include non-vested common stock and options to purchase common stock granted to employees pursuant to the Company's Amended and Restated 2006 Incentive Plan, dated April 29, 2021 ("Incentive Plan"), which replaced the Company's 2015 Stock Incentive Plan (the "Legacy HR Stock Incentive Plan") following the Merger. References to the Incentive Plan include issuances under the Incentive Plan and the Legacy HR Stock Incentive Plan. Legacy HR's 2000 Employee Stock Purchase Plan (the "Legacy HR Employee Stock Purchase Plan") was terminated during 2022 and all outstanding options will expire by 2024. No new options will be issued under this plan. The Company recognizes share-based payments to employees and directors in the Consolidated Statements of Income on a straight-line basis over the requisite service period based on the fair value of the award on the measurement date.
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss)Certain items must be included in comprehensive income, including items such as foreign currency translation adjustments, minimum pension liability adjustments, changes in the fair value of derivative instruments and unrealized gains or losses on available-for-sale securities. As of December 31, 2022, the Company’s accumulated other comprehensive income (loss) consists of the loss for changes in the fair value of active derivatives designated as cash flow hedges and the loss on the unamortized settlement of forward starting swaps and treasury hedges.
Revenue from Contract with Customers (Topic 606)	Revenue from Contracts with Customers (Topic 606) The Company recognizes certain revenue under the core principle of Topic 606. This requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. The Company’s three major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time and the Company recognizes revenue monthly based on this principle. In most cases, the revenue is due and payable on a monthly basis. The Company had a receivable balance of $1.5 million and $1.4 million for the years ended December 31, 2022 and 2021, respectively. Management fee income includes property management services provided to third parties and certain of the properties in the Company's unconsolidated joint ventures and is generally calculated, accrued and billed monthly based on a percentage of cash collections of tenant receivables for the month or a stated amount per square foot. Management fee income also includes amounts paid to the Company for its asset management services for certain of its unconsolidated joint ventures. Internal management fee income, where the Company manages its owned properties, is eliminated in consolidation. Rental Income Rental income related to non-cancelable operating leases is recognized as earned over the life of the lease agreements on a straight-line basis. The Company's lease agreements generally include provisions for stated annual increases or increases based on a Consumer Price Index ("CPI"). Rental income from properties under multi-tenant office lease arrangements and rental income from properties with single-tenant lease arrangements are included in rental income on the Company's Consolidated Statements of Income. For lessors, the new standard requires a lessor to classify leases as either sales-type, direct-financing or operating. A lease will be treated as a sale if it is considered to transfer control of the underlying asset to the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control. Otherwise, the lease is treated as an operating lease. Nonlease components, such as common area maintenance, are generally accounted for under Topic 606 and separated from the lease payments. However, the Company elected the lessor practical expedient allowing the Company to not separate these components when certain conditions are met. The combined component is accounted for under Accounting Standards Codification, Topic 842.
Federal Income Taxes	Federal Income Taxes The Company believes it has qualified to be taxed as a REIT and intends at all times to continue to qualify as a REIT under Sections 856 through 860 of the Internal Revenue Code. The Company must distribute at least 90% per annum of its real estate investment trust taxable income to its stockholders and meet other requirements to continue to qualify as a real estate investment trust. As a REIT, the Company is generally not subject to federal income tax on net income it distributes to its stockholders, but may be subject to certain state and local taxes and fees. See Note 16 for further discussion. If HR fails to qualify as a REIT in any taxable year, it will be subject to U.S. federal income taxes on its taxable income and will not be permitted to qualify for treatment as a REIT for U.S. federal income tax purposes for four years following the year during which the qualification is lost unless the IRS grants it relief under certain statutory provisions. Such event could have a material adverse effect on its business, financial condition, results of operations and net cash available for dividend distributions to its stockholders. HR conducts substantially all of its operations through the OP. As a partnership, the OP generally is not liable for federal income taxes. The income and loss from the operations of the OP is included in the tax returns of its partners, including HR, who are responsible for reporting their allocable share of the partnership income and loss. Accordingly no provision for income tax has been made in the accompanying consolidated financial statements. The Company classifies interest and penalties related to uncertain tax positions, if any, in the Consolidated Financial Statements as a component of general and administrative expenses. No such amounts were recognized during the three years ended December 31, 2022. Federal tax returns for the years 2019, 2020, 2021 and 2022 are currently subject to examination by taxing authorities.
State Income Taxes	State Income TaxesThe Company must pay certain state income taxes and the provisions for such taxes are generally included in general and administrative expense on the Company’s Consolidated Statements of Income.
Sales and Use Taxes	Sales and Use Taxes The Company must pay sales and use taxes to certain state tax authorities based on rents collected from tenants in properties located in those states. The Company is generally reimbursed for these taxes by the tenant. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis in rental income in the Company’s Consolidated Statements of Income.
Assets Held for Sale	Assets Held for SaleLong-lived assets held for sale are reported at the lower of their carrying amount or their fair value less estimated cost to sell. Further, depreciation of these assets ceases at the time the assets are classified as held for sale. Losses resulting from the sale of such properties are characterized as impairment losses in the Consolidated Statements of Income.
Earnings Per Share	Earnings per Share The Company uses the two-class method of computing net earnings per common share. Earnings per common share is calculated by considering share-based payment awards that contain nonforfeitable rights to dividends or dividend equivalents as participating securities. Undistributed earnings (excess net income over dividend payments) are allocated on a pro rata basis to common shareholders and restricted shareholders. Undistributed losses (dividends in excess of net income) do not get allocated to restricted stockholders as they do not have the contractual obligation to share in losses. The amount of undistributed losses that applies to the restricted stockholders is allocated to the common stockholders.
Redeemable Non-Controlling Interests	Redeemable Non-Controlling InterestsThe Company accounts for redeemable equity securities in accordance with Accounting Standards Update 2009-04 Liabilities (Topic 480): Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders’ equity. The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Consolidated Balance Sheet. Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest’s share of net income or loss and distributions) or the redemption value. We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.
Investments in Financing Receivables, Net	Investments in Financing Receivables, Net In accordance with Accounting Standards Codification ("ASC") 842, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale-leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC 310 “Receivables”. The Company had two and four medical office buildings that were accounted for as separate sale-lease back transactions and recorded as investments in financing receivables as of December 31, 2022 and 2021, respectively. Income from Financing Receivables, net The Company recognizes the related interest income from the financing receivable based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable will not equal the cash payments from the lease. Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income from financing receivable, net over the life of the lease. Real Estate Notes Receivable
New Accounting Pronouncements	New Accounting Pronouncements Accounting Standards Update No. 2020-04 and 2022-06 On March 12, 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04, Reference Rate Reform (Topic 848) . ASU 2020-04 contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance in ASU 2020-04 is optional and may be elected over time as reference rate reform activities occur. The Company has elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR and Term SOFR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Schedule of consolidated balance sheets	Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate: (dollars in thousands) DECEMBER 31, 2022 Assets: Net real estate investments $ 46,322 Cash and cash equivalents 3,645 Receivables and other assets 2,385 Total assets $ 52,352 Liabilities: Accrued expenses and other liabilities $ 12,214 Total equity 40,138 Total liabilities and equity $ 52,352
Schedule of variable interest entity	Therefore, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method. See below for additional information regarding the Company's unconsolidated VIEs: ORIGINATION DATE LOCATION SOURCE CARRYING AMOUNT MAXIMUM EXPOSURE TO LOSS 2021 Houston, TX 1 Note receivable $ 29,753 $ 31,150 2021 Charlotte, NC 1 Note receivable 5,984 6,000 2022 Texas 2 Equity method 23,219 23,219 1 Assumed mortgage note receivable in connection with the Merger. 2 Includes investments in six properties.
Schedule of assets' estimated useful life	Depreciation and amortization of real estate assets in place as of December 31, 2022, is provided for on a straight-line basis over the asset’s estimated useful life: Land improvements 2.0 to 39.0 years Buildings and improvements 3.0 to 49.0 years Lease intangibles (including ground lease intangibles) 1.2 to 99.0 years Personal property 3.0 to 20.0 years
Schedule of disaggregation of revenue	Below is a detail of the amounts by category: YEAR ENDED DECEMBER 31, Dollars in thousands 2022 2021 2020 Type of Revenue Parking income $ 8,513 $ 7,859 $ 6,720 Management fee income 4,668 2,049 343 Miscellaneous 525 383 304 $ 13,706 $ 10,291 $ 7,367
Schedule of rental income	The components of rental income are as follows: YEAR ENDED DECEMBER 31, Dollars in thousands 2022 2021 2020 Property operating income $ 883,953 $ 514,533 $ 488,527 Straight-line rent 23,498 5,801 3,735 Rental income $ 907,451 $ 520,334 $ 492,262
Schedule of notes receivable	(dollars in thousands) ORIGINATION MATURITY STATED INTEREST RATE MAXIMUM LOAN COMMITMENT OUTSTANDING as of Mezzanine loans Texas 6/24/2021 6/24/2024 8 % $ 54,119 $ 54,119 North Carolina 12/22/2021 12/22/2024 8 % 6,000 6,000 60,119 60,119 Mortgage loan Texas 6/30/2021 12/31/2023 7 % $ 31,150 $ 31,150 Florida 5/17/2022 2/27/2026 6 % 65,000 13,062 $ 96,150 $ 44,212 Accrued interest 758 Fair-value discount and fees (5,446) $ 99,643

Merger with HTA (Tables)

Merger with HTA (Tables)	12 Months Ended
	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Consideration Transferred	The implied consideration transferred on the Closing Date is as follows: Dollars in thousands, except for per share data Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (a) 228,520,990 Exchange ratio 1.00 Implied shares of Legacy HR Common Stock issued 228,520,990 Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (b) $ 24.37 Value of implied Legacy HR Common Stock issued $ 5,569,057 Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services (c) 7,406 Consideration transferred $ 5,576,463 (a) Includes 228,520,990 shares of Legacy HTA Common Stock as of July 20, 2022. The number of shares of HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 HTA fractional shares that were paid in cash less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares and units were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 per share of HTA Common Stock. (b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.
Schedule of Fair Values of the Assets Acquired And Liabilities Assumed	The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: Dollars in thousands PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE MEASUREMENT PERIOD ADJUSTMENTS PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE ASSETS Real estate investments Land $ 985,926 $ 6,775 $ 992,701 Buildings and improvements 6,960,418 (83,662) 6,876,756 Lease intangible assets (a) 831,920 1,230 833,150 Financing lease right-of-use assets 9,874 3,146 13,020 Construction in progress 10,071 (6,744) 3,327 Land held for development 46,538 — 46,538 Total real estate investments $ 8,844,747 $ (79,255) $ 8,765,492 Assets held for sale, net 707,442 (7,946) 699,496 Investments in unconsolidated joint ventures 67,892 — 67,892 Cash and cash equivalents 26,034 11,403 37,437 Restricted cash 1,123,647 (1,247) 1,122,400 Operating lease right-of-use assets 198,261 17,786 216,047 Other assets, net (b) (c) 209,163 (3,840) 205,323 Total assets acquired $ 11,177,186 $ (63,099) $ 11,114,087 LIABILITIES Notes and bonds payable $ 3,991,300 $ — $ 3,991,300 Accounts payable and accrued liabilities 1,227,570 17,374 1,244,944 Liabilities of assets held for sale 28,677 (3,939) 24,738 Operating lease liabilities 173,948 10,173 184,121 Financing lease liabilities 10,720 (855) 9,865 Other liabilities 203,210 (11,541) 191,669 Total liabilities assumed $ 5,635,425 $ 11,212 $ 5,646,637 Net identifiable assets acquired $ 5,541,761 $ (74,311) $ 5,467,450 Non-controlling interest $ 110,702 $ — $ 110,702 Goodwill $ 145,404 $ 74,311 $ 219,715 (a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years. (b) Includes $15.9 million of contractual accounts receivable, which approximates fair value. (c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date. The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2022 as of the acquisition date: ESTIMATED ESTIMATED Building $ 250.7 14.0 - 38.0 Land 76.1 — Land Improvements 11.2 5.0 - 14.0 Intangibles At-market lease intangibles 48.8 1.5 - 13.4 Above-market lease intangibles (lessor) 15.9 1.3 - 15.6 Below-market lease intangibles (lessor) (2.2) 1.3 - 19.3 Below-market lease intangibles (lessee) 1.2 13.1 Other assets acquired 0.4 Accounts payable, accrued liabilities and other liabilities assumed (2.9) Total cash paid $ 399.2 The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2021 as of the acquisition date: ESTIMATED ESTIMATED Building $ 275.1 18.0 - 44.0 Investment in financing receivables, net 185.9 0.5 - 34.0 Financing lease right of use assets 1 8.9 15.0 - 34.0 Land 34.1 — Land Improvements 8.9 6.0 - 16.0 Intangibles At-market lease intangibles 58.8 2.6 - 16.6 Above-market lease intangibles (lessor) 3.4 1.9 - 8.1 Below-market lease intangibles (lessor) (1.4) 3.1 - 21.8 Above-market lease intangibles (lessee) (0.3) 36.7 - 64.5 Below-market lease intangibles (lessee) 4.7 45.4 Mortgage notes payable assumed, including fair value adjustments (11.8) Other assets acquired 0.8 Accounts payable, accrued liabilities and other liabilities assumed (5.6) Total cash paid $ 561.5
Schedule of Business Acquisition, Pro Forma Information	The following pro forma financial information is not necessarily indicative of the results of operations had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including, but not limited to, differences between the assumptions used to prepare the pro forma information, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses. YEAR ENDED Dollars in thousands 2022 2021 Total revenues $ 1,391,096 $ 1,316,743 Net income $ 130,445 $ (78,990)

Property Investments (Tables)

Property Investments (Tables)	12 Months Ended
	Dec. 31, 2022
Real Estate Investment Property, Net [Abstract]
Schedule of property investment	The following table summarizes the Company’s consolidated investments at December 31, 2022. Dollars in thousands NUMBER OF PROPERTIES LAND BUILDINGS AND IMPROVEMENTS LEASE INTANGIBLES PERSONAL PROPERTY TOTAL ACCUMULATED DEPRECIATION Dallas, TX 45 $ 95,010 $ 1,116,725 $ 77,589 $ 551 $ 1,289,875 $ (202,031) Seattle, WA 29 64,295 623,166 13,444 726 701,631 (164,423) Los Angeles, CA 23 98,524 460,780 31,790 453 591,547 (129,663) Boston, MA 18 128,904 396,002 63,134 — 588,040 (13,513) Charlotte, NC 32 35,402 450,076 29,839 105 515,422 (95,363) Houston, TX 34 85,389 633,474 64,045 57 782,965 (63,486) Miami, FL 23 72,364 400,839 46,355 105 519,663 (52,920) Atlanta, GA 28 49,379 437,312 36,170 95 522,956 (63,773) Tampa, FL 20 31,533 377,455 36,838 33 445,859 (18,991) Denver, CO 33 76,698 497,235 45,854 609 620,396 (65,123) Raleigh, NC 27 56,620 363,359 37,446 9 457,434 (15,566) Phoenix, AZ 35 20,262 430,396 37,097 425 488,180 (30,281) Chicago, IL 7 32,374 266,672 20,608 81 319,735 (28,243) Indianapolis, IN 36 52,180 265,070 32,739 13 350,002 (19,705) Hartford, CT 30 43,326 204,049 31,803 — 279,178 (8,015) Nashville, TN 12 43,348 346,312 10,205 1,424 401,289 (92,720) New York, NY 14 64,402 167,819 26,430 — 258,651 (4,771) Austin, TX 13 27,064 271,692 18,568 142 317,466 (40,363) Orlando, FL 8 20,708 180,694 21,581 1 222,984 (11,654) Memphis, TN 11 13,901 184,540 4,211 317 202,969 (60,624) Other (51 markets) 210 326,262 3,256,027 273,568 1,223 3,857,080 (457,572) 688 1,437,945 11,329,694 959,314 6,369 13,733,322 (1,638,800) Construction in progress — — — — 35,560 — Land held for development — — — — — 74,265 (1,183) Financing lease right-of-use assets — — — — — 83,824 — Investment in financing receivables, net — — — — — 120,236 — Corporate property 1 — 1,853 2,343 684 5,538 10,418 (5,288) Total real estate investments 688 $ 1,439,798 $ 11,332,037 $ 959,998 $ 11,907 $ 14,057,625 $ (1,645,271) 1 Includes a 15,014 square foot building located in Charleston, South Carolina that is used as one of the Company's corporate offices.

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Schedule of future minimum lease payments due to the Company under property operating agreements	Future minimum lease payments under the non-cancelable operating leases, excluding any reimbursements, as of December 31, 2022 are as follows: In thousands 2023 $ 928,516 2024 814,132 2025 701,659 2026 603,051 2027 500,645 2028 and thereafter 1,633,847 $ 5,181,850
Schedule of future minimum operating lease payments	The Company’s future lease payments (primarily for its 167 non-prepaid ground leases) as of December 31, 2022 were as follows: In thousands OPERATING FINANCING 2023 $ 15,641 $ 2,140 2024 $ 15,227 $ 2,182 2025 $ 14,814 $ 2,218 2026 $ 14,852 $ 2,255 2027 $ 14,921 $ 2,294 2028 and thereafter $ 939,165 $ 396,398 Total undiscounted lease payments $ 1,014,620 $ 407,487 Discount $ (734,725) $ (334,548) Lease liabilities $ 279,895 $ 72,939
Schedule of future minimum finance lease payments	The Company’s future lease payments (primarily for its 167 non-prepaid ground leases) as of December 31, 2022 were as follows: In thousands OPERATING FINANCING 2023 $ 15,641 $ 2,140 2024 $ 15,227 $ 2,182 2025 $ 14,814 $ 2,218 2026 $ 14,852 $ 2,255 2027 $ 14,921 $ 2,294 2028 and thereafter $ 939,165 $ 396,398 Total undiscounted lease payments $ 1,014,620 $ 407,487 Discount $ (734,725) $ (334,548) Lease liabilities $ 279,895 $ 72,939
Schedule of lease cost	The following table provides details of the Company's total lease expense for the year ended December 31, 2022: In thousands YEAR ENDED YEAR ENDED Operating lease cost Operating lease expense $ 12,699 $ 4,765 Variable lease expense 4,529 3,929 Finance lease cost Amortization of right-of-use assets 1,288 388 Interest on lease liabilities 2,876 1,032 Total lease expense $ 21,392 $ 10,114 Other information Operating cash flows outflows related to operating leases $ 12,816 $ 7,706 Operating cash flows outflows related to financing leases $ 1,838 $ 809 Financing cash flows outflows related to financing leases $ — $ 9,182 Right-of-use assets obtained in exchange for new finance lease liabilities $ 53,765 $ 3,827 Right-of-use assets obtained in exchange for new operating lease liabilities $ 216,047 $ 8,298 Weighted-average remaining lease term (excluding renewal options) - operating leases 47.5 47.6 Weighted-average remaining lease term (excluding renewal options) -finance leases 58.9 62.1 Weighted-average discount rate - operating leases 5.8 % 5.6 % Weighted-average discount rate - finance leases 5.0 % 5.3 %

Acquisitions, Dispositions an_2

Acquisitions, Dispositions and Mortgage Repayments (Tables)	12 Months Ended
	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of acquisitions	The following table details the Company's acquisitions, exclusive of the Merger, for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE CASH 2 REAL OTHER 3 SQUARE FOOTAGE Dallas, TX 4 MOB 2/11/22 $ 8,175 $ 8,185 $ 8,202 $ (17) 18,000 San Francisco, CA 5 MOB 3/7/22 114,000 112,986 108,687 4,299 166,396 Atlanta, GA MOB 4/7/22 6,912 7,054 7,178 (124) 21,535 Denver, CO MOB 4/13/22 6,320 5,254 5,269 (15) 12,207 Colorado Springs, CO 6 MOB 4/13/22 13,680 13,686 13,701 (15) 25,800 Seattle, WA MOB 4/28/22 8,350 8,334 8,370 (36) 13,256 Houston, TX MOB 4/28/22 36,250 36,299 36,816 (517) 76,781 Los Angeles, CA MOB 4/29/22 35,000 35,242 25,400 9,842 34,282 Oklahoma City, OK MOB 4/29/22 11,100 11,259 11,334 (75) 34,944 Raleigh, NC 5 MOB 5/31/22 27,500 26,710 27,127 (417) 85,113 Tampa. FL 6 MOB 6/9/22 18,650 18,619 18,212 407 55,788 Seattle, WA MOB 8/1/22 4,850 4,806 4,882 (76) 10,593 Raleigh, NC MOB 8/9/22 3,783 3,878 3,932 (54) 11,345 Jacksonville, FL MOB 8/9/22 18,195 18,508 18,583 (75) 34,133 Atlanta, GA MOB 8/10/22 11,800 11,525 12,038 (513) 43,496 Denver, CO MOB 8/11/22 14,800 13,902 13,918 (16) 34,785 Raleigh, NC MOB 8/18/22 11,375 10,670 10,547 123 31,318 Nashville, TN MOB 9/15/22 21,000 20,764 20,572 192 61,932 Austin, TX MOB 9/29/22 5,450 5,449 5,572 (123) 15,000 Jacksonville, FL 4 MOB 10/12/22 3,600 3,530 3,609 (79) 6,200 Houston, TX MOB 11/21/22 5,500 5,469 5,513 (44) 28,369 Austin, TX 7 MOB 12/28/22 888 890 889 1 2,219 Denver, CO MOB 12/28/22 16,400 16,170 16,467 (297) 39,692 $ 403,578 $ 399,189 $ 386,818 $ 12,371 863,184 1 MOB = medical office building. 2 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Represents a single-tenant property. 5 Includes three properties. 6 Includes two properties. 7 The Company acquired additional ownership interests in an existing building bringing the Company's ownership to 71.4%. The following table details the Company's acquisitions for the year ended December 31, 2021: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE 2 MORTGAGES ASSUMED 3 CASH 4 REAL ESTATE 2 OTHER 5 SQUARE FOOTAGE San Diego, CA 6 MOB 1/7/21 $ 17,150 $ — $ 17,182 $ 17,182 $ — 22,461 Dallas, TX 8 MOB 2/1/21 22,515 — 22,299 22,641 (342) 121,709 Atlanta, GA 8 MOB 2/17/21 9,800 — 10,027 10,073 (46) 44,567 Washington, D.C. MOB 3/3/21 12,750 — 12,709 12,658 51 26,496 Houston, TX MOB 5/14/21 13,500 — 12,986 13,379 (393) 45,393 San Diego, CA 6,7 MOB 5/28/21 102,650 — 103,984 104,629 (645) 160,394 Greensboro, NC MOB 6/28/21 9,390 — 9,475 10,047 (572) 25,168 Baltimore, MD MOB 6/29/21 14,600 — 14,357 14,437 (80) 33,316 Denver, CO 9 MOB 7/16/21 70,426 — 69,151 65,100 4,051 259,555 Greensboro, NC 6 MOB 7/19/21 6,400 — 6,374 6,514 (140) 18,119 Colorado Springs, CO MOB 7/27/21 33,400 — 32,738 33,241 (503) 69,526 Birmingham, AL MOB 8/19/21 9,250 — 9,355 9,388 (33) 29,942 Raleigh, NC MOB 9/20/21 5,780 — 5,821 5,810 11 18,280 Denver, CO MOB 9/22/21 20,250 — 19,630 19,405 225 83,604 Raleigh, NC MOB 9/30/21 10,000 — 9,921 9,874 47 29,178 Denver, CO MOB 11/15/21 7,700 — 7,383 7,431 (48) 18,599 Denver, CO MOB 11/18/21 22,400 — 22,343 22,422 (79) 30,185 Columbus, OH 10 MOB 12/1/21 16,275 — 15,970 7,365 8,605 71,930 Nashville, TN MOB 12/2/21 11,300 — 11,245 11,263 (18) 34,908 Colorado Springs, CO MOB 12/20/21 10,575 — 10,541 11,009 (468) 44,166 Columbus, OH 8 MOB 12/28/21 9,525 — 9,521 9,601 (80) 28,962 Los Angeles, CA MOB 12/28/21 20,500 (11,000) 9,396 20,316 80 56,762 Nashville, TN 11 MOB 12/29/21 19,775 — 19,833 19,982 (149) 85,590 Austin, TX MOB 12/29/21 20,500 — 20,696 20,741 (45) 62,548 Atlanta, GA MOB 12/30/21 4,900 — 4,772 4,419 353 11,840 Nashville, TN 12 MOB 12/30/21 54,000 — 53,923 54,072 (149) 74,489 Nashville, TN 12 MOB 12/30/21 20,500 — 19,833 19,825 8 32,454 $ 575,811 $ (11,000) $ 561,465 $ 562,824 $ 9,641 1,540,141 1 MOB = medical office building. 2 Includes investments in financing receivables and an $8.9 million right-of-use asset related to the Columbus, Ohio transaction. 3 The mortgages assumed in the acquisitions do not reflect the fair value adjustments totaling $0.8 million in aggregate recorded by the Company upon acquisition (included in Other). 4 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 5 Includes other assets acquired, liabilities assumed, intangibles, and fair value mortgage adjustments recognized at acquisition. 6 Represents a single-tenant property. 7 The Company acquired a single-tenant net lease property in San Diego, CA in a sale-leaseback transaction which was accounted for as a financing arrangement as required under ASC 842, Leases. 8 Includes two properties. 9 Includes three properties. 10 This sale-leaseback transaction was a multi-tenant lease property. A portion of the transaction totaling $7.4 million was accounted for as a financing receivable and the remaining $8.9 million was accounted for as an imputed lease arrangement. See Note 1 to the Consolidated Financial Statements accompanying this report for more information. 11 Includes purchase of an adjoining 2.7 acre land parcel that will be held for development. 12 This sale-leaseback transaction was a multi-tenant lease property which was accounted for as a financing arrangement as required under ASC 842, Leases.
Schedule of assets acquired and liabilities assumed	The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: Dollars in thousands PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE MEASUREMENT PERIOD ADJUSTMENTS PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE ASSETS Real estate investments Land $ 985,926 $ 6,775 $ 992,701 Buildings and improvements 6,960,418 (83,662) 6,876,756 Lease intangible assets (a) 831,920 1,230 833,150 Financing lease right-of-use assets 9,874 3,146 13,020 Construction in progress 10,071 (6,744) 3,327 Land held for development 46,538 — 46,538 Total real estate investments $ 8,844,747 $ (79,255) $ 8,765,492 Assets held for sale, net 707,442 (7,946) 699,496 Investments in unconsolidated joint ventures 67,892 — 67,892 Cash and cash equivalents 26,034 11,403 37,437 Restricted cash 1,123,647 (1,247) 1,122,400 Operating lease right-of-use assets 198,261 17,786 216,047 Other assets, net (b) (c) 209,163 (3,840) 205,323 Total assets acquired $ 11,177,186 $ (63,099) $ 11,114,087 LIABILITIES Notes and bonds payable $ 3,991,300 $ — $ 3,991,300 Accounts payable and accrued liabilities 1,227,570 17,374 1,244,944 Liabilities of assets held for sale 28,677 (3,939) 24,738 Operating lease liabilities 173,948 10,173 184,121 Financing lease liabilities 10,720 (855) 9,865 Other liabilities 203,210 (11,541) 191,669 Total liabilities assumed $ 5,635,425 $ 11,212 $ 5,646,637 Net identifiable assets acquired $ 5,541,761 $ (74,311) $ 5,467,450 Non-controlling interest $ 110,702 $ — $ 110,702 Goodwill $ 145,404 $ 74,311 $ 219,715 (a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years. (b) Includes $15.9 million of contractual accounts receivable, which approximates fair value. (c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date. The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2022 as of the acquisition date: ESTIMATED ESTIMATED Building $ 250.7 14.0 - 38.0 Land 76.1 — Land Improvements 11.2 5.0 - 14.0 Intangibles At-market lease intangibles 48.8 1.5 - 13.4 Above-market lease intangibles (lessor) 15.9 1.3 - 15.6 Below-market lease intangibles (lessor) (2.2) 1.3 - 19.3 Below-market lease intangibles (lessee) 1.2 13.1 Other assets acquired 0.4 Accounts payable, accrued liabilities and other liabilities assumed (2.9) Total cash paid $ 399.2 The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2021 as of the acquisition date: ESTIMATED ESTIMATED Building $ 275.1 18.0 - 44.0 Investment in financing receivables, net 185.9 0.5 - 34.0 Financing lease right of use assets 1 8.9 15.0 - 34.0 Land 34.1 — Land Improvements 8.9 6.0 - 16.0 Intangibles At-market lease intangibles 58.8 2.6 - 16.6 Above-market lease intangibles (lessor) 3.4 1.9 - 8.1 Below-market lease intangibles (lessor) (1.4) 3.1 - 21.8 Above-market lease intangibles (lessee) (0.3) 36.7 - 64.5 Below-market lease intangibles (lessee) 4.7 45.4 Mortgage notes payable assumed, including fair value adjustments (11.8) Other assets acquired 0.8 Accounts payable, accrued liabilities and other liabilities assumed (5.6) Total cash paid $ 561.5
Schedule of Joint Venture Transactions	2022 Acquisitions The following table details the joint venture acquisitions for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE CASH 2 REAL OTHER 3 SQUARE FOOTAGE San Francisco, CA 4 MOB 3/7/22 $ 67,175 $ 66,789 $ 65,179 $ 1,610 110,865 Los Angeles, CA 5 MOB 3/7/22 33,800 32,384 32,390 (6) 103,259 $ 100,975 $ 99,173 $ 97,569 $ 1,604 214,124 1 MOB = medical office building. 2 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Includes three properties. 5 Includes two properties. The following table details the joint venture acquisitions for the year ended December 31, 2021: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE CASH 2 REAL OTHER 3 SQUARE FOOTAGE Denver, CO MOB 3/30/21 $ 14,375 $ 14,056 $ 14,550 $ (494) 59,359 Colorado Springs, CO MOB 4/1/21 7,200 7,288 7,347 (59) 27,510 Los Angeles, CA MOB 4/8/21 31,335 30,179 30,642 (463) 57,573 San Antonio, TX MOB 4/30/21 13,600 13,412 13,656 (244) 45,000 Los Angeles, CA MOB 5/10/21 24,600 24,259 24,147 112 73,078 Colorado Springs, CO 4 MOB 7/27/21 9,133 9,137 9,135 2 23,956 Denver, CO MOB 10/21/21 23,000 22,638 23,021 (383) 57,257 San Antonio, TX 5 MOB 12/10/21 42,300 41,892 42,190 (298) 117,597 San Antonio, TX MOB 12/29/21 6,094 6,218 6,308 (90) 22,381 San Antonio, TX MOB 12/29/21 8,850 8,915 8,866 49 30,542 $ 180,487 $ 177,994 $ 179,862 $ (1,868) 514,253 1 MOB = medical office building. 2 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Includes purchase of an adjoining 3.0 acre land parcel. 5 Includes three properties.
Schedule of equity method investments	The Company's investment in and loss recognized for the years ended December 31, 2022 and 2021 related to its joint ventures accounted for under the equity method are shown in the table below: DECEMBER 31, Dollars in millions 2022 2021 Investments in unconsolidated joint ventures, beginning of period $ 161.9 $ 73.1 New investments during the period 1 167.9 89.6 Equity loss recognized during the period (0.7) (0.8) Owner distributions (1.9) — Investments in unconsolidated joint ventures, end of period $ 327.2 $ 161.9 1 For the year ended December 31, 2022, this included unconsolidated joint ventures acquired as part of the Merger, as well as investments in two joint ventures representing a 20% and 40% ownership interest in portfolios in Los Angeles, California and Dallas, Texas, respectively. Also, see 2022 Real Estate Asset Dispositions below for additional information.
Schedule of dispositions	The following table details the Company's dispositions for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE DISPOSED SALES PRICE CLOSING ADJUSTMENTS NET PROCEEDS NET REAL ESTATE INVESTMENT OTHER 2 GAIN/ SQUARE FOOTAGE Loveland, CO 3, 4 MOB 2/24/22 $ 84,950 $ (45) $ 84,905 $ 40,095 $ 4 $ 44,806 150,291 San Antonio, TX 3 MOB 4/15/22 25,500 (2,272) 23,228 14,381 284 8,563 201,523 GA, FL, PA 5, 11 MOB 7/29/22 133,100 (8,109) 124,991 124,991 — — 316,739 GA, FL, TX 7, 11 MOB 8/4/22 160,917 (5,893) 155,024 151,819 3,205 — 343,545 Los Angeles, CA 5, 9, 11 MOB 8/5/22 134,845 (3,102) 131,743 131,332 411 — 283,780 Dallas, TX 7, 10, 11 MOB 8/30/22 114,290 (682) 113,608 113,608 — — 189,385 Indianapolis, IN 6, 12 MOB 8/31/22 238,845 (5,846) 232,999 84,767 4,324 143,908 506,406 Dallas, TX 3 MOB 10/4/22 104,025 (5,883) 98,142 38,872 6,436 52,834 291,328 Houston, TX MOB 10/21/22 32,000 (280) 31,720 10,762 744 20,214 134,910 College Station, TX MOB 11/10/22 49,177 (3,755) 45,422 44,918 475 28 122,942 El Paso, TX MOB 12/22/22 55,326 (4,002) 51,324 56,427 (1,897) (3,205) 110,465 Atlanta, GA 8 MOB 12/22/22 91,243 (4,326) 86,917 109,051 235 (22,369) 348,416 St. Louis, MO MOB 12/28/22 18,000 (1,471) 16,529 18,340 4 (1,815) 69,394 $ 1,242,218 $ (45,666) $ 1,196,552 $ 939,363 $ 14,225 $ 242,964 3,069,124 1 MOB = medical office building 2 Includes straight-line rent receivables, leasing commissions and lease inducements. 3 Includes two properties. 4 The Company deferred the tax gain through a 1031 exchange and reinvested the proceeds. 5 Includes four properties. 6 Includes five properties. 7 Includes six properties. 8 Includes nine properties. 9 Values and square feet are represented at 100%. The Company retained a 20% ownership interest in the joint venture with an unrelated third party that purchased these properties. 10 Values and square feet are represented at 100%. The Company retained a 40% ownership interest in the joint venture with an unrelated third party that purchased these properties. 11 These properties were acquired as part of the Merger and were included as assets held for sale in the purchase price allocation. 12 Two of the five properties included in this portfolio were acquired in the Merger and were included as assets held for sale in the purchase price allocation. The following table details the Company's dispositions for the year ended December 31, 2021: Dollars in thousands TYPE 1 DATE DISPOSED SALES PRICE CLOSING ADJUSTMENTS NET PROCEEDS NET REAL ESTATE INVESTMENT OTHER 2 GAIN/ SQUARE FOOTAGE Los Angeles, CA 3 MOB 3/11/21 $ 26,000 $ (555) $ 25,445 $ 6,046 $ 509 $ 18,890 73,906 Atlanta, GA MOB 4/12/21 8,050 (272) 7,778 5,675 151 1,952 19,732 Richmond, VA MOB 5/18/21 52,000 (314) 51,686 29,414 3,270 19,002 142,856 Gadsden, AL 4 MOB 5/19/21 5,500 (280) 5,220 5,914 175 (869) 120,192 Dallas, TX 5 MOB 7/9/21 23,000 (1,117) 21,883 18,733 1,966 1,184 190,160 Chicago, IL MOB 10/28/21 13,300 (388) 12,912 23,213 706 (11,007) 95,436 Des Moines, IA 6 MOB 12/8/21 47,000 (901) 46,099 32,312 1,037 12,750 132,617 Aberdeen, SD MOB 12/22/21 12,750 (299) 12,451 10,337 — 2,114 58,285 Dallas, TX MOB 12/23/21 800 (103) 697 712 167 (182) 13,818 $ 188,400 $ (4,229) $ 184,171 $ 132,356 $ 7,981 $ 43,834 847,002 1 MOB = medical office building 2 Includes straight-line rent receivables, leasing commissions and lease inducements. 3 Includes two properties sold to a single purchaser in two transactions which closed on March 5 and March 11, 2021. 4 Includes three properties. 5 Includes four properties and a land parcel sold under a single purchase agreement.

Held for Sale (Tables)

Held for Sale (Tables)	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Schedule of disposal groups, including discontinued operations, income statement, balance sheet and additional disclosures	The table below reflects the assets and liabilities classified as held for sale as of December 31, 2022 and 2021. DECEMBER 31, Dollars in thousands 2022 2021 Balance Sheet data Land $ 1,700 $ — Buildings and improvements 15,164 — Lease intangibles 1,986 — 18,850 — Accumulated depreciation — — Real estate assets held for sale, net 18,850 — Other assets, net 43 57 Assets held for sale, net $ 18,893 $ 57 Accounts payable and accrued liabilities $ 282 $ 169 Other liabilities 155 125 Liabilities of properties held for sale $ 437 $ 294

Other Assets and Liabilities (T

Other Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of other assets	Items included in "Other assets, net" on the Company’s Consolidated Balance Sheets as of December 31, 2022 and 2021 are detailed in the table below: Dollars in thousands December 31, 2022 December 31, 2021 Real estate notes receivable, net $ 99,643 $ — Straight-line rent receivables 88,868 70,784 Prepaid assets 81,900 58,618 Above-market intangible assets, net 80,720 4,966 Accounts receivable, net 1 47,498 14,072 Additional long-lived assets, net 21,446 20,048 Interest rate swap assets 14,512 — Other receivables, net 7,169 — Investment in securities (2) 6,011 — Debt issuance costs, net 5,977 1,813 Project costs 4,337 5,129 Net investment in lease 1,828 — Customer relationship intangible assets, net 1,120 1,174 Other 8,961 9,069 $ 469,990 $ 185,673 1 This amount is net of allowance for doubtful accounts of $4.0 million 2 This amount represents the value of the Company's preferred stock investment in a data analytics platform.
Schedule of accounts payable and accrued liabilities	The following table provides details of the items included in "Accounts payable and accrued liabilities" on the Company's Consolidated Balance Sheets as of December 31, 2022 and 2021: Dollars in thousands December 31, 2022 December 31, 2021 Accrued property taxes $ 78,185 $ 35,295 Accounts payable and capital expenditures 57,352 17,036 Accrued interest 50,037 12,060 Other operating accruals 58,459 21,717 $ 244,033 $ 86,108
Schedule of other liabilities	The following table provides details of the items included in "Other liabilities" on the Company's Consolidated Balance Sheets as of December 31, 2022 and 2021: Dollars in thousands December 31, 2022 December 31, 2021 Below-market intangible liabilities, net $ 97,935 $ 4,931 Deferred revenue 87,325 45,130 Security deposits 28,521 11,116 Interest rate swap liability 4,269 5,917 Other 618 293 $ 218,668 $ 67,387

Intangible Assets and Liabili_2

Intangible Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of finite lived intangible assets and liabilities	The Company’s intangible assets and liabilities, including assets held for sale and excluding certain debt issuance costs, as of December 31, 2022 and 2021 consisted of the following: GROSS BALANCE ACCUMULATED AMORTIZATION WEIGHTED AVG. BALANCE SHEET CLASSIFICATION Dollars in millions 2022 2021 2022 2021 Goodwill $ 223.2 $ 3.5 $ — $ — N/A Goodwill Credit facility debt issuance costs 6.9 5.1 0.9 3.3 2.9 Other assets, net Above-market lease intangibles (lessor) 91.5 7.0 10.7 2.0 5.3 Other assets, net Customer relationship intangibles (lessor) 2.1 2.1 1.0 0.9 20.6 Other assets, net Below-market lease intangibles (lessor) (112.5) (10.1) (14.6) (5.1) 5.7 Other liabilities At-market lease intangibles 1,067.4 213.0 188.3 77.5 5.2 Real estate properties $ 1,278.6 $ 220.6 $ 186.3 $ 78.6 5.3
Schedule of expected net future amortization expense	The following table represents expected amortization over the next five years of the Company’s intangible assets and liabilities in place as of December 31, 2022: Dollars in millions FUTURE AMORTIZATION OF INTANGIBLES, NET 2023 $ 233.8 2024 197.9 2025 151.1 2026 97.6 2027 64.3

Notes and Bonds Payable (Tables

Notes and Bonds Payable (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Instrument [Line Items]
Schedule of debt	DECEMBER 31, MATURITY DATES CONTRACTUAL INTEREST RATES EFFECTIVE INTEREST RATES PRINCIPAL PAYMENTS INTEREST PAYMENTS Dollars in thousands 2022 2021 $700M Unsecured Credit Facility $ — $ 210,000 5/23 LIBOR + 0.90% N/A At maturity Monthly $1.5B Unsecured Credit Facility 385,000 — 10/25 SOFR + 0.95% 5.27 % At maturity Monthly $350M Unsecured Term Loan 1 349,114 — 7/23 SOFR + 1.05% 5.17 % At maturity Monthly $200M Unsecured Term Loan 1 199,670 199,460 5/24 SOFR + 1.05% 5.17 % At maturity Monthly $150M Unsecured Term Loan 1 149,495 149,376 6/26 SOFR + 1.05% 5.17 % At maturity Monthly $300M Unsecured Term Loan 1 299,936 — 10/25 SOFR + 1.05% 5.17 % At maturity Monthly $200M Unsecured Term Loan 1 199,362 — 7/27 SOFR + 1.05% 5.17 % At maturity Monthly $300M Unsecured Term Loan 1 297,869 — 1/28 SOFR + 1.05% 5.17 % At maturity Monthly Senior Notes due 2025 1 249,115 249,040 5/25 3.88 % 4.12 % At maturity Semi-annual Senior Notes due 2026 1 571,587 — 8/26 3.50 % 4.94 % At maturity Semi-annual Senior Notes due 2027 1 479,553 — 7/27 3.75 % 4.76 % At maturity Semi-annual Senior Notes due 2028 1 296,852 296,612 1/28 3.63 % 3.85 % At maturity Semi-annual Senior Notes due 2030 1 565,402 — 2/30 3.10 % 5.30 % At maturity Semi-annual Senior Notes due 2030 1 296,385 296,813 3/30 2.40 % 2.72 % At maturity Semi-annual Senior Notes due 2031 1 295,547 295,374 3/31 2.05 % 2.25 % At maturity Semi-annual Senior Notes due 2031 1 632,693 — 3/31 2.00 % 5.13 % At maturity Semi-annual Mortgage notes payable 2 84,247 104,650 8/23-12/26 3.31%-4.77% 3.42%-4.84% Monthly Monthly $ 5,351,827 $ 1,801,325 1 Balances are shown net of discounts and unamortized issuance costs. 2 Balances are shown net of discounts and unamortized issuance costs and include premiums.
Schedule of debt exchange offers	The following sets forth the results of the Exchange Offers: Series of Old HR Notes Tenders and Consents Received as of the Expiration Date Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes 3.875 % Senior Notes due 2025 $235,016,000 94.01 % 3.625 % Senior Notes due 2028 $290,246,000 96.75 % 2.400 % Senior Notes due 2030 $297,507,000 99.17 % 2.050 % Senior Notes due 2031 $298,858,000 99.62 %
Schedule of senior notes assumed with the merger	The Legacy Senior Notes assumed by the Company consist of the following: COUPON PRINCIPAL OUTSTANDING AS OF Dollars in thousands FACE VALUE 12/31/2022 12/31/2021 Senior Notes due 2026 3.50% $ 600,000 $ 600,000 $ — Senior Notes due 2027 3.75% 500,000 500,000 — Senior Notes due 2030 3.10% 650,000 650,000 — Senior Notes due 2031 2.00% 800,000 800,000 — $ 2,550,000 $ 2,550,000 $ —
Schedule of mortgage notes payable	The following table details the Company’s mortgage notes payable, with related collateral. ORIGINAL BALANCE EFFECTIVE INTEREST RATE 10 MATURITY COLLATERAL 11 PRINCIPAL AND INTEREST PAYMENTS 9 INVESTMENT IN COLLATERAL BALANCE Dollars in millions 2022 2022 2021 Commercial Bank 1 15.0 5.25 % 4/27 MOB Monthly/20-yr amort. — — 6.1 Life Insurance Co. 2 11.0 3.64 % 5/27 MOB Monthly/10-yr amort. — — 11.6 Life Insurance Co. 3 12.3 3.86 % 8/23 MOB Monthly/7-yr amort. 25.9 10.0 10.3 Life Insurance Co. 4 9.0 4.84 % 12/23 MOB,OFC Monthly/10-yr amort. 24.5 6.8 7.1 Life Insurance Co. 5 13.3 4.13 % 1/24 MOB Monthly/10-yr amort. 22.5 11.7 12.0 Life Insurance Co. 6 6.8 3.96 % 2/24 MOB Monthly/7-yr amort. 14.7 5.8 6.0 Financial Services 7 9.7 4.32 % 9/24 MOB Monthly/10-yr amort. 16.6 7.5 7.8 Life Insurance Co. 8 16.5 3.43 % 12/25 MOB,OFC Monthly/7-yr amort. 39.1 16.2 16.7 Financial Services 11.5 3.71 % 1/26 MOB Monthly/10-yr amort. 40.5 8.3 8.7 Life Insurance Co. 19.2 4.08 % 12/26 MOB Monthly/10-yr amort. 44.5 17.9 18.4 $ 228.3 $ 84.2 $ 104.7 1 The Company repaid this loan at the time of disposal in February 2022. 2 The Company repaid this loan in February 2022. The Company's unencumbered gross investment was $20.6 million at December 31, 2022. 3 The unaccreted portion of the $0.2 million discount recorded on this note upon acquisition is included in the balance above. 4 The unamortized portion of the $0.1 million premium recorded on this note upon acquisition is included in the balance above. 5 The unamortized portion of the $0.8 million premium recorded on this note upon acquisition is included in the balance above. 6 The unamortized portion of the $0.2 million premium recorded on this note upon acquisition is included in the balance above. 7 The unamortized portion of the $0.1 million premium recorded on this note upon acquisition is included in the balance above. 8 The unamortized portion of the $0.7 million premium recorded on this note upon acquisition is included in the balance above. 9 Payable in monthly installments of principal and interest with the final payment due at maturity (unless otherwise noted). 10 The contractual interest rates for the eight outstanding mortgage notes ranged from 3.3% to 4.8% as of December 31, 2022. 11 MOB-Medical office building; OFC-Office
Schedule of future contractual maturities of the company's notes and bonds payable	Future maturities of the Company’s notes and bonds payable as of December 31, 2022 were as follows: Dollars in thousands PRINCIPAL MATURITIES NET ACCRETION/ AMORTIZATION 1 DEBT ISSUANCE COSTS 2 NOTES AND % 2023 $ 368,880 $ (38,805) $ (3,258) $ 326,817 6.1 % 2024 225,352 (40,922) (2,211) 182,219 3.4 % 2025 951,250 (43,193) (1,851) 906,206 16.9 % 2026 773,640 (41,798) (1,636) 730,206 13.6 % 2027 700,000 (36,192) (1,518) 662,290 12.4 % 2028 and thereafter 2,649,500 (103,561) (1,850) 2,544,089 47.6 % $ 5,668,622 $ (304,471) $ (12,324) $ 5,351,827 100.0 % 1 Includes discount accretion and premium amortization related to the Company’s Senior Notes and six mortgage notes payable. 2 Excludes approximately $6.0 million in debt issuance costs related to the Company's Unsecured Credit Facility included in other assets, net.
Senior Notes
Debt Instrument [Line Items]
Schedule of senior notes assumed with the merger	The following table reconciles the Company’s aggregate Senior notes principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2022 and 2021 DECEMBER 31, Dollars in thousands 2022 2021 Senior notes principal balance $ 3,699,500 $ 1,150,000 Unaccreted discount (304,919) (4,730) Debt issuance costs (7,447) (7,431) Senior notes carrying amount $ 3,387,134 $ 1,137,839
Term Loan Net | Term Loan
Debt Instrument [Line Items]
Schedule of debt	The following table reconciles the Company’s aggregate term loan principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2022 and 2021. DECEMBER 31, Dollars in thousands 2022 2021 Term loan principal balances $ 1,500,000 $ 350,000 Debt issuance costs (4,554) (1,164) Term Loans carrying amount $ 1,495,446 $ 348,836
Mortgage Notes Payable | Mortgage Notes
Debt Instrument [Line Items]
Schedule of debt	The following table reconciles the Company’s aggregate mortgage notes principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2022 and 2021. DECEMBER 31, Dollars in thousands 2022 2021 Mortgage notes payable principal balance $ 84,122 $ 103,664 Unamortized premium 486 1,720 Unaccreted discount (38) (83) Debt issuance costs (323) (651) Mortgage notes payable carrying amount $ 84,247 $ 104,650

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of cash flow hedges included in accumulated other comprehensive income (loss)	the Company had interest rate derivatives that were designated as cash flow hedges of interest rate risk. The table below presents the notional value and weighted average rates of the Company's derivative financial instruments as of December 31, 2022 and 2021: NOTIONAL VALUE AS OF WEIGHTED AVERAGE RATE EXPIRATION DATE DECEMBER 31, 2022 January 31, 2023 $ 300,000 1.42 % January 15, 2024 200,000 1.21 % May 1, 2026 100,000 2.15 % December 1, 2026 150,000 3.84 % June 1, 2027 150,000 4.13 % December 1, 2027 250,000 3.79 % $ 1,150,000 2.63 % On February 16, 2023, the Company entered into a swap transaction with a notional amount of $50.0 million and a fixed rate of 4.16%. The swap agreement has an effective date of March 1, 2023 and a termination date of June 1, 2026. The table below presents the effect of cash flow hedge accounting on Accumulated other comprehensive income (loss) as of December 31, 2022 related to the Company's outstanding interest rate swaps. AMOUNT OF GAIN/(LOSS) RECOGNIZED IN OCI AMOUNT OF (GAIN)/LOSS RECLASSIFIED Dollars in thousands 2022 2022 2021 Interest rate swaps 2017 $ 302 Interest expense $ 118 $ 527 Interest rate swaps 2018 616 Interest expense 361 1,194 Interest rate swaps 2019 12,964 Interest expense 563 2,157 Interest rate swaps 2022 (3,252) Interest expense (109) — Settled treasury hedges — Interest expense 426 426 Settled interest rate swaps — Interest expense 168 168 $ 10,630 Total interest expense $ 1,527 $ 4,472
Schedule of derivative instruments in statement of financial position, fair value	The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the Consolidated Balance Sheets as of December 31, 2022 and 2021. AS OF DECEMBER 31, 2022 AS OF DECEMBER 31, 2021 Dollars in thousands BALANCE SHEET LOCATION FAIR BALANCE SHEET LOCATION FAIR Derivatives designated as hedging instruments Interest rate swaps 2017 Other liabilities $ (420) Interest rate swaps 2018 Other liabilities (976) Interest rate swaps 2019 Other Assets $ 13,603 Other liabilities (4,521) Interest rate swaps 2022 Other Assets 909 — Interest rate swaps 2022 Other Liabilities (4,269) — Total derivatives designated as hedging instruments $ 10,243 $ (5,917)
Schedule of offsetting assets	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company's derivatives as of December 31, 2022. The net amounts of derivative liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative liabilities are presented on the Company's Consolidated Balance Sheets. Offsetting of Derivative Assets GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF ASSETS GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ 14,512 $ — $ 14,512 $ (4,269) $ — $ 10,243 Offsetting of Derivative Liabilities GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF LIABILITIES GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ (4,269) $ — $ (4,269) $ 4,269 $ — $ —
Schedule of offsetting liabilities	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company's derivatives as of December 31, 2022. The net amounts of derivative liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative liabilities are presented on the Company's Consolidated Balance Sheets. Offsetting of Derivative Assets GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF ASSETS GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ 14,512 $ — $ 14,512 $ (4,269) $ — $ 10,243 Offsetting of Derivative Liabilities GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF LIABILITIES GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ (4,269) $ — $ (4,269) $ 4,269 $ — $ —

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Schedule of reconciliation of the beginning and ending common stock outstanding	The Company had no preferred shares outstanding and had common shares outstanding for the three years ended December 31, 2022, 2021, and 2020 as follows: YEAR ENDED DECEMBER 31, 2022 2021 2020 Balance, beginning of year 150,457,433 139,487,375 134,706,154 Issuance of common stock 229,618,304 10,899,301 4,637,445 Non-vested share-based awards, net of withheld shares and forfeitures 514,157 70,757 143,776 Balance, end of year 380,589,894 150,457,433 139,487,375
Schedule of sale of stock under market equity offering Program	The Company has in place an ATM equity offering program to sell shares of the Company’s common stock from time to time in at-the-market sales transactions. The Company has equity distribution agreements with various sales agents with respect to the ATM offering program of common stock with an aggregate sales amount of up to $750.0 million. As of December 31, 2022, $750.0 million remained available for issuance under the current ATM offering program. The Company's previous ATM agreements involving Legacy HR are no longer in effect following the Merger on July 20, 2022. The following table details the Company's at-the-market activity, including any forward transactions: WEIGHTED AVERAGE SALE PRICE SHARES PRICED SHARES SETTLED SHARES REMAINING TO BE SETTLED NET PROCEEDS 2021 $ 31.09 9,763,680 10,859,539 727,400 $ 330.3 2022 $ 31.73 — 727,400 — $ 22.3
Schedule of reconciliation of beginning and ending balances of accumulated other comprehensive income	The following table represents the changes in accumulated other comprehensive income (loss) during the years ended December 31, 2022 and 2021: INTEREST RATE SWAPS Dollars in thousands 2022 2021 Beginning balance $ (9,981) $ (17,832) Other comprehensive loss before reclassifications 1,531 4,472 Amounts reclassified from accumulated other comprehensive income 10,590 3,379 Net current-period other comprehensive income 12,121 7,851 Ending balance $ 2,140 $ (9,981)
Schedule of reclassifications out of accumulated other comprehensive income	The following table represents the details regarding the reclassifications from accumulated other comprehensive income (loss) during the year ended December 31, 2022 (dollars in thousands): DETAILS ABOUT ACCUMULATED OTHER COMPREHENSIVE AMOUNT RECLASSIFIED AFFECTED LINE ITEM Amounts reclassified from accumulated other comprehensive income (loss) related to settled interest rate swaps $ 594 Interest Expense Amounts reclassified from accumulated other comprehensive income (loss) related to current interest rate swaps 937 Interest Expense $ 1,531

Stock and Other Incentive Pla_2

Stock and Other Incentive Plans (Tables)	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of unrecognized compensation cost, nonvested awards	The following table represents expected amortization of the Company's non-vested shares issued as of December 31, 2022: Dollars in millions FUTURE AMORTIZATION 2023 $ 12.0 2024 10.0 2025 8.3 2026 5.5 2027 0.4 2028 and thereafter 0.1 Total $ 36.3
Schedule of other than stock options, valuation assumptions	The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $30.56 for the absolute TSR component and $41.30 for the relative TSR component for the January 2022 grant using the following assumptions: Volatility 30.0 % Dividend Assumption Accrued Expected term in years 3 years Risk-free rate 1.02 % Stock price (per share) $31.68
Schedule of the activity under the incentive plans the previous directors' plan	A summary of the activity under the Incentive Plans and related information for the three years in the period ended December 31, 2022 follows: YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2022 2021 2020 Share-based awards, beginning of year 1,562,028 1,766,061 1,754,066 Granted 657,475 203,701 197,999 Vested (418,949) (404,777) (186,004) Forfeited (5,426) (2,957) — Share-based awards, end of year 1,795,128 1,562,028 1,766,061 Weighted-average grant date fair value of Share-based awards, beginning of year $ 31.10 $ 30.51 $ 29.82 Share-based awards granted during the year $ 28.11 $ 30.86 $ 30.33 Share-based awards vested during the year $ 31.52 $ 28.38 $ 23.82 Stock-based awards forfeited during the year $ 31.48 $ 33.04 $ — Share-based awards, end of year $ 29.91 $ 31.10 $ 30.51 Grant date fair value of shares granted during the year $ 18,480 $ 6,286 $ 6,006
Schedule of the employee stock purchase plan activity	A summary of the Legacy HR Employee Stock Purchase Plan activity and related information for the three years in the period ended December 31, 2022 is as follows: YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2022 2021 2020 Options outstanding, beginning of year 348,514 341,647 332,659 Granted 255,960 253,200 212,716 Exercised (20,246) (30,281) (21,713) Forfeited (102,619) (71,630) (42,221) Expired (140,633) (144,422) (139,794) Options outstanding and exercisable, end of year 340,976 348,514 341,647 Weighted-average exercise price of Options outstanding, beginning of year $ 25.38 $ 24.70 $ 25.59 Options granted during the year $ 26.89 $ 25.16 $ 28.36 Options exercised during the year $ 20.97 $ 25.03 $ 24.10 Options forfeited during the year $ 21.88 $ 25.45 $ 25.29 Options expired during the year $ 23.36 $ 24.17 $ 23.74 Options outstanding, end of year $ 16.38 $ 25.38 $ 24.70 Weighted-average fair value of options granted during the year (calculated as of the grant date) $ 9.91 $ 9.05 $ 8.06 Intrinsic value of options exercised during the year $ 75 $ 165 $ 101 Intrinsic value of options outstanding and exercisable (calculated as of December 31) $ 985 $ 1,997 $ 1,673 Exercise prices of options outstanding (calculated as of December 31) $ 16.38 $ 25.91 $ 24.70 Weighted-average contractual life of outstanding options (calculated as of December 31, in years) 0.8 0.8 0.8
Schedule of stock options, valuation assumptions	2022 2021 2020 Risk-free interest rates 0.73 % 0.13 % 1.58 % Expected dividend yields 3.97 % 4.11 % 3.69 % Expected life (in years) 1.44 1.43 1.43 Expected volatility 49.0 % 48.2 % 28.6 % Expected forfeiture rates 85 % 85 % 85 %

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of earnings per share	The table below sets forth the computation of basic and diluted earnings per common share for the three years in the period ended December 31, 2022. YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2022 2021 2020 Weighted average common shares outstanding Weighted average common shares outstanding 254,296,810 144,411,835 135,666,503 Non-vested shares (1,940,607) (1,774,669) (1,736,358) Weighted average common shares outstanding - basic 252,356,203 142,637,166 133,930,145 Weighted average common shares outstanding - basic 252,356,203 142,637,166 133,930,145 Dilutive effect of forward equity shares — — 6,283 Dilutive effect of OP Units 1,451,599 — — Dilutive effect of employee stock purchase plan 65,519 73,062 70,512 Weighted average common shares outstanding - diluted 253,873,321 142,710,228 134,006,940 Net income attributable to common stockholders $ 40,897 $ 66,659 $ 72,195 Dividends paid on nonvested share-based awards (2,437) (2,154) (2,083) Net income applicable to common stockholders - basic $ 38,460 $ 64,505 $ 70,112 Net income attributable to OP Units 81 — — Net income applicable to common stockholders - diluted $ 38,541 $ 64,505 $ 70,112 Basic earnings per common share - net income $ 0.15 $ 0.45 $ 0.52 Diluted earnings per common share - net income $ 0.15 $ 0.45 $ 0.52

Other Data (Tables)

Other Data (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of characterization of distributions on common stock	For the three years ended December 31, 2022, there were no preferred shares outstanding. As such, no dividends were distributed related to preferred shares for those periods. YEAR ENDED DECEMBER 31, 2022 2021 2020 PER SHARE PER SHARE PER SHARE Tax Treatment of Dividends Pre-Merger Healthcare Trust of America Ordinary income 1 $ 0.5862 $ 0.7920 $ 0.6976 Return of capital 4.0162 0.4930 0.5582 Capital gain 1.2216 — 0.0092 Common stock distributions $ 5.8240 $ 1.2850 $ 1.2650 Tax Treatment of Dividends Pre-Merger Healthcare Realty Ordinary income 1 $ 0.2655 $ 0.7500 $ 0.7738 Return of capital 0.5555 0.3600 0.1084 Capital gain — 0.0964 0.3178 Common stock distributions $ 0.8210 $ 1.2064 $ 1.2000 Tax Treatment of Dividends Post-Merger Healthcare Realty Ordinary income 1 $ 0.0422 $ — $ — Return of capital 0.2889 — — Capital gain 0.0879 — — Common stock distributions $ 0.4190 $ — $ —
Schedule of state income taxes	State income tax expense and state income tax payments for the three years ended December 31, 2022 are detailed in the table below: YEAR ENDED DECEMBER 31, Dollars in thousands 2022 2021 2020 State income tax expense Texas gross margins tax $ 1,693 $ 564 $ 546 Other 151 8 8 Total state income tax expense $ 1,844 $ 572 $ 554 State income tax payments, net of refunds and collections $ 1,834 $ 560 $ 557

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of fair value and carrying values for notes and bonds payable, mortgage notes receivable and notes receivable	The table below details the fair value and carrying values for our other financial instruments as of December 31, 2022 and 2021. December 31, 2022 December 31, 2021 Dollars in millions CARRYING VALUE FAIR VALUE CARRYING VALUE FAIR VALUE Notes and bonds payable 1, 2 $ 5,351.8 $ 5,149.6 $ 1,801.3 $ 1,797.4 Real estate notes receivable 1 $ 99.6 $ 99.6 $ — $ — 1 Level 2 – model-derived valuations in which significant inputs and significant value drivers are observable in active markets. 2 Fair value for senior notes includes accrued interest as of December 31, 2022.

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details) shares in Millions, ft² in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) ft² property variable_interest_entity state jointVenture reporting_unit note_receivable building shares	Dec. 31, 2021 USD ($) property	Dec. 31, 2020 USD ($)	Jul. 20, 2022 USD ($)
Business Overview [Abstract]
Gross investment, amount, total	$ 14,100,000,000
Real estate properties and mortgages | property	688
Number of owned real estate properties | property	688
Number of states that the Company owns real estate in | state	35
Square footage of owned real estate properties | ft²	40.3
Number of buildings | building	33
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Equity ownership for consolidation (percent)	100%
Number of entities | variable_interest_entity	3
Segment Reporting [Abstract]
Number of Reporting Units | reporting_unit	1
Real Estate Properties [Abstract]
Elimination of real estate lease intangibles against accumulated depreciation	$ 133,600,000	$ 33,700,000
Depreciation	$ 320,800,000	$ 170,000,000	$ 162,400,000
Maximum period up to which interest capitalize on properties in stabilization	1 year
Land Held for Development [Abstract]
Number of land parcels held for development | property	20	7
Land held for development	$ 74,300,000	$ 24,800,000
Goodwill and Intangible Assets [Abstract]
Goodwill	223,202,000	3,487,000		$ 219,715,000
Revenue from Contract with Customer [Abstract]
Revenue Received	$ 1,500,000	1,400,000
Federal Income Taxes [Abstract]
Percentage of distribution of taxable income for qualify as REIT	90%
Unrecognized tax benefits, income tax penalties and interest expense	$ 0	0	$ 0
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]
Redeemable non-controlling interests	2,014,000	$ 0
Leases [Abstract]
Investments in notes receivable	$ 99,600,000
Variable Interest Entity
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of entities | variable_interest_entity	3
Number of notes receivable | note_receivable	2
Number of joint ventures | jointVenture	1
Healthcare Trustof America Holdings L P | Non-Controlling Interest Holders
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Limited partners capital account outstanding | shares	4
Limited partners ownership interest (in percent)	1.10%
Medical Office Building
Business Overview [Abstract]
Number of buildings | property	2	4
Real Estate Properties Held In Joint Ventures Member
Real Estate Properties [Line Items]
Weighted average ownership interest (percent)	48%
Business Overview [Abstract]
Weighted average ownership interest (percent)	48%
Property Entities Not Determined to be VIEs
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Equity interest owned (percent)	100%
Healthcare Trustof America Holdings L P
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Equity interest owned (percent)	98.90%
Interest Rate Swap
Derivative Instrument Detail [Abstract]
Accumulated other comprehensive income (loss), net of tax	$ 2,100,000	$ 10,000,000
Tenant and Capital Improvements
Real Estate Properties [Abstract]
Fully depreciated tenant and capital improvements eliminated against accumulated depreciation	4,100,000	9,900,000
Buildings and improvements
Real Estate Properties [Abstract]
Fully depreciated tenant and capital improvements eliminated against accumulated depreciation	7,100,000
At Market Lease Intangibles
Real Estate Properties [Abstract]
Elimination of real estate lease intangibles against accumulated depreciation	$ 19,600,000	$ 16,300,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Consolidated balance sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Assets:
Net real estate investments	$ 12,412,354	$ 3,766,199
Cash and cash equivalents	60,961	13,175
Total assets	13,849,631	4,258,919
Liabilities:
Total equity	7,571,076	2,185,116
Total liabilities, redeemable non-controlling interests, and stockholders' equity	13,849,631	$ 4,258,919
Variable interest entity
Assets:
Net real estate investments	46,322
Cash and cash equivalents	3,645
Receivables and other assets	2,385
Total assets	52,352
Liabilities:
Accrued expenses and other liabilities	12,214
Total equity	40,138
Total liabilities, redeemable non-controlling interests, and stockholders' equity	$ 52,352

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Variable interest entity (Details) $ in Thousands	Dec. 31, 2022 USD ($) property
Variable Interest Entity [Line Items]
Number of owned real estate properties | property	688
Houston, TX | Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Notes receivable, carrying amount	$ 29,753
MAXIMUM EXPOSURE TO LOSS	31,150
Charlotte, NC | Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Notes receivable, carrying amount	5,984
MAXIMUM EXPOSURE TO LOSS	$ 6,000
Texas | Variable Interest Entity
Variable Interest Entity [Line Items]
Number of owned real estate properties | property	6
Texas | Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Equity method investments	$ 23,219
MAXIMUM EXPOSURE TO LOSS	$ 23,219

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Useful lives of real estate assets and liabilities (Details)	12 Months Ended
	Dec. 31, 2022
Land improvements | Minimum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	2 years
Land improvements | Maximum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	39 years
Buildings and improvements | Minimum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	3 years
Buildings and improvements | Maximum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	49 years
Lease intangibles (including ground lease intangibles) | Minimum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	1 year 2 months 12 days
Intangible asset useful life	1 year 2 months 12 days
Lease intangibles (including ground lease intangibles) | Maximum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	99 years
Intangible asset useful life	99 years
Personal property | Minimum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	3 years
Personal property | Maximum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	20 years

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Other operating	$ 13,706	$ 10,291	$ 7,367
Parking income
Disaggregation of Revenue [Line Items]
Other operating	8,513	7,859	6,720
Management fee income
Disaggregation of Revenue [Line Items]
Other operating	4,668	2,049	343
Miscellaneous
Disaggregation of Revenue [Line Items]
Other operating	$ 525	$ 383	$ 304

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Components of rental income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Property operating income	$ 883,953	$ 514,533	$ 488,527
Straight-line rent	23,498	5,801	3,735
Rental income	$ 907,451	$ 520,334	$ 492,262

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accrued interest	$ 758
Fair-value discount and fees	(5,446)
Investment in financing receivables, net	120,236	$ 186,745
Other Assets
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment in financing receivables, net	$ 99,643
Mezzanine Loans Texas
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	8%
MAXIMUM LOAN COMMITMENT	$ 54,119
REAL ESTATE NOTES RECEIVABLE, GROSS	$ 54,119
Mezzanine Loan - North Carolina
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	8%
MAXIMUM LOAN COMMITMENT	$ 6,000
REAL ESTATE NOTES RECEIVABLE, GROSS	6,000
Mezzanine Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
MAXIMUM LOAN COMMITMENT	60,119
REAL ESTATE NOTES RECEIVABLE, GROSS	$ 60,119
Mortgage Loan Texas
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	7%
MAXIMUM LOAN COMMITMENT	$ 31,150
REAL ESTATE NOTES RECEIVABLE, GROSS	$ 31,150
Mortgage Loan Florida
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	6%
MAXIMUM LOAN COMMITMENT	$ 65,000
REAL ESTATE NOTES RECEIVABLE, GROSS	13,062
Mortgage Loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
MAXIMUM LOAN COMMITMENT	96,150
REAL ESTATE NOTES RECEIVABLE, GROSS	$ 44,212

Merger with HTA - Narrative (De

Merger with HTA - Narrative (Details) - USD ($)		12 Months Ended
	Jul. 20, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Common stock, par value (dollars per share)		$ 0.01	$ 0.01
Goodwill	$ 219,715,000	$ 223,202,000	$ 3,487,000
Goodwill expected to be tax deductible	0
Merger-related costs		103,380,000	$ 0	$ 0
Revenues contributed from Legacy HTA		351,800,000
Results of operations from Legacy HTA		$ 79,300,000
MEASUREMENT PERIOD ADJUSTMENTS
Business Acquisition [Line Items]
Goodwill adjustment incomplete	$ 74,300,000
HealthCare Realty Trust Incorporated | Common Class A
Business Acquisition [Line Items]
Common stock, par value (dollars per share)	$ 0.01
HealthCare Realty Trust, Inc.
Business Acquisition [Line Items]
Common stock, par value (dollars per share)	0.01
Healthcare Trust Of America, Inc
Business Acquisition [Line Items]
Common stock, par value (dollars per share)	$ 0.01
Conversion Ratio	1
Dividends per share to common stockholders, declared (in USD per share)	$ 4.82

Merger with HTA (Details)

Merger with HTA (Details)		12 Months Ended
	Jul. 20, 2022 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	228,857,717	380,590,000	150,457,000
Implied shares of Legacy HR Common Stock issued (in shares)	228,520,990
Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (in dollars per share) | $ / shares	$ 24.37
Value of implied Legacy HR Common Stock issued | $	$ 5,569,057,000
Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services | $		$ 7,406,000
PURCHASE PRICE | $		$ 5,576,463,000	$ 8,900,000
Healthcare Trust Of America, Inc
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	228,520,990
Exchange ratio	1
Common Stock, fractional (in shares)	192
Healthcare Trust Of America, Inc | Restricted Stock
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	336,535
Common Stock, withheld (in shares)	215,764

Merger with HTA - Schedule of F

Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details) - USD ($) $ in Thousands		12 Months Ended
	Jul. 20, 2022	Dec. 31, 2022	Dec. 31, 2021
Real estate investments
Land	$ 992,701
Buildings and improvements	6,876,756
Lease intangible assets	833,150
Financing lease right-of-use assets	13,020
Construction in progress	3,327
Land held for development	46,538
Total real estate investments	8,765,492
Assets held for sale, net	699,496
Investments in unconsolidated joint ventures	67,892
Cash and cash equivalents	37,437
Restricted cash	1,122,400
Operating lease right-of-use assets	216,047
Other assets, net	205,323	$ 400	$ 800
Total assets acquired	11,114,087
LIABILITIES
Notes and bonds payable	3,991,300
Accounts payable and accrued liabilities	1,244,944
Liabilities of assets held for sale	24,738
Operating lease liabilities	184,121
Financing lease liabilities	9,865
Other liabilities	191,669
Total liabilities assumed	5,646,637
Net identifiable assets acquired	5,467,450	399,200	561,500
Non-controlling interest	110,702
Goodwill	219,715	$ 223,202	$ 3,487
Weighted average amortization period for the acquired lease intangible assets		6 years
Gross contractual accounts receivable	15,900
Gross contractual real estate notes receivable	78,700
Gross contractual real estate notes receivable at fair value	74,800
MEASUREMENT PERIOD ADJUSTMENTS
Land	6,775
Buildings and improvements	(83,662)
Lease intangible assets	1,230
Financing lease right-of-use assets	3,146
Construction in progress	(6,744)
Total real estate investments	(79,255)
Assets held for sale, net	(7,946)
Cash and cash equivalents	11,403
Restricted cash	(1,247)
Operating lease right-of-use assets	17,786
Other assets, net	(3,840)
Total assets acquired	(63,099)
Accounts payable and accrued liabilities	17,374
Liabilities of assets held for sale	(3,939)
Operating lease liabilities	10,173
Financing lease liabilities	(855)
Other liabilities	(11,541)
Total liabilities assumed	11,212
Net identifiable assets acquired	(74,311)
Goodwill	74,311
Previously Reported
Real estate investments
Land	985,926
Buildings and improvements	6,960,418
Lease intangible assets	831,920
Financing lease right-of-use assets	9,874
Construction in progress	10,071
Land held for development	46,538
Total real estate investments	8,844,747
Assets held for sale, net	707,442
Investments in unconsolidated joint ventures	67,892
Cash and cash equivalents	26,034
Restricted cash	1,123,647
Operating lease right-of-use assets	198,261
Other assets, net	209,163
Total assets acquired	11,177,186
LIABILITIES
Notes and bonds payable	3,991,300
Accounts payable and accrued liabilities	1,227,570
Liabilities of assets held for sale	28,677
Operating lease liabilities	173,948
Financing lease liabilities	10,720
Other liabilities	203,210
Total liabilities assumed	5,635,425
Net identifiable assets acquired	5,541,761
Non-controlling interest	110,702
Goodwill	$ 145,404

Merger with HTA - Schedule of B

Merger with HTA - Schedule of Business Acquisition, Pro Forma Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]
Total revenues	$ 1,391,096	$ 1,316,743
Net income	$ 130,445	$ (78,990)

Property Investments (Details)

Property Investments (Details) $ in Thousands	Dec. 31, 2022 USD ($) ft² property	Dec. 31, 2021 USD ($)
Summary of Company's investment
NUMBER OF PROPERTIES | property	688
LAND	$ 1,439,798
BUILDINGS AND IMPROVEMENTS	11,332,037	$ 4,337,641
LEASE INTANGIBLES	959,998
Personal property	11,907	11,761
Total real estate investments	14,057,625	5,104,942
ACCUMULATED DEPRECIATION	$ (1,645,271)	$ (1,338,743)
Construction in progress
Summary of Company's investment
NUMBER OF PROPERTIES | property	0
LAND	$ 0
BUILDINGS AND IMPROVEMENTS	0
LEASE INTANGIBLES
Personal property	0
Total real estate investments	35,560
ACCUMULATED DEPRECIATION	$ 0
Land held for development
Summary of Company's investment
NUMBER OF PROPERTIES | property	0
LAND	$ 0
BUILDINGS AND IMPROVEMENTS	0
LEASE INTANGIBLES	0
Personal property	0
Total real estate investments	74,265
ACCUMULATED DEPRECIATION	$ (1,183)
Financing lease right-of-use assets
Summary of Company's investment
NUMBER OF PROPERTIES | property	0
LAND	$ 0
BUILDINGS AND IMPROVEMENTS	0
LEASE INTANGIBLES	0
Personal property	0
Total real estate investments	83,824
ACCUMULATED DEPRECIATION	$ 0
Investment in financing receivables, net
Summary of Company's investment
NUMBER OF PROPERTIES | property	0
LAND	$ 0
BUILDINGS AND IMPROVEMENTS	0
LEASE INTANGIBLES	0
Personal property	0
Total real estate investments	120,236
ACCUMULATED DEPRECIATION	$ 0
Corporate Property
Summary of Company's investment
NUMBER OF PROPERTIES | property	0
LAND	$ 1,853
BUILDINGS AND IMPROVEMENTS	2,343
LEASE INTANGIBLES	684
Personal property	5,538
Total real estate investments	10,418
ACCUMULATED DEPRECIATION	$ (5,288)
Area of land | ft²	15,014
Number of corporate office | property	1
Medical office/outpatient
Summary of Company's investment
NUMBER OF PROPERTIES | property	688
LAND	$ 1,437,945
BUILDINGS AND IMPROVEMENTS	11,329,694
LEASE INTANGIBLES	959,314
Personal property	6,369
Total real estate investments	13,733,322
ACCUMULATED DEPRECIATION	$ (1,638,800)
Medical office/outpatient | Dallas, TX
Summary of Company's investment
NUMBER OF PROPERTIES | property	45
LAND	$ 95,010
BUILDINGS AND IMPROVEMENTS	1,116,725
LEASE INTANGIBLES	77,589
Personal property	551
Total real estate investments	1,289,875
ACCUMULATED DEPRECIATION	$ (202,031)
Medical office/outpatient | Seattle, WA
Summary of Company's investment
NUMBER OF PROPERTIES | property	29
LAND	$ 64,295
BUILDINGS AND IMPROVEMENTS	623,166
LEASE INTANGIBLES	13,444
Personal property	726
Total real estate investments	701,631
ACCUMULATED DEPRECIATION	$ (164,423)
Medical office/outpatient | Los Angeles, CA
Summary of Company's investment
NUMBER OF PROPERTIES | property	23
LAND	$ 98,524
BUILDINGS AND IMPROVEMENTS	460,780
LEASE INTANGIBLES	31,790
Personal property	453
Total real estate investments	591,547
ACCUMULATED DEPRECIATION	$ (129,663)
Medical office/outpatient | Boston, MA
Summary of Company's investment
NUMBER OF PROPERTIES | property	18
LAND	$ 128,904
BUILDINGS AND IMPROVEMENTS	396,002
LEASE INTANGIBLES	63,134
Personal property	0
Total real estate investments	588,040
ACCUMULATED DEPRECIATION	$ (13,513)
Medical office/outpatient | Charlotte, NC
Summary of Company's investment
NUMBER OF PROPERTIES | property	32
LAND	$ 35,402
BUILDINGS AND IMPROVEMENTS	450,076
LEASE INTANGIBLES	29,839
Personal property	105
Total real estate investments	515,422
ACCUMULATED DEPRECIATION	$ (95,363)
Medical office/outpatient | Houston, TX
Summary of Company's investment
NUMBER OF PROPERTIES | property	34
LAND	$ 85,389
BUILDINGS AND IMPROVEMENTS	633,474
LEASE INTANGIBLES	64,045
Personal property	57
Total real estate investments	782,965
ACCUMULATED DEPRECIATION	$ (63,486)
Medical office/outpatient | Florida
Summary of Company's investment
NUMBER OF PROPERTIES | property	23
LAND	$ 72,364
BUILDINGS AND IMPROVEMENTS	400,839
LEASE INTANGIBLES	46,355
Personal property	105
Total real estate investments	519,663
ACCUMULATED DEPRECIATION	$ (52,920)
Medical office/outpatient | Atlanta, GA
Summary of Company's investment
NUMBER OF PROPERTIES | property	28
LAND	$ 49,379
BUILDINGS AND IMPROVEMENTS	437,312
LEASE INTANGIBLES	36,170
Personal property	95
Total real estate investments	522,956
ACCUMULATED DEPRECIATION	$ (63,773)
Medical office/outpatient | Tampa, FL
Summary of Company's investment
NUMBER OF PROPERTIES | property	20
LAND	$ 31,533
BUILDINGS AND IMPROVEMENTS	377,455
LEASE INTANGIBLES	36,838
Personal property	33
Total real estate investments	445,859
ACCUMULATED DEPRECIATION	$ (18,991)
Medical office/outpatient | Denver, CO
Summary of Company's investment
NUMBER OF PROPERTIES | property	33
LAND	$ 76,698
BUILDINGS AND IMPROVEMENTS	497,235
LEASE INTANGIBLES	45,854
Personal property	609
Total real estate investments	620,396
ACCUMULATED DEPRECIATION	$ (65,123)
Medical office/outpatient | Raleigh, NC
Summary of Company's investment
NUMBER OF PROPERTIES | property	27
LAND	$ 56,620
BUILDINGS AND IMPROVEMENTS	363,359
LEASE INTANGIBLES	37,446
Personal property	9
Total real estate investments	457,434
ACCUMULATED DEPRECIATION	$ (15,566)
Medical office/outpatient | Phoenix, AZ
Summary of Company's investment
NUMBER OF PROPERTIES | property	35
LAND	$ 20,262
BUILDINGS AND IMPROVEMENTS	430,396
LEASE INTANGIBLES	37,097
Personal property	425
Total real estate investments	488,180
ACCUMULATED DEPRECIATION	$ (30,281)
Medical office/outpatient | Chicago, IL
Summary of Company's investment
NUMBER OF PROPERTIES | property	7
LAND	$ 32,374
BUILDINGS AND IMPROVEMENTS	266,672
LEASE INTANGIBLES	20,608
Personal property	81
Total real estate investments	319,735
ACCUMULATED DEPRECIATION	$ (28,243)
Medical office/outpatient | Indianapolis, IN
Summary of Company's investment
NUMBER OF PROPERTIES | property	36
LAND	$ 52,180
BUILDINGS AND IMPROVEMENTS	265,070
LEASE INTANGIBLES	32,739
Personal property	13
Total real estate investments	350,002
ACCUMULATED DEPRECIATION	$ (19,705)
Medical office/outpatient | Hartford, CT
Summary of Company's investment
NUMBER OF PROPERTIES | property	30
LAND	$ 43,326
BUILDINGS AND IMPROVEMENTS	204,049
LEASE INTANGIBLES	31,803
Personal property	0
Total real estate investments	279,178
ACCUMULATED DEPRECIATION	$ (8,015)
Medical office/outpatient | Nashville, TN
Summary of Company's investment
NUMBER OF PROPERTIES | property	12
LAND	$ 43,348
BUILDINGS AND IMPROVEMENTS	346,312
LEASE INTANGIBLES	10,205
Personal property	1,424
Total real estate investments	401,289
ACCUMULATED DEPRECIATION	$ (92,720)
Medical office/outpatient | New York, NY
Summary of Company's investment
NUMBER OF PROPERTIES | property	14
LAND	$ 64,402
BUILDINGS AND IMPROVEMENTS	167,819
LEASE INTANGIBLES	26,430
Personal property	0
Total real estate investments	258,651
ACCUMULATED DEPRECIATION	$ (4,771)
Medical office/outpatient | Austin, TX
Summary of Company's investment
NUMBER OF PROPERTIES | property	13
LAND	$ 27,064
BUILDINGS AND IMPROVEMENTS	271,692
LEASE INTANGIBLES	18,568
Personal property	142
Total real estate investments	317,466
ACCUMULATED DEPRECIATION	$ (40,363)
Medical office/outpatient | Orlando, FL
Summary of Company's investment
NUMBER OF PROPERTIES | property	8
LAND	$ 20,708
BUILDINGS AND IMPROVEMENTS	180,694
LEASE INTANGIBLES	21,581
Personal property	1
Total real estate investments	222,984
ACCUMULATED DEPRECIATION	$ (11,654)
Medical office/outpatient | Memphis, TN
Summary of Company's investment
NUMBER OF PROPERTIES | property	11
LAND	$ 13,901
BUILDINGS AND IMPROVEMENTS	184,540
LEASE INTANGIBLES	4,211
Personal property	317
Total real estate investments	202,969
ACCUMULATED DEPRECIATION	$ (60,624)
Medical office/outpatient | Other (51 markets)
Summary of Company's investment
NUMBER OF PROPERTIES | property	210
LAND	$ 326,262
BUILDINGS AND IMPROVEMENTS	3,256,027
LEASE INTANGIBLES	273,568
Personal property	1,223
Total real estate investments	3,857,080
ACCUMULATED DEPRECIATION	$ (457,572)

Leases - Narrative (Details)

Leases - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) renewal_option	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Leases [Abstract]
Rental income	$ 907,451	$ 520,334	$ 492,262
Approximate Investment in real estate properties subject to outstanding contractual option to purchase	$ 100,400
Number of exercisable purchase options | renewal_option	5

Leases - Non-cancelable Operati

Leases - Non-cancelable Operating Leases (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Leases [Abstract]
2023	$ 928,516
2024	814,132
2025	701,659
2026	603,051
2027	500,645
2028 and thereafter	1,633,847
Lease payments receivable	$ 5,181,850

Leases - Ground Leases (Details

Leases - Ground Leases (Details) ft² in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) ft² property	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Real Estate [Line Items]
Number of properties subject to ground leases	242
Square feet subject to ground leases | ft²	17.8
Number of ground leases prepaid	75
Amortization of prepaid rent | $	$ 1.1	$ 0.6	$ 0.6
Number of ground leases, excluding prepaid leases	167
Minimum
Real Estate [Line Items]
Ground leases, initial term	40 years
Maximum
Real Estate [Line Items]
Ground leases, initial term	99 years

Leases - Future Minimum Lease P

Leases - Future Minimum Lease Payments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
OPERATING
2023	$ 15,641
2024	15,227
2025	14,814
2026	14,852
2027	14,921
2028 and thereafter	939,165
Total undiscounted lease payments	1,014,620
Discount	(734,725)
Lease liabilities	279,895	$ 96,138
FINANCING
2023	2,140
2024	2,182
2025	2,218
2026	2,255
2027	2,294
2028 and thereafter	396,398
Total undiscounted lease payments	407,487
Discount	(334,548)
Lease liabilities	$ 72,939	$ 22,551

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating lease cost
Operating lease expense	$ 12,699	$ 4,765
Variable lease expense	4,529	3,929
Finance lease cost
Finance lease right of use asset	1,288	388
Interest on lease liabilities	2,876	1,032
Total lease expense	21,392	10,114
Other information
Operating cash flows outflows related to operating leases	12,816	7,706
Operating cash flows outflows related to financing leases	1,838	809
Financing cash flows outflows related to financing leases	0	9,182	$ 3,417
Right-of-use assets obtained in exchange for new finance lease liabilities	216,047	3,827
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 53,765	$ 8,298
Weighted-average remaining lease term (excluding renewal options) - operating leases	47 years 6 months	47 years 7 months 6 days
Weighted-average remaining lease term (excluding renewal options) -finance leases	58 years 10 months 24 days	62 years 1 month 6 days
Weighted-average discount rate - operating leases	5.80%	5.60%
Weighted-average discount rate - finance leases	5%	5.30%

Acquisitions, Dispositions an_3

Acquisitions, Dispositions and Mortgage Repayments - Acquisitions (Details) $ in Thousands																																										12 Months Ended
	Dec. 28, 2022 USD ($) ft²	Nov. 21, 2022 USD ($) ft²	Oct. 12, 2022 USD ($) ft²	Sep. 29, 2022 USD ($) ft²	Sep. 15, 2022 USD ($) ft²	Aug. 18, 2022 USD ($) ft²	Aug. 11, 2022 USD ($) ft²	Aug. 10, 2022 USD ($) ft²	Aug. 09, 2022 USD ($) ft²	Aug. 01, 2022 USD ($) ft²	Jun. 09, 2022 USD ($) ft²	May 31, 2022 USD ($) ft²	Apr. 29, 2022 USD ($) ft²	Apr. 28, 2022 USD ($) ft²	Apr. 13, 2022 USD ($) ft²	Apr. 07, 2022 USD ($) ft²	Mar. 07, 2022 USD ($) ft²	Feb. 11, 2022 USD ($) ft²	Dec. 30, 2021 USD ($) ft²	Dec. 29, 2021 USD ($) ft²	Dec. 28, 2021 USD ($) ft²	Dec. 20, 2021 USD ($) ft²	Dec. 02, 2021 USD ($) ft²	Dec. 01, 2021 USD ($) ft²	Nov. 18, 2021 USD ($) ft²	Nov. 15, 2021 USD ($) ft²	Sep. 30, 2021 USD ($)	Sep. 22, 2021 USD ($) ft²	Sep. 20, 2021 USD ($) ft²	Aug. 19, 2021 USD ($) ft²	Jul. 27, 2021 USD ($) ft²	Jul. 19, 2021 USD ($) ft²	Jul. 16, 2021 USD ($) ft²	Jun. 29, 2021 USD ($) ft²	Jun. 28, 2021 USD ($) ft²	May 28, 2021 USD ($) ft²	May 14, 2021 USD ($) ft²	Mar. 03, 2021 USD ($) ft²	Feb. 17, 2021 USD ($) ft²	Feb. 01, 2021 USD ($) ft²	Jan. 07, 2021 USD ($) ft²	Dec. 31, 2022 USD ($) a ft² property	Dec. 31, 2021 USD ($) ft² property	Sep. 30, 2022 USD ($) ft²
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																																										$ 5,576,463	$ 8,900
Operating lease right-of-use assets																																										336,983	128,386
Financing lease receivable																																										7,400	16,300
Imputed lease arrangement																																										$ 8,900	$ 7,400
Dallas, TX
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property																																											2
San Francisco, CA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property																																										3
Atlanta, GA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property																																										9	2
Denver, CO
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property																																											3
Columbus, OH
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property																																											2
Colorado Springs, CO
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property																																										2
Raleigh, NC
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property																																										3
Tampa, FL
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property																																										2
Nashville, TN
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Area of land | a																																										2.7
Austin,TX
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Additional of ownership existing																																										71.40%
Medical Office Building
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																																										$ 403,578	$ 575,811
MORTAGES ASSUMED																																											(11,000)
CASH CONSIDERATION																																										399,189	561,465
REAL ESTATE																																										386,818	562,824
OTHER																																										$ 12,371	$ 9,641
Purchase price allocation square footage | ft²																																										863,184	1,540,141
Fair value adjustments included in Other																																											$ 800
Medical Office Building | San Diego, CA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																																				$ 102,650					$ 17,150
MORTAGES ASSUMED																																				0					0
CASH CONSIDERATION																																				103,984					17,182
REAL ESTATE																																				104,629					17,182
OTHER																																				$ (645)					$ 0
Purchase price allocation square footage | ft²																																				160,394					22,461
Medical Office Building | Dallas, TX
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																		$ 8,175																						$ 22,515
MORTAGES ASSUMED																																								0
CASH CONSIDERATION																		8,185																						22,299
REAL ESTATE																		8,202																						22,641
OTHER																		$ (17)																						$ (342)
Purchase price allocation square footage | ft²																		18,000																						121,709
Medical Office Building | San Francisco, CA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																	$ 114,000
CASH CONSIDERATION																	112,986
REAL ESTATE																	108,687
OTHER																	$ 4,299
Purchase price allocation square footage | ft²																	166,396
Medical Office Building | Atlanta, GA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE								$ 11,800								$ 6,912			$ 4,900																				$ 9,800
MORTAGES ASSUMED																			0																				0
CASH CONSIDERATION								11,525								7,054			4,772																				10,027
REAL ESTATE								12,038								7,178			4,419																				10,073
OTHER								$ (513)								$ (124)			$ 353																				$ (46)
Purchase price allocation square footage | ft²								43,496								21,535			11,840																				44,567
Medical Office Building | Denver, CO
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE	$ 16,400						$ 14,800								$ 6,320										$ 22,400	$ 7,700		$ 20,250					$ 70,426
MORTAGES ASSUMED																									0	0		0					0
CASH CONSIDERATION	16,170						13,902								5,254										22,343	7,383		19,630					69,151
REAL ESTATE	16,467						13,918								5,269										22,422	7,431		19,405					65,100
OTHER	$ (297)						$ (16)								$ (15)										$ (79)	$ (48)		$ 225					$ 4,051
Purchase price allocation square footage | ft²	39,692						34,785								12,207										30,185	18,599		83,604					259,555
Medical Office Building | Columbus, OH
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																					$ 9,525			$ 16,275
MORTAGES ASSUMED																					0			0
CASH CONSIDERATION																					9,521			15,970
REAL ESTATE																					9,601			7,365
OTHER																					$ (80)			$ 8,605
Purchase price allocation square footage | ft²																					28,962			71,930
Operating lease right-of-use assets																																										$ 8,900
Medical Office Building | Colorado Springs, CO
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE															$ 13,680							$ 10,575									$ 33,400
MORTAGES ASSUMED																						0									0
CASH CONSIDERATION															13,686							10,541									32,738
REAL ESTATE															13,701							11,009									33,241
OTHER															$ (15)							$ (468)									$ (503)
Purchase price allocation square footage | ft²															25,800							44,166									69,526
Medical Office Building | Seattle, WA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE										$ 4,850				$ 8,350
CASH CONSIDERATION										4,806				8,334
REAL ESTATE										4,882				8,370
OTHER										$ (76)				$ (36)
Purchase price allocation square footage | ft²										10,593				13,256
Medical Office Building | Houston, TX
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE		$ 5,500												$ 36,250																							$ 13,500
MORTAGES ASSUMED																																					0
CASH CONSIDERATION		5,469												36,299																							12,986
REAL ESTATE		5,513												36,816																							13,379
OTHER		$ (44)												$ (517)																							$ (393)
Purchase price allocation square footage | ft²		28,369												76,781																							45,393
Medical Office Building | Los Angeles, CA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE													$ 35,000								$ 20,500
MORTAGES ASSUMED																					(11,000)
CASH CONSIDERATION													35,242								9,396
REAL ESTATE													25,400								20,316
OTHER													$ 9,842								$ 80
Purchase price allocation square footage | ft²													34,282								56,762
Medical Office Building | Oklahoma City, OK
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE													$ 11,100
CASH CONSIDERATION													11,259
REAL ESTATE													11,334
OTHER													$ (75)
Purchase price allocation square footage | ft²													34,944
Medical Office Building | Raleigh, NC
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE						$ 11,375			$ 3,783			$ 27,500															$ 10,000		$ 5,780
MORTAGES ASSUMED																											0		0
CASH CONSIDERATION						10,670			3,878			26,710															$ 9,921		5,821
REAL ESTATE						10,547			3,932			27,127																	5,810															$ 9,874
OTHER						$ 123			$ (54)			$ (417)																	$ 11															$ 47
Purchase price allocation square footage | ft²						31,318			11,345			85,113																	18,280															29,178
Medical Office Building | Tampa, FL
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE											$ 18,650
CASH CONSIDERATION											18,619
REAL ESTATE											18,212
OTHER											$ 407
Purchase price allocation square footage | ft²											55,788
Medical Office Building | Jacksonville, FL
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE			$ 3,600						$ 18,195
CASH CONSIDERATION			3,530						18,508
REAL ESTATE			3,609						18,583
OTHER			$ (79)						$ (75)
Purchase price allocation square footage | ft²			6,200						34,133
Medical Office Building | Nashville, TN
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE					$ 21,000														$ 54,000	$ 19,775			$ 11,300
MORTAGES ASSUMED																			0	0			0
CASH CONSIDERATION					20,764														53,923	19,833			11,245
REAL ESTATE					20,572														54,072	19,982			11,263
OTHER					$ 192														$ (149)	$ (149)			$ (18)
Purchase price allocation square footage | ft²					61,932														74,489	85,590			34,908
Medical Office Building | Austin,TX
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE	$ 888			$ 5,450																$ 20,500
MORTAGES ASSUMED																				0
CASH CONSIDERATION	890			5,449																20,696
REAL ESTATE	889			5,572																20,741
OTHER	$ 1			$ (123)																$ (45)
Purchase price allocation square footage | ft²	2,219			15,000																62,548
Medical Office Building | Washington, D.C.
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																																						$ 12,750
MORTAGES ASSUMED																																						0
CASH CONSIDERATION																																						12,709
REAL ESTATE																																						12,658
OTHER																																						$ 51
Purchase price allocation square footage | ft²																																						26,496
Medical Office Building | Greensboro, NC
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																																$ 6,400			$ 9,390
MORTAGES ASSUMED																																0			0
CASH CONSIDERATION																																6,374			9,475
REAL ESTATE																																6,514			10,047
OTHER																																$ (140)			$ (572)
Purchase price allocation square footage | ft²																																18,119			25,168
Medical Office Building | Baltimore, MD
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																																		$ 14,600
MORTAGES ASSUMED																																		0
CASH CONSIDERATION																																		14,357
REAL ESTATE																																		14,437
OTHER																																		$ (80)
Purchase price allocation square footage | ft²																																		33,316
Medical Office Building | Birmingham, AL
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																														$ 9,250
MORTAGES ASSUMED																														0
CASH CONSIDERATION																														9,355
REAL ESTATE																														9,388
OTHER																														$ (33)
Purchase price allocation square footage | ft²																														29,942
Medical Office Building 2 | Nashville, TN
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																			$ 20,500
MORTAGES ASSUMED																			0
CASH CONSIDERATION																			19,833
REAL ESTATE																			19,825
OTHER																			$ 8
Purchase price allocation square footage | ft²																			32,454

Acquisitions, Dispositions an_4

Acquisitions, Dispositions and Mortgage Repayments - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands			12 Months Ended
	Dec. 28, 2021	Dec. 01, 2021	Dec. 31, 2022	Dec. 31, 2021	Jul. 20, 2022
Business Acquisition [Line Items]
Building					$ 6,876,756
Land					992,701
Mortgage notes payable assumed, including fair value adjustments				$ (11,800)
Other assets acquired			$ 400	800	205,323
Accounts payable, accrued liabilities and other liabilities assumed			(2,900)	(5,600)
Total cash paid			399,200	561,500	$ 5,467,450
Financing lease receivable			7,400	16,300
Purchase price			5,576,463	8,900
Imputed lease arrangement			8,900	7,400
Medical Office Building
Business Acquisition [Line Items]
Purchase price			403,578	575,811
Medical Office Building | Columbus, OH
Business Acquisition [Line Items]
Purchase price	$ 9,525	$ 16,275
At-market lease intangibles
Business Acquisition [Line Items]
Intangibles			48,800	58,800
Above-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangibles			15,900	3,400
Below-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangibles			(2,200)	(1,400)
Above-market lease intangibles (lessee)
Business Acquisition [Line Items]
Intangibles				300
Below-market lease intangibles (lessee)
Business Acquisition [Line Items]
Intangibles			$ 1,200	$ 4,700
Intangible asset useful life			13 years 1 month 6 days	45 years 4 months 24 days
Building
Business Acquisition [Line Items]
Building			$ 250,700	$ 275,100
Investment in financing receivables, net
Business Acquisition [Line Items]
Investment in financing receivables, net				185,900
Financing lease right-of-use assets
Business Acquisition [Line Items]
Financing lease right of use assets 1				8,900
Land
Business Acquisition [Line Items]
Land			76,100	34,100
Land Improvements
Business Acquisition [Line Items]
Land Improvements			$ 11,200	$ 8,900
Minimum | At-market lease intangibles
Business Acquisition [Line Items]
Intangible asset useful life			1 year 6 months	2 years 7 months 6 days
Minimum | Above-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangible asset useful life			1 year 3 months 18 days	1 year 10 months 24 days
Minimum | Below-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangible asset useful life			1 year 3 months 18 days	3 years 1 month 6 days
Minimum | Above-market lease intangibles (lessee)
Business Acquisition [Line Items]
Intangible asset useful life				36 years 8 months 12 days
Minimum | Building
Business Acquisition [Line Items]
Asset estimated useful life			14 years	18 years
Minimum | Investment in financing receivables, net
Business Acquisition [Line Items]
Asset estimated useful life				6 months
Minimum | Financing lease right-of-use assets
Business Acquisition [Line Items]
Asset estimated useful life				15 years
Minimum | Land Improvements
Business Acquisition [Line Items]
Asset estimated useful life			5 years	6 years
Maximum | At-market lease intangibles
Business Acquisition [Line Items]
Intangible asset useful life			13 years 4 months 24 days	16 years 7 months 6 days
Maximum | Above-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangible asset useful life			15 years 7 months 6 days	8 years 1 month 6 days
Maximum | Below-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangible asset useful life			19 years 3 months 18 days	21 years 9 months 18 days
Maximum | Above-market lease intangibles (lessee)
Business Acquisition [Line Items]
Intangible asset useful life				64 years 6 months
Maximum | Building
Business Acquisition [Line Items]
Asset estimated useful life			38 years	44 years
Maximum | Investment in financing receivables, net
Business Acquisition [Line Items]
Asset estimated useful life				34 years
Maximum | Financing lease right-of-use assets
Business Acquisition [Line Items]
Asset estimated useful life				34 years
Maximum | Land Improvements
Business Acquisition [Line Items]
Asset estimated useful life			14 years	16 years

Acquisitions, Dispositions an_5

Acquisitions, Dispositions and Mortgage Repayments - Narrative (Details) $ in Thousands	Jan. 30, 2023 USD ($) ft²	Feb. 10, 2023 USD ($) ft²	Jan. 13, 2023 USD ($) ft² property	Dec. 31, 2022 USD ($) ft² building
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of buildings | building				33
Area of building sold | ft²				3,069,124
SALES PRICE | $				$ 1,242,218
Subsequent Event
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of medical buildings included in disposition | property			2
Area of building sold | ft²	36,691	6,500	224,037
SALES PRICE | $	$ 19,200	$ 400	$ 93,300
Joint venture, ownership (in percentage)	40%
Real Estate Properties Held In Joint Ventures Member
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Weighted average ownership interest (percent)				48%

Acquisitions, Dispositions an_6

Acquisitions, Dispositions and Mortgage Repayments - Subsequent Acquisitions (Details) $ in Thousands	Dec. 31, 2022 USD ($) ft²	Dec. 31, 2021 USD ($) ft²
Business Acquisition [Line Items]
SQUARE FOOTAGE unaudited | ft²	214,124	514,253
PURCHASE PRICE | $	$ 100,975	$ 180,487

Acquisitions, Dispositions an_7

Acquisitions, Dispositions and Mortgage Repayments - Joint Ventures (Details) $ in Thousands												12 Months Ended
	Aug. 30, 2022	Mar. 07, 2022 USD ($) ft² property	Dec. 29, 2021 USD ($) ft²	Dec. 10, 2021 USD ($) ft²	Oct. 21, 2021 USD ($) ft²	Jul. 27, 2021 USD ($) ft²	May 10, 2021 USD ($) ft²	Apr. 30, 2021 USD ($) ft²	Apr. 08, 2021 USD ($) ft²	Apr. 01, 2021 USD ($) ft²	Mar. 30, 2021 USD ($) ft²	Dec. 31, 2022 USD ($) a ft² property jointVenture building	Dec. 31, 2021 USD ($) ft² property	Dec. 31, 2020 USD ($)
Real Estate [Line Items]
Number of buildings | building												33
PURCHASE PRICE												$ 100,975	$ 180,487
CASH CONSIDERATION												99,173	177,994
REAL ESTATE												97,569	179,862
OTHER												$ 1,604	$ (1,868)
SQUARE FOOTAGE unaudited | ft²												214,124	514,253
NUMBER OF PROPERTIES | property												688
Equity Method Investments [Roll Forward]
Equity loss recognized during the period												$ (687)	$ (795)	$ (463)
Owner distributions												$ (1,900)	$ 0
Real Estate Properties Held In Joint Ventures Member
Real Estate [Line Items]
Joint venture ownership (percent)												48%
San Francisco, CA
Real Estate [Line Items]
PURCHASE PRICE		$ 67,175
CASH CONSIDERATION		66,789
REAL ESTATE		65,179
OTHER		$ 1,610
SQUARE FOOTAGE unaudited | ft²		110,865
Los Angeles, CA
Real Estate [Line Items]
PURCHASE PRICE		$ 33,800					$ 24,600		$ 31,335
CASH CONSIDERATION		32,384					24,259		30,179
REAL ESTATE		32,390					24,147		30,642
OTHER		$ (6)					$ 112		$ (463)
SQUARE FOOTAGE unaudited | ft²		103,259					73,078		57,573
Denver, CO
Real Estate [Line Items]
PURCHASE PRICE					$ 23,000						$ 14,375
CASH CONSIDERATION					22,638						14,056
REAL ESTATE					23,021						14,550
OTHER					$ (383)						$ (494)
SQUARE FOOTAGE unaudited | ft²					57,257						59,359
Colorado Springs, CO
Real Estate [Line Items]
PURCHASE PRICE						$ 9,133				$ 7,200
CASH CONSIDERATION						9,137				7,288
REAL ESTATE						9,135				7,347
OTHER						$ 2				$ (59)
SQUARE FOOTAGE unaudited | ft²						23,956				27,510
San Antonio, TX
Real Estate [Line Items]
PURCHASE PRICE				$ 42,300				$ 13,600
CASH CONSIDERATION				41,892				13,412
REAL ESTATE				42,190				13,656
OTHER				$ (298)				$ (244)
SQUARE FOOTAGE unaudited | ft²				117,597				45,000
Area of land | a												3
NUMBER OF PROPERTIES | property													3
Dallas, TX
Equity Method Investments [Roll Forward]
Joint venture, ownership (in percentage)	40%
Medical Office Building
Real Estate [Line Items]
Number of buildings | property												2	4
Medical Office Building | San Francisco, CA
Real Estate [Line Items]
NUMBER OF PROPERTIES | property		3
Medical Office Building | San Antonio, TX
Real Estate [Line Items]
PURCHASE PRICE			$ 6,094
CASH CONSIDERATION			6,218
REAL ESTATE			6,308
OTHER			$ (90)
SQUARE FOOTAGE unaudited | ft²			22,381
Medical Office Building 2 | Los Angeles, CA
Real Estate [Line Items]
NUMBER OF PROPERTIES | property		2
Medical Office Building 2 | San Antonio, TX
Real Estate [Line Items]
PURCHASE PRICE			$ 8,850
CASH CONSIDERATION			8,915
REAL ESTATE			8,866
OTHER			$ 49
SQUARE FOOTAGE unaudited | ft²			30,542
Parking Garages
Equity Method Investments [Roll Forward]
Investments in unconsolidated joint ventures, beginning of period												$ 161,900	$ 73,100
New investments during the period1												167,900	89,600
Equity loss recognized during the period												(700)	(800)
Investments in unconsolidated joint ventures, end of period												$ 327,200	$ 161,900	$ 73,100
Parking Garages | Los Angeles, CA
Equity Method Investments [Roll Forward]
Number of joint ventures | jointVenture												2
Parking Garages | Los Angeles, CA | Limited Liability Company One
Equity Method Investments [Roll Forward]
Joint venture, ownership (in percentage)												20%
Parking Garages | Dallas, TX | Limited Liability Company Two
Equity Method Investments [Roll Forward]
Joint venture, ownership (in percentage)												40%

Acquisitions, Dispositions an_8

Acquisitions, Dispositions and Mortgage Repayments - Dispositions (Details) $ in Thousands																						3 Months Ended	12 Months Ended
	Dec. 28, 2022 USD ($) ft²	Dec. 22, 2022 USD ($) ft²	Nov. 10, 2022 USD ($) ft²	Oct. 21, 2022 USD ($) ft²	Oct. 04, 2022 USD ($) ft² property	Aug. 31, 2022 USD ($) ft² property	Aug. 30, 2022 USD ($) ft² property	Aug. 05, 2022 USD ($) ft² property	Aug. 04, 2022 USD ($) ft² property	Jul. 29, 2022 USD ($) ft² property	Apr. 15, 2022 USD ($) ft² property	Feb. 24, 2022 USD ($) ft² property	Dec. 23, 2021 USD ($) ft²	Dec. 22, 2021 USD ($) ft²	Dec. 08, 2021 USD ($) ft² property	Oct. 28, 2021 USD ($) ft²	Jul. 09, 2021 USD ($) ft² property	May 19, 2021 USD ($) ft² property	May 18, 2021 USD ($) ft²	Apr. 21, 2021 USD ($) ft²	Mar. 11, 2021 USD ($) ft²	Jun. 30, 2021 property	Dec. 31, 2022 USD ($) ft² property	Dec. 31, 2021 USD ($) ft² property	Apr. 12, 2021 USD ($)
Real Estate Dispositions [Line Items]
SALES PRICE																							$ 1,242,218
CLOSING ADJUSTMENTS																							(45,666)
NET PROCEEDS																							1,196,552
NET REAL ESTATE INVESTMENT																							939,363
OTHER including receivables																							14,225
GAIN/ (IMPAIRMENT)																							$ 242,964
SQUARE FOOTAGE unaudited | ft²																							3,069,124
Purchase price																							$ 5,576,463	$ 8,900
Number of properties sold | property																							12	5
Number of land parcels held for development | property																							20	7
Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALES PRICE																								$ 188,400
CLOSING ADJUSTMENTS																								(4,229)
NET PROCEEDS																								184,171
NET REAL ESTATE INVESTMENT																								132,356
OTHER including receivables																								7,981
GAIN/ (IMPAIRMENT)																								$ 43,834
SQUARE FOOTAGE unaudited | ft²																								847,002
Loveland, CO
Real Estate Dispositions [Line Items]
SALES PRICE												$ 84,950
CLOSING ADJUSTMENTS												(45)
NET PROCEEDS												84,905
NET REAL ESTATE INVESTMENT												40,095
OTHER including receivables												4
GAIN/ (IMPAIRMENT)												$ 44,806
SQUARE FOOTAGE unaudited | ft²												150,291
Number of buildings acquired | property												2
San Antonio, TX
Real Estate Dispositions [Line Items]
SALES PRICE											$ 25,500
CLOSING ADJUSTMENTS											(2,272)
NET PROCEEDS											23,228
NET REAL ESTATE INVESTMENT											14,381
OTHER including receivables											284
GAIN/ (IMPAIRMENT)											$ 8,563
SQUARE FOOTAGE unaudited | ft²											201,523
Number of buildings acquired | property											2
GA, FL, PA
Real Estate Dispositions [Line Items]
SALES PRICE										$ 133,100
CLOSING ADJUSTMENTS										(8,109)
NET PROCEEDS										124,991
NET REAL ESTATE INVESTMENT										124,991
OTHER including receivables										0
GAIN/ (IMPAIRMENT)										$ 0
SQUARE FOOTAGE unaudited | ft²										316,739
Number of buildings acquired | property										4
GA, FL, TX
Real Estate Dispositions [Line Items]
SALES PRICE									$ 160,917
CLOSING ADJUSTMENTS									(5,893)
NET PROCEEDS									155,024
NET REAL ESTATE INVESTMENT									151,819
OTHER including receivables									3,205
GAIN/ (IMPAIRMENT)									$ 0
SQUARE FOOTAGE unaudited | ft²									343,545
Number of buildings acquired | property									6
Los Angeles, CA
Real Estate Dispositions [Line Items]
SALES PRICE								$ 134,845
CLOSING ADJUSTMENTS								(3,102)
NET PROCEEDS								131,743
NET REAL ESTATE INVESTMENT								131,332
OTHER including receivables								411
GAIN/ (IMPAIRMENT)								$ 0
SQUARE FOOTAGE unaudited | ft²								283,780
Number of buildings acquired | property								4
Values and square feet, represented percentage (in percent)								100%
Joint venture, ownership (in percentage)								20%
Los Angeles, CA | Real Estate Dispositions
Real Estate Dispositions [Line Items]
Number of properties sold | property																						2
Dallas, TX
Real Estate Dispositions [Line Items]
SALES PRICE					$ 104,025		$ 114,290
CLOSING ADJUSTMENTS					(5,883)		(682)
NET PROCEEDS					98,142		113,608
NET REAL ESTATE INVESTMENT					38,872		113,608
OTHER including receivables					6,436		0
GAIN/ (IMPAIRMENT)					$ 52,834		$ 0
SQUARE FOOTAGE unaudited | ft²					291,328		189,385
Number of buildings acquired | property					2		6
Values and square feet, represented percentage (in percent)							100%
Joint venture, ownership (in percentage)							40%
Dallas, TX | Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALES PRICE													$ 800				$ 23,000
CLOSING ADJUSTMENTS													(103)				(1,117)
NET PROCEEDS													697				21,883
NET REAL ESTATE INVESTMENT													712				18,733
OTHER including receivables													167				1,966
GAIN/ (IMPAIRMENT)													$ (182)				$ 1,184
SQUARE FOOTAGE unaudited | ft²													13,818				190,160
Number of properties sold | property																	4
Indianapolis, IN
Real Estate Dispositions [Line Items]
SALES PRICE						$ 238,845
CLOSING ADJUSTMENTS						(5,846)
NET PROCEEDS						232,999
NET REAL ESTATE INVESTMENT						84,767
OTHER including receivables						4,324
GAIN/ (IMPAIRMENT)						$ 143,908
SQUARE FOOTAGE unaudited | ft²						506,406
Number of buildings acquired | property						5
Number of properties acquired in the merger | property						2
Los Angeles, CA | Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALES PRICE																					$ 26,000
CLOSING ADJUSTMENTS																					(555)
NET PROCEEDS																					25,445
NET REAL ESTATE INVESTMENT																					6,046
OTHER including receivables																					509
GAIN/ (IMPAIRMENT)																					$ 18,890
SQUARE FOOTAGE unaudited | ft²																					73,906
Atlanta, GA
Real Estate Dispositions [Line Items]
SALES PRICE		$ 91,243
CLOSING ADJUSTMENTS		(4,326)
NET PROCEEDS		86,917
NET REAL ESTATE INVESTMENT		109,051
OTHER including receivables		235
GAIN/ (IMPAIRMENT)		$ (22,369)
SQUARE FOOTAGE unaudited | ft²		348,416
Number of buildings acquired | property																							9	2
Atlanta, GA | Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALES PRICE																				$ 8,050
CLOSING ADJUSTMENTS																				(272)
NET PROCEEDS																				7,778
NET REAL ESTATE INVESTMENT																				5,675
OTHER including receivables																									$ 151
GAIN/ (IMPAIRMENT)																				$ 1,952
SQUARE FOOTAGE unaudited | ft²																				19,732
Richmond, VA | Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALES PRICE																			$ 52,000
CLOSING ADJUSTMENTS																			(314)
NET PROCEEDS																			51,686
NET REAL ESTATE INVESTMENT																			29,414
OTHER including receivables																			3,270
GAIN/ (IMPAIRMENT)																			$ 19,002
SQUARE FOOTAGE unaudited | ft²																			142,856
Gadsden, AL | Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALES PRICE																		$ 5,500
CLOSING ADJUSTMENTS																		(280)
NET PROCEEDS																		5,220
NET REAL ESTATE INVESTMENT																		5,914
OTHER including receivables																		175
GAIN/ (IMPAIRMENT)																		$ (869)
SQUARE FOOTAGE unaudited | ft²																		120,192
Number of properties sold | property																		3
Chicago, IL | Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALES PRICE																$ 13,300
CLOSING ADJUSTMENTS																(388)
NET PROCEEDS																12,912
NET REAL ESTATE INVESTMENT																23,213
OTHER including receivables																706
GAIN/ (IMPAIRMENT)																$ (11,007)
SQUARE FOOTAGE unaudited | ft²																95,436
Des Moines, IA | Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALES PRICE															$ 47,000
CLOSING ADJUSTMENTS															(901)
NET PROCEEDS															46,099
NET REAL ESTATE INVESTMENT															32,312
OTHER including receivables															1,037
GAIN/ (IMPAIRMENT)															$ 12,750
SQUARE FOOTAGE unaudited | ft²															132,617
Number of properties sold | property															3
Number of land parcels held for development | property																	2
Aberdeen, SD | Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALES PRICE														$ 12,750
CLOSING ADJUSTMENTS														(299)
NET PROCEEDS														12,451
NET REAL ESTATE INVESTMENT														10,337
OTHER including receivables														0
GAIN/ (IMPAIRMENT)														$ 2,114
SQUARE FOOTAGE unaudited | ft²														58,285
Houston, TX
Real Estate Dispositions [Line Items]
SALES PRICE				$ 32,000
CLOSING ADJUSTMENTS				(280)
NET PROCEEDS				31,720
NET REAL ESTATE INVESTMENT				10,762
OTHER including receivables				744
GAIN/ (IMPAIRMENT)				$ 20,214
SQUARE FOOTAGE unaudited | ft²				134,910
College Station, TX
Real Estate Dispositions [Line Items]
SALES PRICE			$ 49,177
CLOSING ADJUSTMENTS			(3,755)
NET PROCEEDS			45,422
NET REAL ESTATE INVESTMENT			44,918
OTHER including receivables			475
GAIN/ (IMPAIRMENT)			$ 28
SQUARE FOOTAGE unaudited | ft²			122,942
El Paso, TX
Real Estate Dispositions [Line Items]
SALES PRICE		$ 55,326
CLOSING ADJUSTMENTS		(4,002)
NET PROCEEDS		51,324
NET REAL ESTATE INVESTMENT		56,427
OTHER including receivables		(1,897)
GAIN/ (IMPAIRMENT)		$ (3,205)
SQUARE FOOTAGE unaudited | ft²		110,465
St. Louis, MO
Real Estate Dispositions [Line Items]
SALES PRICE	$ 18,000
CLOSING ADJUSTMENTS	(1,471)
NET PROCEEDS	16,529
NET REAL ESTATE INVESTMENT	18,340
OTHER including receivables	4
GAIN/ (IMPAIRMENT)	$ (1,815)
SQUARE FOOTAGE unaudited | ft²	69,394

Held for Sale - Narrative (Deta

Held for Sale - Narrative (Details) - property	Dec. 31, 2022	Dec. 31, 2021
Asset Held-for-sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties held for sale	1	0

Held for - Sale Assets Held for

Held for - Sale Assets Held for Sale (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Balance Sheet data (as of the period ended):
Land	$ 1,439,798	$ 387,918
Buildings and improvements	11,332,037	4,337,641
Lease intangibles	959,998	120,478
Total real estate investments	14,057,625	5,104,942
Less accumulated depreciation	(1,645,271)	(1,338,743)
Total real estate investments, net	12,412,354	3,766,199
Assets held for sale, net	18,893	57
Liabilities of properties held for sale	437	294
Disposal Group, Held-for-sale, Not Discontinued Operations
Balance Sheet data (as of the period ended):
Land	1,700	0
Buildings and improvements	15,164	0
Lease intangibles	1,986	0
Total real estate investments	18,850	0
Less accumulated depreciation	0	0
Total real estate investments, net	18,850	0
Other assets, net	43	57
Assets held for sale, net	18,893	57
Accounts payable and accrued liabilities	282	169
Other liabilities	155	125
Liabilities of properties held for sale	$ 437	$ 294

Impairment Charges (Details)

Impairment Charges (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) property	Dec. 31, 2021 USD ($) property
Property, Plant and Equipment [Abstract]
Number of properties sold | property	12	5
Number of properties redeveloped | property	3	1
Impairment charges | $	$ 54.4
Impairments | $		$ 17.1

Other Assets and Liabilities -

Other Assets and Liabilities - Other Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Real estate notes receivable, net	$ 99,643	$ 0
Straight-line rent receivables	88,868	70,784
Prepaid assets	81,900	58,618
Above-market intangible assets, net	80,720	4,966
Accounts receivable, net	47,498	14,072
Additional long-lived assets, net	21,446	20,048
Interest rate swap assets	14,512	0
Other receivables, net	7,169	0
Investment in securities	6,011	0
Debt issuance costs, net	5,977	1,813
Project costs	4,337	5,129
Net investment in lease	1,828	0
Customer relationship intangible assets, net	1,120	1,174
Other	8,961	9,069
Other assets	469,990	$ 185,673
Allowance for doubtful accounts	$ 4,000

Other Assets and Liabilities _2

Other Assets and Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Accrued property taxes	$ 78,185	$ 35,295
Accounts payable and capital expenditures	57,352	17,036
Accrued interest	50,037	12,060
Other operating accruals	58,459	21,717
Accounts payable and accrued liabilities	$ 244,033	$ 86,108

Other Assets and Liabilities _3

Other Assets and Liabilities - Other Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Below-market intangible liabilities, net	$ 97,935	$ 4,931
Deferred revenue	87,325	45,130
Security deposits	28,521	11,116
Interest rate swap liability	4,269	5,917
Other	618	293
Other liabilities	$ 218,668	$ 67,387

Intangible Assets and Liabili_3

Intangible Assets and Liabilities - Components of intangible assets and liabilities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of finite lived intangible assets and liabilities
Intangible assets and liabilities, gross	$ 1,278.6	$ 220.6
Intangible assets and liabilities, accumulated amortization	$ 186.3	78.6
Assets and liabilities, weighted avg. life (years)	5 years 3 months 18 days
Below-market lease intangibles (lessor) | Other liabilities
Schedule of finite lived intangible assets and liabilities
Liabilities gross balance	$ (112.5)	(10.1)
Liabilities accumulated amortization	$ (14.6)	(5.1)
Liabilities, weighted avg. life (years)	5 years 8 months 12 days
Goodwill | Goodwill
Schedule of finite lived intangible assets and liabilities
Assets gross balance	$ 223.2	3.5
Assets accumulated amortization	0	0
Credit facility debt issuance costs | Goodwill
Schedule of finite lived intangible assets and liabilities
Assets gross balance	6.9	5.1
Assets accumulated amortization	$ 0.9	3.3
Assets, weighted avg. life (years)	2 years 10 months 24 days
Above-market lease intangibles (lessor) | Goodwill
Schedule of finite lived intangible assets and liabilities
Assets gross balance	$ 91.5	7
Assets accumulated amortization	$ 10.7	2
Assets, weighted avg. life (years)	5 years 3 months 18 days
Customer relationship intangibles (lessor) | Goodwill
Schedule of finite lived intangible assets and liabilities
Assets gross balance	$ 2.1	2.1
Assets accumulated amortization	$ 1	0.9
Assets, weighted avg. life (years)	20 years 7 months 6 days
At-market lease intangibles | At-market lease intangibles
Schedule of finite lived intangible assets and liabilities
Assets gross balance	$ 1,067.4	213
Assets accumulated amortization	$ 188.3	$ 77.5
Assets, weighted avg. life (years)	5 years 2 months 12 days

Intangible Assets and Liabili_4

Intangible Assets and Liabilities - Expected future amortization expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible amortization expense	$ 133.6	$ 33.7
Future Amortization of Intangibles, Net [Abstract]
2023	233.8
2024	197.9
2025	151.1
2026	97.6
2027	$ 64.3

Notes and Bonds Payable (Detail

Notes and Bonds Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Senior notes carrying amount	$ 5,351,827,000	$ 1,801,325,000
Line of Credit | $700M Unsecured Credit Facility
Debt Instrument [Line Items]
Face value	700,000,000
Senior notes carrying amount	$ 0	210,000,000
Line of Credit | $700M Unsecured Credit Facility | LIBOR
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	0.90%
Line of Credit | $1.5B Unsecured Credit Facility
Debt Instrument [Line Items]
Face value	$ 1,500,000,000
Senior notes carrying amount	$ 385,000,000	0
EFFECTIVE INTEREST RATES	5.27%
Line of Credit | $1.5B Unsecured Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	0.95%
Medium-term Notes | $350 million Unsecured Term Loan due 2023, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 350,000,000
Senior notes carrying amount	$ 349,114,000	0
EFFECTIVE INTEREST RATES	5.17%
Medium-term Notes | $350 million Unsecured Term Loan due 2023, net of issuance costs | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Medium-term Notes | $200 million Unsecured Term Loan due 2024, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 200,000,000
Senior notes carrying amount	$ 199,670,000	199,460,000
EFFECTIVE INTEREST RATES	5.17%
Medium-term Notes | $200 million Unsecured Term Loan due 2024, net of issuance costs | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Medium-term Notes | $150 million Unsecured Term Loan due 2026, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 150,000,000
Senior notes carrying amount	$ 149,495,000	149,376,000
EFFECTIVE INTEREST RATES	5.17%
Medium-term Notes | $150 million Unsecured Term Loan due 2026, net of issuance costs | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Medium-term Notes | $300 million Unsecured Term Loan due 2025, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 300,000,000
Senior notes carrying amount	$ 299,936,000	0
EFFECTIVE INTEREST RATES	5.17%
Medium-term Notes | $300 million Unsecured Term Loan due 2025, net of issuance costs | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Medium-term Notes | $200 million Unsecured Term Loan due 2027, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 200,000,000
Senior notes carrying amount	$ 199,362,000	0
EFFECTIVE INTEREST RATES	5.17%
Medium-term Notes | $200 million Unsecured Term Loan due 2027, net of issuance costs | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Medium-term Notes | $300 million Unsecured Term Loan due 2028, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 300,000,000
Senior notes carrying amount	$ 297,869,000	0
EFFECTIVE INTEREST RATES	5.17%
Medium-term Notes | $300 million Unsecured Term Loan due 2028, net of issuance costs | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Senior Notes | Senior Notes due 2025
Debt Instrument [Line Items]
Senior notes carrying amount	$ 249,115,000	249,040,000
Contractual interest rates	3.88%
EFFECTIVE INTEREST RATES	4.12%
Senior Notes | Senior Notes due 2026
Debt Instrument [Line Items]
Senior notes carrying amount	$ 571,587,000	0
Contractual interest rates	3.50%
EFFECTIVE INTEREST RATES	4.94%
Senior Notes | Senior Notes Due 2027
Debt Instrument [Line Items]
Senior notes carrying amount	$ 479,553,000	0
Contractual interest rates	3.75%
EFFECTIVE INTEREST RATES	4.76%
Senior Notes | Senior Notes due 2028
Debt Instrument [Line Items]
Senior notes carrying amount	$ 296,852,000	296,612,000
Contractual interest rates	3.63%
EFFECTIVE INTEREST RATES	3.85%
Senior Notes | Senior Notes Due 2030 One
Debt Instrument [Line Items]
Senior notes carrying amount	$ 565,402,000	0
Contractual interest rates	3.10%
EFFECTIVE INTEREST RATES	5.30%
Senior Notes | Senior Notes Due 2030 Two
Debt Instrument [Line Items]
Senior notes carrying amount	$ 296,385,000	296,813,000
Contractual interest rates	2.40%
EFFECTIVE INTEREST RATES	2.72%
Senior Notes | Senior Notes Due 2031 One
Debt Instrument [Line Items]
Senior notes carrying amount	$ 295,547,000	295,374,000
Contractual interest rates	2.05%
EFFECTIVE INTEREST RATES	2.25%
Senior Notes | Senior Notes Due 2031 Two
Debt Instrument [Line Items]
Senior notes carrying amount	$ 632,693,000	0
Contractual interest rates	2%
EFFECTIVE INTEREST RATES	5.13%
Mortgage Notes | Mortgage Notes Payable
Debt Instrument [Line Items]
Face value	$ 84,122,000	103,664,000
Senior notes carrying amount	$ 84,247,000	$ 104,650,000
Minimum | Mortgage Notes
Debt Instrument [Line Items]
Contractual interest rates	3.30%
Minimum | Mortgage Notes | Mortgage Notes Payable
Debt Instrument [Line Items]
Contractual interest rates	3.31%
EFFECTIVE INTEREST RATES	3.42%
Maximum | Mortgage Notes
Debt Instrument [Line Items]
Contractual interest rates	4.80%
Maximum | Mortgage Notes | Mortgage Notes Payable
Debt Instrument [Line Items]
Contractual interest rates	4.77%
EFFECTIVE INTEREST RATES	4.84%

Notes and Bonds Payable - Narra

Notes and Bonds Payable - Narrative (Details)	Jul. 20, 2022 USD ($) extension_option	Feb. 24, 2022 USD ($) ft²	Feb. 18, 2022 USD ($) ft²	Dec. 31, 2022 USD ($)	Jul. 22, 2022 USD ($)	Dec. 31, 2021 USD ($)
Debt Instrument [Line Items]
Senior notes carrying amount				$ 5,351,827,000		$ 1,801,325,000
Mortgage Notes
Debt Instrument [Line Items]
Amount of debt repaid		$ 5,800,000	$ 11,000,000
Effective interest rate		6.17%	4.70%
Encumbered square footage | ft²			56,762
Redemption price		$ 6,400,000	$ 12,600,000
Debt redeemed, make whole amount			1,600,000
Unamortized premium		600,000	800,000
Write off of deferred debt issuance cost		$ 100,000	$ 100,000
Mortgage Notes | Colorado Springs, CO
Debt Instrument [Line Items]
Encumbered square footage | ft²		80,153
Amended and Restated Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Amount of debt repaid	$ 700,000,000
Term Loan Facility Due May 2026
Debt Instrument [Line Items]
Amount of debt repaid	200,000,000
Term Loan Facility Due June 2026
Debt Instrument [Line Items]
Amount of debt repaid	150,000,000
Amended Term Loan Facility Due May 2026
Debt Instrument [Line Items]
FACE VALUE	$ 200,000,000
Number of extension options | extension_option	2
Extension option period	1 year
Amended Term Loan Facility Due June 2026
Debt Instrument [Line Items]
FACE VALUE	$ 150,000,000
Credit Facility Maturing October 2025 | Revolving Credit Facility
Debt Instrument [Line Items]
Number of extension options | extension_option	2
Credit facility	$ 1,500,000,000			1,000,000,000
Term Loan Facility Due October 2025
Debt Instrument [Line Items]
Credit facility	300,000,000
Term Loan Facility Due January 2024 - July 20, 2027
Debt Instrument [Line Items]
Credit facility	$ 200,000,000
Delayed Term Loan Facility due July 20, 2023
Debt Instrument [Line Items]
Number of extension options | extension_option	2
Credit facility	$ 350,000,000
Delayed credit facility, period available for draws	12 months
Term Loan Facility Due January 20, 2028
Debt Instrument [Line Items]
Credit facility	$ 300,000,000
1.125 billion Asset Sale Term Loan | Medium-term Notes
Debt Instrument [Line Items]
FACE VALUE				1,125,000,000
Healthcare Trust Of America, Inc
Debt Instrument [Line Items]
FACE VALUE				3,699,500,000	$ 2,550,000,000	1,150,000,000
Senior notes carrying amount				3,387,134,000		$ 1,137,839,000
Healthcare Trust Of America, Inc | 3.875% Senior Notes Due 2025
Debt Instrument [Line Items]
Business combination, validly tendered and accepted notes, exchange amount				$ 250,000,000
Interest rate on senior notes				3.875%	3.875%
Healthcare Trust Of America, Inc | 3.625% Senior Notes Due 2028
Debt Instrument [Line Items]
Business combination, validly tendered and accepted notes, exchange amount				$ 300,000,000
Interest rate on senior notes				3.625%	3.625%
Healthcare Trust Of America, Inc | 2.400% Senior Notes Due 2030
Debt Instrument [Line Items]
Business combination, validly tendered and accepted notes, exchange amount				$ 300,000,000
Interest rate on senior notes				2.40%	2.40%
Healthcare Trust Of America, Inc | 2.050% Senior Notes Due 2031
Debt Instrument [Line Items]
Business combination, validly tendered and accepted notes, exchange amount				$ 300,000,000
Interest rate on senior notes				2.05%	2.05%

Notes and Bonds Payable - Sched

Notes and Bonds Payable - Schedule of Debt Exchange Offers (Details) - Healthcare Trust Of America, Inc - USD ($)	Dec. 31, 2022	Jul. 22, 2022
3.875% Senior Notes Due 2025
Debt Instrument [Line Items]
Tenders and Consents Received as of the Expiration Date		$ 235,016,000
Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes		94.01%
Fixed interest rate (percent)	3.875%	3.875%
3.625% Senior Notes Due 2028
Debt Instrument [Line Items]
Tenders and Consents Received as of the Expiration Date		$ 290,246,000
Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes		96.75%
Fixed interest rate (percent)	3.625%	3.625%
2.400% Senior Notes Due 2030
Debt Instrument [Line Items]
Tenders and Consents Received as of the Expiration Date		$ 297,507,000
Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes		99.17%
Fixed interest rate (percent)	2.40%	2.40%
2.050% Senior Notes Due 2031
Debt Instrument [Line Items]
Tenders and Consents Received as of the Expiration Date		$ 298,858,000
Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes		99.62%
Fixed interest rate (percent)	2.05%	2.05%

Notes and Bonds Payable - Sch_2

Notes and Bonds Payable - Schedule of Senior Notes Assumed with the Merger (Details) - Healthcare Trust Of America, Inc - USD ($)	12 Months Ended
	Dec. 31, 2022	Jul. 22, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
FACE VALUE	$ 3,699,500,000	$ 2,550,000,000	$ 1,150,000,000
Debt instrument, debt default, amount	$ 2,550,000,000		0
Senior Notes due 2026
Debt Instrument [Line Items]
Fixed interest rate (percent)	350%
FACE VALUE		600,000,000
Debt instrument, debt default, amount	$ 600,000,000		0
Senior Notes due 2027
Debt Instrument [Line Items]
Fixed interest rate (percent)	375%
FACE VALUE		500,000,000
Debt instrument, debt default, amount	$ 500,000,000		0
Senior Notes due 2030
Debt Instrument [Line Items]
Fixed interest rate (percent)	310%
FACE VALUE		650,000,000
Debt instrument, debt default, amount	$ 650,000,000		0
Senior Notes due 2031
Debt Instrument [Line Items]
Fixed interest rate (percent)	200%
FACE VALUE		$ 800,000,000
Debt instrument, debt default, amount	$ 800,000,000		$ 0

Notes and Bonds Payable - Senio

Notes and Bonds Payable - Senior and Term Notes (Details) - USD ($)	Dec. 31, 2022	Jul. 22, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Debt issuance costs	$ (5,977,000)		$ (1,813,000)
Notes and bonds payable	5,351,827,000		1,801,325,000
Healthcare Trust Of America, Inc
Debt Instrument [Line Items]
FACE VALUE	3,699,500,000	$ 2,550,000,000	1,150,000,000
Unaccreted discount	(304,919,000)		(4,730,000)
Debt issuance costs	(7,447,000)		(7,431,000)
Notes and bonds payable	$ 3,387,134,000		$ 1,137,839,000

Notes and Bonds Payable - Mortg

Notes and Bonds Payable - Mortgage Notes (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Debt issuance costs	$ (5,977,000)	$ (1,813,000)
Notes and bonds payable	5,351,827,000	1,801,325,000
Term Loan Net | Term Loan
Debt Instrument [Line Items]
Face value	1,500,000,000	350,000,000
Debt issuance costs	(4,554,000)	(1,164,000)
Notes and bonds payable	1,495,446,000	348,836,000
Mortgage Notes Payable | Mortgage Notes
Debt Instrument [Line Items]
Face value	84,122,000	103,664,000
Unamortized premium	486,000	1,720,000
Unaccreted discount	(38,000)	(83,000)
Debt issuance costs	(323,000)	(651,000)
Notes and bonds payable	$ 84,247,000	$ 104,650,000

Notes and Bonds Payable - Detai

Notes and Bonds Payable - Details of Mortgage Notes (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) mortage_note_payable	Dec. 31, 2021 USD ($)
Debt Instrument [Line Items]
Number of outstanding mortgage notes | mortage_note_payable	6
Mortgage Notes
Debt Instrument [Line Items]
Investment in collateral	$ 228,300,000
Mortgage notes payable carrying amount	$ 84,200,000	$ 104,700,000
Number of outstanding mortgage notes | mortage_note_payable	8
Mortgage Notes | Minimum
Debt Instrument [Line Items]
Contractual interest rates	3.30%
Mortgage Notes | Maximum
Debt Instrument [Line Items]
Contractual interest rates	4.80%
Mortgage Notes | Mortgage Notes 5.25% | Commercial Bank
Debt Instrument [Line Items]
FACE VALUE	$ 15,000,000
Effective interest rate	5.25%
Collateral	MOB
Investment in collateral	$ 0
Mortgage notes payable carrying amount	$ 0	6,100,000
Principal and interest amortization period	20 years
Mortgage Notes | Mortgage Notes 3.64% | Life Insurance Co.
Debt Instrument [Line Items]
FACE VALUE	$ 11,000,000
Effective interest rate	3.64%
Collateral	MOB
Investment in collateral	$ 0
Mortgage notes payable carrying amount	$ 0	11,600,000
Principal and interest amortization period	10 years
Mortgage Notes | Mortgage Notes 3.64% | Financial Services
Debt Instrument [Line Items]
Unencumbered gross investment	$ 20,600,000
Mortgage Notes | Mortgage Notes 3.86% | Life Insurance Co.
Debt Instrument [Line Items]
FACE VALUE	$ 12,300,000
Effective interest rate	3.86%
Collateral	MOB
Investment in collateral	$ 25,900,000
Mortgage notes payable carrying amount	10,000,000	10,300,000
Unaccreted discount	$ 200,000
Principal and interest amortization period	7 years
Mortgage Notes | Mortgage Notes 4.84% | Life Insurance Co.
Debt Instrument [Line Items]
FACE VALUE	$ 9,000,000
Effective interest rate	4.84%
Collateral	MOB,OFC
Investment in collateral	$ 24,500,000
Mortgage notes payable carrying amount	6,800,000	7,100,000
Unamortized premium	100,000
Mortgage Notes | Mortgage Notes 4.13% | Life Insurance Co.
Debt Instrument [Line Items]
FACE VALUE	$ 13,300,000
Effective interest rate	4.13%
Collateral	MOB
Investment in collateral	$ 22,500,000
Mortgage notes payable carrying amount	11,700,000	12,000,000
Unamortized premium	$ 800,000
Principal and interest amortization period	10 years
Mortgage Notes | Mortgage Notes 3.96% | Life Insurance Co.
Debt Instrument [Line Items]
FACE VALUE	$ 6,800,000
Effective interest rate	3.96%
Collateral	MOB
Investment in collateral	$ 14,700,000
Mortgage notes payable carrying amount	5,800,000	6,000,000
Unamortized premium	$ 200,000
Principal and interest amortization period	7 years
Mortgage Notes | Mortgage Notes 4.32% | Life Insurance Co.
Debt Instrument [Line Items]
Mortgage notes payable carrying amount		7,800,000
Mortgage Notes | Mortgage Notes 4.32% | Financial Services
Debt Instrument [Line Items]
FACE VALUE	$ 9,700,000
Effective interest rate	4.32%
Collateral	MOB
Investment in collateral	$ 16,600,000
Mortgage notes payable carrying amount	7,500,000
Unamortized premium	$ 100,000
Principal and interest amortization period	10 years
Mortgage Notes | Mortgage Notes 3.43% | Life Insurance Co.
Debt Instrument [Line Items]
FACE VALUE	$ 16,500,000
Effective interest rate	3.43%
Collateral	MOB,OFC
Investment in collateral	$ 39,100,000
Mortgage notes payable carrying amount	16,200,000	16,700,000
Unamortized premium	$ 700,000
Principal and interest amortization period	7 years
Mortgage Notes | Mortgage Notes 3.71% | Financial Services
Debt Instrument [Line Items]
FACE VALUE	$ 11,500,000
Effective interest rate	3.71%
Collateral	MOB
Investment in collateral	$ 40,500,000
Mortgage notes payable carrying amount	$ 8,300,000	8,700,000
Principal and interest amortization period	10 years
Mortgage Notes | Mortgage Notes 4.08% | Life Insurance Co.
Debt Instrument [Line Items]
FACE VALUE	$ 19,200,000
Effective interest rate	4.08%
Collateral	MOB
Investment in collateral	$ 44,500,000
Mortgage notes payable carrying amount	$ 17,900,000	$ 18,400,000
Principal and interest amortization period	10 years
Mortgage Notes | Mortgage Notes 4.84% | Life Insurance Co.
Debt Instrument [Line Items]
Principal and interest amortization period	10 years

Notes and Bonds Payable - Futur

Notes and Bonds Payable - Future Maturities (Details) $ in Thousands	Dec. 31, 2022 USD ($) mortage_note_payable	Dec. 31, 2021 USD ($)
Long Term Debt Maturities [Line Items]
Number of outstanding mortgage notes | mortage_note_payable	6
Excluded debt issuance costs	$ 6,000
Future contractual maturities of the Company's notes and bonds payable
Debt issuance costs	(5,977)	$ (1,813)
Notes and bonds payable	5,351,827	$ 1,801,325
2023
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	368,880
Net Accretion/Amortization	(38,805)
Debt issuance costs	(3,258)
Notes and bonds payable	$ 326,817
%	6.10%
2024
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 225,352
Net Accretion/Amortization	(40,922)
Debt issuance costs	(2,211)
Notes and bonds payable	$ 182,219
%	3.40%
2025
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 951,250
Net Accretion/Amortization	(43,193)
Debt issuance costs	(1,851)
Notes and bonds payable	$ 906,206
%	16.90%
2026
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 773,640
Net Accretion/Amortization	(41,798)
Debt issuance costs	(1,636)
Notes and bonds payable	$ 730,206
%	13.60%
2027
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 700,000
Net Accretion/Amortization	(36,192)
Debt issuance costs	(1,518)
Notes and bonds payable	$ 662,290
%	12.40%
2028 and thereafter
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 2,649,500
Net Accretion/Amortization	(103,561)
Debt issuance costs	(1,850)
Notes and bonds payable	$ 2,544,089
%	47.60%
Net of Unsecured Credit Facility
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 5,668,622
Net Accretion/Amortization	(304,471)
Debt issuance costs	(12,324)
Notes and bonds payable	$ 5,351,827
%	100%

Derivative Financial Instrume_3

Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details) - Cash Flow Hedging - Designated as Hedging Instrument - USD ($) $ in Thousands	Feb. 16, 2023	Dec. 31, 2022	Dec. 31, 2021
Interest Rate Swap
Derivative [Line Items]
Derivative notional amount		$ 1,150,000
Derivative, Fixed Interest Rate			2.63%
Interest Rate Swap, Expiring January31, 2023
Derivative [Line Items]
Derivative notional amount		300,000
Derivative, Fixed Interest Rate			1.42%
Interest Rate Swap, Expiring January 15, 2024
Derivative [Line Items]
Derivative notional amount		200,000
Derivative, Fixed Interest Rate			1.21%
Interest Rate Swap, Expiring May 1, 2026
Derivative [Line Items]
Derivative notional amount		100,000
Derivative, Fixed Interest Rate			2.15%
Interest Rate Swap, Expiring December 1, 2026
Derivative [Line Items]
Derivative notional amount		150,000
Derivative, Fixed Interest Rate			3.84%
Interest Rate Swap, Expiring June 1, 2027
Derivative [Line Items]
Derivative notional amount		150,000
Derivative, Fixed Interest Rate			4.13%
Interest Rate Swap, Expiring December 1, 2027
Derivative [Line Items]
Derivative notional amount		$ 250,000
Derivative, Fixed Interest Rate			3.79%
Interest Rate Swap, Expiring December 1, 2027 | Subsequent Event
Derivative [Line Items]
Derivative notional amount	$ 50,000
Derivative, Fixed Interest Rate	4.16%

Derivative Financial Instrume_4

Derivative Financial Instruments (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($) derivative
Derivative [Line Items]
Amount of loss recognized in OCI on derivatives	$ (10,630)
Treasury Rate Locks
Derivative [Line Items]
Number of interest rate derivatives | derivative			2
Amount of loss recognized in OCI on derivatives	0	$ 0	$ 4,267
Term of senior notes			10 years
Treasury Lock 1
Derivative [Line Items]
Derivative notional amount			$ 75,000
Treasury Lock 2
Derivative [Line Items]
Derivative notional amount			40,000
Interest rate swaps 2017
Derivative [Line Items]
Amount of loss recognized in OCI on derivatives	(302)
Interest rate swaps 2018
Derivative [Line Items]
Amount of loss recognized in OCI on derivatives	(616)
Interest rate swaps 2019
Derivative [Line Items]
Amount of loss recognized in OCI on derivatives	(12,964)
Interest Rate Swap
Derivative [Line Items]
Amount of loss recognized in OCI on derivatives	(10,630)	$ (3,379)	$ 10,862
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap
Derivative [Line Items]
Derivative notional amount	$ 1,150,000

Derivative Financial Instrume_5

Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Gross Amounts of Recognized Liabilities	$ (4,269)
GROSS AMOUNTS of recognized assets	14,512
Interest rate swaps 2017 | Designated as Hedging Instrument | Other liabilities
Derivatives, Fair Value [Line Items]
Gross Amounts of Recognized Liabilities		$ (420)
Interest rate swaps 2018 | Designated as Hedging Instrument | Other liabilities
Derivatives, Fair Value [Line Items]
Gross Amounts of Recognized Liabilities		(976)
Interest rate swaps 2019 | Designated as Hedging Instrument | Goodwill
Derivatives, Fair Value [Line Items]
GROSS AMOUNTS of recognized assets	13,603
Interest rate swaps 2019 | Designated as Hedging Instrument | Other liabilities
Derivatives, Fair Value [Line Items]
Gross Amounts of Recognized Liabilities		(4,521)
Interest rate swaps 2022 | Designated as Hedging Instrument | Goodwill
Derivatives, Fair Value [Line Items]
GROSS AMOUNTS of recognized assets	909
Interest rate swaps 2022 | Designated as Hedging Instrument | Other liabilities
Derivatives, Fair Value [Line Items]
Gross Amounts of Recognized Liabilities	(4,269)	0
Interest Rate Swap | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Gross Amounts of Recognized Liabilities	$ 10,243	$ (5,917)

Derivative Financial Instrume_6

Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Gains (losses) arising during the period on interest rate swaps and treasury rate locks	$ 10,630
Reclassification adjustments for losses included in net income (interest expense)	(1,527)	$ (4,472)	$ (3,472)
Interest rate swaps 2017
Derivative [Line Items]
Gains (losses) arising during the period on interest rate swaps and treasury rate locks	302
Interest rate swaps 2018
Derivative [Line Items]
Gains (losses) arising during the period on interest rate swaps and treasury rate locks	616
Interest rate swaps 2019
Derivative [Line Items]
Gains (losses) arising during the period on interest rate swaps and treasury rate locks	12,964
Interest rate swaps 2022
Derivative [Line Items]
Gains (losses) arising during the period on interest rate swaps and treasury rate locks	(3,252)
Settled treasury hedges
Derivative [Line Items]
Gains (losses) arising during the period on interest rate swaps and treasury rate locks	0	0	$ (4,267)
Settled interest rate swaps
Derivative [Line Items]
Gains (losses) arising during the period on interest rate swaps and treasury rate locks	0
Interest Expense
Derivative [Line Items]
Reclassification adjustments for losses included in net income (interest expense)	1,527	4,472
Interest Expense | Interest rate swaps 2017
Derivative [Line Items]
Reclassification adjustments for losses included in net income (interest expense)	118	527
Interest Expense | Interest rate swaps 2018
Derivative [Line Items]
Reclassification adjustments for losses included in net income (interest expense)	361	1,194
Interest Expense | Interest rate swaps 2019
Derivative [Line Items]
Reclassification adjustments for losses included in net income (interest expense)	563	2,157
Interest Expense | Interest rate swaps 2022
Derivative [Line Items]
Reclassification adjustments for losses included in net income (interest expense)	(109)	0
Interest Expense | Settled treasury hedges
Derivative [Line Items]
Reclassification adjustments for losses included in net income (interest expense)	426	426
Interest Expense | Settled interest rate swaps
Derivative [Line Items]
Reclassification adjustments for losses included in net income (interest expense)	$ 168	$ 168

Derivative Financial Instrume_7

Derivative Financial Instruments - Offsetting Derivatives (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Offsetting Derivative Liabilities [Abstract]
GROSS AMOUNTS of recognized liabilities	$ (4,269)
GROSS AMOUNTS OFFSET in the Consolidated Balance Sheets	0
NET AMOUNTS OF ASSETS presented in the Consolidated Balance Sheets	(4,269)	$ (5,917)
FINANCIAL INSTRUMENTS	4,269
CASH COLLATERAL	0
NET AMOUNT	0
Offsetting Derivative Assets [Abstract]
GROSS AMOUNTS of recognized assets	14,512
GROSS AMOUNTS OFFSET in the Consolidated Balance Sheets	0
NET AMOUNTS OF ASSETS presented in the Consolidated Balance Sheets	14,512	$ 0
FINANCIAL INSTRUMENTS	(4,269)
CASH COLLATERAL	0
NET AMOUNT	$ 10,243

Derivative Financial Instrume_8

Derivative Financial Instruments - Narrative (Details) $ in Millions	Dec. 31, 2022 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Reclassified from accumulated other comprehensive loss	$ 10.3
Fair value of derivatives in a net liability position	2.1
Assets needed if immediate settlement is required, aggregate fair value	$ 2.1

Stockholders' Equity - Common s

Stockholders' Equity - Common shares (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of the beginning and ending common stock outstanding
Balance, beginning of year (in shares)	150,457,000
Balance, end of year (in shares)	380,590,000	150,457,000
Common Stock
Reconciliation of the beginning and ending common stock outstanding
Balance, beginning of year (in shares)	150,457,433	139,487,375	134,706,154
Issuance of common stock (in shares)	229,618,304	10,899,301	4,637,445
Non-vested stock-based awards, net of withheld shares and forfeitures (in shares)	514,157	70,757	143,776
Balance, end of year (in shares)	380,589,894	150,457,433	139,487,375

Stockholders' Equity - Equity O

Stockholders' Equity - Equity Offering Programs (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Net proceeds	$ 22,902,000	$ 331,119,000	$ 142,000,000
Common Stock [Member]
Class of Stock [Line Items]
Equity offering program of common stock	$ 750,000,000
At the Market Equity Offering Program
Class of Stock [Line Items]
Weighted average sale price per share (in dollars per share)		$ 31.73	$ 31.09
Shares priced		0	9,763,680
Shares settled		727,400	10,859,539
Shares remaining to be settled		0	727,400
Net proceeds		$ 22,300,000	$ 330,300,000

Stockholders' Equity (Stock Tra

Stockholders' Equity (Stock Transactions - Narrative) (Details) - USD ($)		12 Months Ended
	Feb. 24, 2023	Dec. 31, 2022	Aug. 02, 2022
Class of Stock [Line Items]
Dividends per share to common stockholders, paid per quarter (in USD per share)		$ 0.31
Stock repurchase, amount authorized			$ 500,000,000
Subsequent Event
Class of Stock [Line Items]
Dividends per share to common stockholders, declared (in USD per share)	$ 0.31
Dividend Declared
Class of Stock [Line Items]
Dividends per share to common stockholders, declared (in USD per share)		$ 1.24

Stockholders' Equity - Accumula

Stockholders' Equity - Accumulated Other Comprehensive Income (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($) derivative
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amount of loss recognized in OCI on derivatives	$ (10,630)
Period of impact on net income			10 years
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Net current-period other comprehensive income	12,157	$ 7,851	$ (11,657)
Settled treasury hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Number of interest rate derivatives | derivative			2
Amount of loss recognized in OCI on derivatives	0	0	$ 4,267
Forward Starting Swaps | Reclassification out of Accumulated Other Comprehensive Income
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	(9,981)	(17,832)
Other comprehensive loss before reclassifications	1,531	4,472
Amounts reclassified from accumulated other comprehensive income	10,590	3,379
Net current-period other comprehensive income	12,121	7,851
Balance, end of period	$ 2,140	$ (9,981)	$ (17,832)

Stockholders' Equity - Reclassi

Stockholders' Equity - Reclassifications out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest Expense	$ 146,691	$ 53,124	$ 56,174
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts reclassified from accumulated other comprehensive income (loss)	1,531
Amounts reclassified from accumulated other comprehensive income (loss) related to settled interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest Expense	594
Amounts reclassified from accumulated other comprehensive income (loss) related to current interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest Expense	$ 937

Stock and Other Incentive Pla_3

Stock and Other Incentive Plans - Narrative (Details) $ / shares in Units, $ in Millions

1 Months Ended

3 Months Ended

12 Months Ended

Feb. 22, 2027 USD ($)

Jan. 04, 2027 USD ($)

Feb. 22, 2026 USD ($)

Jan. 04, 2026 USD ($)

Jan. 03, 2026 USD ($)

Dec. 12, 2025 USD ($)

Feb. 22, 2025 USD ($)

Jan. 04, 2025 USD ($)

Jan. 03, 2025 USD ($)

Dec. 12, 2024 USD ($)

Feb. 22, 2024 USD ($)

Jan. 04, 2024 USD ($)

Jan. 03, 2024 USD ($)

Dec. 12, 2023 USD ($)

Feb. 22, 2023 USD ($)

Jan. 04, 2023 USD ($) shares

Jan. 03, 2023 USD ($)

Dec. 12, 2022 USD ($) shares

Aug. 02, 2022 USD ($) director shares

May 13, 2022 USD ($) director shares

Feb. 22, 2022 USD ($) shares

Jan. 03, 2022 USD ($) shares

Jan. 31, 2022 $ / shares

Mar. 31, 2022 USD ($) shares

Mar. 31, 2021

Dec. 31, 2022 USD ($) employee $ / shares shares

Dec. 31, 2021 USD ($) $ / shares shares

Dec. 31, 2020 USD ($) $ / shares shares

Dec. 31, 2016 award

May 31, 2015 shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares issued under the plan (in shares) | shares

19,679

Vested grant date fair value (in dollars per share) | $ / shares

$ 33.04

Value of performance based awards released

$ 0.6

Number of executive officers granted awards (in shares) | shares

19,204

401(k) Plan [Abstract]

Percentage of matching contribution

3%

Value of matching contribution

$ 1.2

$ 0.7

$ 0.6

At the Market Equity Offering Program

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Percentage of RSUnits

43%

Market Condition 1

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted, fair value | $ / shares

$ 30.56

Market Condition 2

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted, fair value | $ / shares

$ 41.30

Performance Conditions

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Percentage of RSUnits

57%

Vested grant date fair value (in dollars per share) | $ / shares

$ 31.68

Deferral Option One

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employer matching contribution, percent

30%

Deferral Option Two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employer matching contribution, percent

50%

Deferral Option Three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employer matching contribution, percent

100%

Performance Shares | Weighted Average

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

5 years

Employee Stock Purchase Plan

401(k) Plan [Abstract]

Cash received from employees upon exercising options

$ 0.4

0.8

0.7

Employee Stock Purchase Plan | General and Administrative Expense

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Accelerated stock compensation expense

$ 0.4

$ 0.4

$ 0.3

Legacy HR Incentive Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Authorization of common shares to issue (in shares) | shares

3,500,000

Common shares issued, net of forfeitures (in shares) | shares

2,386,822

Legacy HR Incentive Plan | Restricted Stock | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

3 years

Legacy HR Incentive Plan | Restricted Stock | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

8 years

Stock Incentive Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common shares issued, net of forfeitures (in shares) | shares

3,417,696

Granted in period (in shares) | shares

657,475

203,701

197,999

Vested grant date fair value (in dollars per share) | $ / shares

$ 31.52

$ 28.38

$ 23.82

Stock Incentive Plan | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Accelerated stock compensation expense

$ 0.8

$ 0.7

$ 0.8

Number of one-time non-vested share grants | award

3

Stock Incentive Plan | Director

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

1 year

Accelerated stock compensation expense

1.5

1.2

1

Stock Incentive Plan | Restricted Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Accelerated stock compensation expense

$ 13.9

$ 10.4

$ 9.7

Withheld of common stock (in shares) | shares

137,892

129,987

54,223

Weighted average remaining contractual terms

4 years 3 months 18 days

Stock Incentive Plan | Performance Shares | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

1 year

Stock Incentive Plan | Performance Shares | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

8 years

Stock Incentive Plan | Performance Shares | Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Accelerated stock compensation expense

$ 0.9

$ 1

$ 1.1

Stock Incentive Plan | Restricted Stock and Performance Based Awards | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

1 year

Stock Incentive Plan | Restricted Stock and Performance Based Awards | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

8 years

Stock Incentive Plan | Employee Stock Purchase Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted in period (in shares) | shares

5,806

Number of employees | employee

3

Executive Incentive Plan | Restricted Stock | Subsequent Event

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

5 years

Executive Incentive Plan | Performance Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

3 years

5 years

5 years

Accelerated stock compensation expense

$ 1.6

$ 9.8

6.6

5.9

Granted in period

$ 2.7

$ 3.9

$ 7.9

Shares issued under the plan (in shares) | shares

140,809

126,930

249,689

Executive Incentive Plan | Performance Shares | Subsequent Event

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

5 years

Granted in period

$ 4.1

Shares issued under the plan (in shares) | shares

205,264

Executive Incentive Plan | Performance Shares | Forecast

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Accelerated stock compensation expense

$ 0.1

$ 0.8

$ 0.8

$ 0.8

$ 0.9

$ 0.8

$ 0.8

$ 1.6

$ 0.9

$ 0.8

$ 0.8

$ 1.6

$ 0.9

$ 0.8

$ 1.6

Executive Incentive Plan | Performance Shares | Forecast | Subsequent Event

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Accelerated stock compensation expense

$ 0.8

Executive Incentive Plan | Operating Partnership Performance Units | Subsequent Event | Share-Based Payment Arrangement, Nonemployee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

5 years

Performance period

3 years

Granted in period (in shares) | shares

627,547

Executive Incentive Plan | Operating Partnership Performance Units | Subsequent Event | Share-based Payment Arrangement, Tranche Two | Share-Based Payment Arrangement, Nonemployee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

50%

Executive Incentive Plan | Operating Partnership Performance Units | Subsequent Event | Share-Based Payment Arrangement, Tranche Three | Share-Based Payment Arrangement, Nonemployee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

50%

Executive Incentive Plan | Non Vested Stock Award

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

1 year

Granted in period

$ 1.8

$ 0.8

Granted in period (in shares) | shares

70,816

26,840

Executive Incentive Plan | Non Vested Stock Award | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

1 year

Executive Incentive Plan | Non Vested Stock Award | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

3 years

Executive Incentive Plan | Non Vested Stock Award | Director

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of directors | director

12

8

Executive Incentive Plan | Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Accelerated stock compensation expense

$ 1.9

Granted in period

$ 9.7

Shares issued under the plan (in shares) | shares

294,932

Performance period

3 years

Executive Incentive Plan | Restricted Stock Units (RSUs) | Subsequent Event

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

5 years

Accelerated stock compensation expense

$ 1.9

Shares issued under the plan (in shares) | shares

165,174

Executive Incentive Plan | Restricted Stock Units (RSUs) | Subsequent Event | Share-based Payment Arrangement, Tranche Two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

50%

Executive Incentive Plan | Restricted Stock Units (RSUs) | Subsequent Event | Share-Based Payment Arrangement, Tranche Three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

50%

Executive Incentive Plan | Restricted Stock Units (RSUs) | Forecast

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Accelerated stock compensation expense

$ 1.9

$ 1.9

$ 1.9

Salary Deferral Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Accelerated stock compensation expense

$ 0.9

$ 0.9

$ 0.9

Shares issued under the plan (in shares) | shares

17,381

21,396

17,570

Maximum salary deferral for officers under the plan, percent

50%

Salary Deferral Plan | Deferral Option One

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

3 years

Salary Deferral Plan | Deferral Option Two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

5 years

Salary Deferral Plan | Deferral Option Three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

8 years

Stock and Other Incentive Pla_4

Stock and Other Incentive Plans - Amortization of Compensation for Nonvested Shares (Details) $ in Millions	Dec. 31, 2022 USD ($)
Share-Based Payment Arrangement [Abstract]
2023	$ 12
2024	10
2025	8.3
2026	5.5
2027	0.4
2028 and thereafter	0.1
Total	$ 36.3

Stock and Other Incentive Pla_5

Stock and Other Incentive Plans - Black-Scholes Options Pricing Model (Details) - $ / shares	1 Months Ended	12 Months Ended
	Jan. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restricted Stock
Fair value of options issued based on weighted-average assumptions
Risk-free interest rates	1.02%
Expected life (in years)	3 years
Expected volatility	30%
Stock price (per share)	$ 31.68
Employee Stock Purchase Plan
Fair value of options issued based on weighted-average assumptions
Risk-free interest rates		0.73%	0.13%	1.58%
Expected dividend yields		3.97%	4.11%	3.69%
Expected life (in years)		1 year 5 months 8 days	1 year 5 months 4 days	1 year 5 months 4 days
Expected volatility		49%	48.20%	28.60%
Expected forfeiture rates		85%	85%	85%

Stock and Other Incentive Pla_6

Stock and Other Incentive Plans - 2015 Incentive Plan and related information (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Jan. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Weighted-average grant date fair value of:
Share-based awards vested during the years (in dollars per share)	$ 33.04
Stock Incentive Plan
Summary of the activity under the incentive plans
Share-based awards, beginning of year (in shares)	1,562,028	1,562,028	1,766,061	1,754,066
Granted (in shares)		657,475	203,701	197,999
Vested (in shares)		(418,949)	(404,777)	(186,004)
Forfeited (in shares)		(5,426)	(2,957)	0
Share-based awards, end of year (in shares)		1,795,128	1,562,028	1,766,061
Weighted-average grant date fair value of:
Share-based awards, beginning of year (in dollars per share)	$ 31.10	$ 31.10	$ 30.51	$ 29.82
Share-based awards granted during the year (in dollars per share)		28.11	30.86	30.33
Share-based awards vested during the years (in dollars per share)		31.52	28.38	23.82
Share-based awards forfeitures during the year (in dollars per share)		31.48	33.04	0
Share-based awards, end of year (in dollars per share)		$ 29.91	$ 31.10	$ 30.51
Grant date fair value of shares granted during the year		$ 18,480	$ 6,286	$ 6,006

Stock and Other Incentive Pla_7

Stock and Other Incentive Plans - Employee Stock Purchase Plan (Details) - Employee Stock Purchase Plan - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Stock Options Outstanding:
Options outstanding, beginning of year (in shares)	348,514	341,647	332,659
Granted (in shares)	255,960	253,200	212,716
Exercised (in shares)	(20,246)	(30,281)	(21,713)
Forfeited (in shares)	(102,619)	(71,630)	(42,221)
Expired (in shares)	(140,633)	(144,422)	(139,794)
Outstanding, end of period (in shares)	340,976	348,514	341,647
Weighted-average exercise price:
Options outstanding, beginning of year (in dollars per share)	$ 25.38	$ 24.70	$ 25.59
Options granted during the year (in dollars per share)	26.89	25.16	28.36
Options exercised during the year (in dollars per share)	20.97	25.03	24.10
Options forfeited during the year (in dollars per share)	21.88	25.45	25.29
Options expired during the year (in dollars per share)	23.36	24.17	23.74
Options outstanding, end of year (in dollars per share)	16.38	25.38	24.70
Weighted-average fair value of options granted during the year (calculated as of the grant date) (in dollars per share)	$ 9.91	$ 9.05	$ 8.06
Intrinsic value of options exercised during the year	$ 75	$ 165	$ 101
Intrinsic value of options outstanding (calculated as of December 31)	$ 985	$ 1,997	$ 1,673
Exercise prices of options outstanding (calculated as of December 31) (in dollars per share)	$ 16.38	$ 25.91	$ 24.70
Weighted-average contractual life of outstanding options (calculated as of December 31, in years)	9 months 18 days	9 months 18 days	9 months 18 days

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Dilutive effect of forward equity (in shares)	0	0	6,283
Proceeds from issuance of common stock, adjusted for costs to borrow		$ 23.1
Weighted-average incremental shares of common stock excluded from the computation (in shares)		1,682
At the Market Equity Offering Program
Class of Stock [Line Items]
Dilutive effect of forward equity (in shares)		700,000

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Weighted Average Common Shares
Weighted average common shares outstanding (in shares)	254,296,810	144,411,835	135,666,503
Non-vested shares (in shares)	(1,940,607)	(1,774,669)	(1,736,358)
Weighted average common shares outstanding - Basic (in shares)	252,356,203	142,637,166	133,930,145
Dilutive effect of forward equity (in shares)	0	0	6,283
Dilutive effect of OP Units (in shares)	1,451,599	0	0
Dilutive effect of employee stock purchase plan (in shares)	65,519	73,062	70,512
Weighted average common shares outstanding - diluted (in shares)	253,873,321	142,710,228	134,006,940
Net income attributable to common stockholders	$ 40,897	$ 66,659	$ 72,195
Dividends paid on nonvested share-based awards	(2,437)	(2,154)	(2,083)
Net income applicable to common stockholders - basic	38,460	64,505	70,112
Net income attributable to OP Units	81	0	0
Net income applicable to common stockholders - diluted	$ 38,541	$ 64,505	$ 70,112
Basic earnings per common share - net income (in dollars per share)	$ 0.15	$ 0.45	$ 0.52
Diluted earnings per common share- net income (in dollars per share)	$ 0.15	$ 0.45	$ 0.52

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) property	Dec. 31, 2021 USD ($) property
Property, Plant and Equipment [Line Items]
Construction activity and development properties	$ 60.8
Number of land parcels held for development | property	20	7
Investment in land held for development	$ 74.3	$ 24.8
Letter of Credit
Property, Plant and Equipment [Line Items]
Deposits	32.1
First and Second Generation Leases | Tenant Improvement Allowances
Property, Plant and Equipment [Line Items]
Anticipated amount of investment	$ 195.1

Other Data - Narrative (Details

Other Data - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Tax Credit Carryforward [Line Items]
Condition to qualify as REIT as defined under the internal revenue code	Company must meet a number of organizational and operational requirements, including a requirement that it currently distribute at least 90% of its taxable income to its stockholders.
Number of preferred shares outstanding (in shares)	0	0
Dividends distributed to preferred shares	$ 0
Legacy HR
Tax Credit Carryforward [Line Items]
Estimated aggregate total cost of total assets for federal income tax purposes	$ 13,000,000,000	$ 5,000,000,000	$ 4,700,000,000
Legacy HTA
Tax Credit Carryforward [Line Items]
Estimated aggregate total cost of total assets for federal income tax purposes		$ 8,200,000,000	$ 7,900,000,000

Other Data - Characterization o

Other Data - Characterization of Distributions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Tax Treatment of Dividends Pre-Merger Healthcare Trust of America
Characterization of distributions on common stock
Ordinary income (in dollars per share)	$ 0.5862	$ 0.7920	$ 0.6976
Return of capital (in dollars per share)	4.0162	0.4930	0.5582
Capital gain (in dollars per share)	1.2216	0	0.0092
Common stock distributions (in dollars per share)	5.8240	1.2850	1.2650
Tax Treatment of Dividends Pre-Merger Healthcare Realty
Characterization of distributions on common stock
Ordinary income (in dollars per share)	0.2655	0.7500	0.7738
Return of capital (in dollars per share)	0.5555	0.3600	0.1084
Capital gain (in dollars per share)	0	0.0964	0.3178
Common stock distributions (in dollars per share)	0.8210	1.2064	1.2000
Tax Treatment of Dividends Post-Merger Healthcare Realty
Characterization of distributions on common stock
Ordinary income (in dollars per share)	0.0422	0	0
Return of capital (in dollars per share)	0.2889	0	0
Capital gain (in dollars per share)	0.0879	0	0
Common stock distributions (in dollars per share)	$ 0.4190	$ 0	$ 0

Other Data - State Income Taxes

Other Data - State Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
State income tax expense
Texas gross margins tax	$ 1,693	$ 564	$ 546
Other	151	8	8
Total state income tax expense	1,844	572	554
State income tax payments, net of refunds and collections	$ 1,834	$ 560	$ 557

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
CARRYING VALUE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes and bonds payable	$ 5,351.8	$ 1,801.3
Real estate notes receivable	99.6	0
FAIR VALUE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes and bonds payable	5,149.6	1,797.4
Real estate notes receivable	$ 99.6	$ 0

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts (Details) - Accounts receivable allowance - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 654	$ 604	$ 418
Charged/(Credited) to costs and expenses, additions and deductions	3,306	72	207
Charged to other accounts, additions and deductions	0	0	0
Uncollectible accounts written-off	6	22	21
Balance at end of period	$ 3,954	$ 654	$ 604

Schedule III - Real Estate an_2

Schedule III - Real Estate and Accumulated Depreciation (Details) $ in Thousands	Dec. 31, 2022 USD ($) property	Dec. 31, 2021 USD ($) property	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Summary of real estate properties
NUMBER OF PROPERTIES | property	688
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
Gross real estate asset, Total	$ 14,076,475	$ 5,104,942	$ 4,670,226	$ 4,359,993
Accumulated depreciation	$ 1,645,271	$ 1,338,743	$ 1,249,679	$ 1,121,102
Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	688
LAND 1
INITIAL INVESTMENT	$ 1,398,017
COST CAPITALIZED subsequent to acquisition	41,628
TOTAL	1,439,645
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	11,471,695
COST CAPITALIZED subsequent to acquisition	834,463
TOTAL	12,306,158
PERSONAL PROPERTY	6,369
Gross real estate asset, Total	13,752,172
Accumulated depreciation	1,638,800
Encumbrances	$ 84,697
Land held for develop.
Summary of real estate properties
NUMBER OF PROPERTIES | property	0
LAND 1
INITIAL INVESTMENT	$ 74,265
COST CAPITALIZED subsequent to acquisition	0
TOTAL	74,265
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
PERSONAL PROPERTY	0
Gross real estate asset, Total	74,265
Accumulated depreciation	1,183
Encumbrances	$ 0
Construction in progress
Summary of real estate properties
NUMBER OF PROPERTIES | property	0
LAND 1
INITIAL INVESTMENT	$ 0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	35,560
COST CAPITALIZED subsequent to acquisition	0
TOTAL	35,560
PERSONAL PROPERTY	0
Gross real estate asset, Total	35,560
Accumulated depreciation	0
Encumbrances	$ 0
Corporate Property
Summary of real estate properties
NUMBER OF PROPERTIES | property	0
LAND 1
INITIAL INVESTMENT	$ 1,853
COST CAPITALIZED subsequent to acquisition	0
TOTAL	1,853
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	1,787
COST CAPITALIZED subsequent to acquisition	1,240
TOTAL	3,027
PERSONAL PROPERTY	5,538
Gross real estate asset, Total	10,418
Accumulated depreciation	5,288
Encumbrances	$ 0
Financing lease right-of-use assets
Summary of real estate properties
NUMBER OF PROPERTIES | property	0
LAND 1
INITIAL INVESTMENT	$ 0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
PERSONAL PROPERTY	0
Gross real estate asset, Total	83,824
Accumulated depreciation	0
Encumbrances	$ 0
Investment in financing receivables, net
Summary of real estate properties
NUMBER OF PROPERTIES | property	0
LAND 1
INITIAL INVESTMENT	$ 0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
PERSONAL PROPERTY	0
Gross real estate asset, Total	120,236
Accumulated depreciation	0
Encumbrances	$ 0
Total properties
Summary of real estate properties
NUMBER OF PROPERTIES | property	688
LAND 1
INITIAL INVESTMENT	$ 1,474,135
COST CAPITALIZED subsequent to acquisition	41,628
TOTAL	1,515,763
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	11,509,042
COST CAPITALIZED subsequent to acquisition	835,703
TOTAL	12,344,745
PERSONAL PROPERTY	11,907
Gross real estate asset, Total	14,076,475
Accumulated depreciation	1,645,271
Encumbrances	$ 84,697
Seattle, WA | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	45
LAND 1
INITIAL INVESTMENT	$ 95,647
COST CAPITALIZED subsequent to acquisition	1,063
TOTAL	96,710
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	1,081,969
COST CAPITALIZED subsequent to acquisition	129,495
TOTAL	1,211,464
PERSONAL PROPERTY	551
Gross real estate asset, Total	1,308,725
Accumulated depreciation	202,031
Encumbrances	$ 0
Dallas, TX | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	29
LAND 1
INITIAL INVESTMENT	$ 59,412
COST CAPITALIZED subsequent to acquisition	4,883
TOTAL	64,295
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	558,280
COST CAPITALIZED subsequent to acquisition	78,330
TOTAL	636,610
PERSONAL PROPERTY	726
Gross real estate asset, Total	701,631
Accumulated depreciation	164,423
Encumbrances	$ 0
Los Angeles, CA | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	23
LAND 1
INITIAL INVESTMENT	$ 95,360
COST CAPITALIZED subsequent to acquisition	3,164
TOTAL	98,524
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	436,629
COST CAPITALIZED subsequent to acquisition	55,941
TOTAL	492,570
PERSONAL PROPERTY	453
Gross real estate asset, Total	591,547
Accumulated depreciation	129,663
Encumbrances	$ 38,373
Charlotte, NC | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	18
LAND 1
INITIAL INVESTMENT	$ 128,904
COST CAPITALIZED subsequent to acquisition	0
TOTAL	128,904
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	456,963
COST CAPITALIZED subsequent to acquisition	2,173
TOTAL	459,136
PERSONAL PROPERTY	0
Gross real estate asset, Total	588,040
Accumulated depreciation	13,513
Encumbrances	$ 0
Atlanta, GA | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	32
LAND 1
INITIAL INVESTMENT	$ 35,366
COST CAPITALIZED subsequent to acquisition	36
TOTAL	35,402
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	454,299
COST CAPITALIZED subsequent to acquisition	25,616
TOTAL	479,915
PERSONAL PROPERTY	105
Gross real estate asset, Total	515,422
Accumulated depreciation	95,363
Encumbrances	$ 0
Houston, TX | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	34
LAND 1
INITIAL INVESTMENT	$ 82,539
COST CAPITALIZED subsequent to acquisition	2,850
TOTAL	85,389
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	669,553
COST CAPITALIZED subsequent to acquisition	27,966
TOTAL	697,519
PERSONAL PROPERTY	57
Gross real estate asset, Total	782,965
Accumulated depreciation	63,486
Encumbrances	$ 0
Houston, TX | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	23
LAND 1
INITIAL INVESTMENT	$ 72,304
COST CAPITALIZED subsequent to acquisition	60
TOTAL	72,364
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	429,781
COST CAPITALIZED subsequent to acquisition	17,413
TOTAL	447,194
PERSONAL PROPERTY	105
Gross real estate asset, Total	519,663
Accumulated depreciation	52,920
Encumbrances	$ 0
Washington, D.C. | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	28
LAND 1
INITIAL INVESTMENT	$ 45,220
COST CAPITALIZED subsequent to acquisition	4,159
TOTAL	49,379
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	463,963
COST CAPITALIZED subsequent to acquisition	9,519
TOTAL	473,482
PERSONAL PROPERTY	95
Gross real estate asset, Total	522,956
Accumulated depreciation	63,773
Encumbrances	$ 15,778
Nashville, TN | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	20
LAND 1
INITIAL INVESTMENT	$ 30,790
COST CAPITALIZED subsequent to acquisition	743
TOTAL	31,533
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	419,354
COST CAPITALIZED subsequent to acquisition	(5,061)
TOTAL	414,293
PERSONAL PROPERTY	33
Gross real estate asset, Total	445,859
Accumulated depreciation	18,991
Encumbrances	$ 0
Memphis, TN | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	33
LAND 1
INITIAL INVESTMENT	$ 70,478
COST CAPITALIZED subsequent to acquisition	6,220
TOTAL	76,698
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	491,881
COST CAPITALIZED subsequent to acquisition	51,208
TOTAL	543,089
PERSONAL PROPERTY	609
Gross real estate asset, Total	620,396
Accumulated depreciation	65,123
Encumbrances	$ 6,818
Indianapolis, IN | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	27
LAND 1
INITIAL INVESTMENT	$ 52,954
COST CAPITALIZED subsequent to acquisition	3,666
TOTAL	56,620
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	394,574
COST CAPITALIZED subsequent to acquisition	6,231
TOTAL	400,805
PERSONAL PROPERTY	9
Gross real estate asset, Total	457,434
Accumulated depreciation	15,566
Encumbrances	$ 0
HAWAII | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	35
LAND 1
INITIAL INVESTMENT	$ 20,257
COST CAPITALIZED subsequent to acquisition	5
TOTAL	20,262
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	448,657
COST CAPITALIZED subsequent to acquisition	18,836
TOTAL	467,493
PERSONAL PROPERTY	425
Gross real estate asset, Total	488,180
Accumulated depreciation	30,281
Encumbrances	$ 0
Chicago, IL | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	7
LAND 1
INITIAL INVESTMENT	$ 32,374
COST CAPITALIZED subsequent to acquisition	0
TOTAL	32,374
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	271,285
COST CAPITALIZED subsequent to acquisition	15,995
TOTAL	287,280
PERSONAL PROPERTY	81
Gross real estate asset, Total	319,735
Accumulated depreciation	28,243
Encumbrances	$ 0
San Francisco, CA 4 | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	36
LAND 1
INITIAL INVESTMENT	$ 52,180
COST CAPITALIZED subsequent to acquisition	0
TOTAL	52,180
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	292,372
COST CAPITALIZED subsequent to acquisition	5,437
TOTAL	297,809
PERSONAL PROPERTY	13
Gross real estate asset, Total	350,002
Accumulated depreciation	19,705
Encumbrances	$ 0
Hartford, CT | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	30
LAND 1
INITIAL INVESTMENT	$ 43,326
COST CAPITALIZED subsequent to acquisition	0
TOTAL	43,326
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	234,702
COST CAPITALIZED subsequent to acquisition	1,150
TOTAL	235,852
PERSONAL PROPERTY	0
Gross real estate asset, Total	279,178
Accumulated depreciation	8,015
Encumbrances	$ 0
Nashville, TN | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	12
LAND 1
INITIAL INVESTMENT	$ 41,291
COST CAPITALIZED subsequent to acquisition	2,057
TOTAL	43,348
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	272,122
COST CAPITALIZED subsequent to acquisition	84,395
TOTAL	356,517
PERSONAL PROPERTY	1,424
Gross real estate asset, Total	401,289
Accumulated depreciation	92,720
Encumbrances	$ 0
New York, NY | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	14
LAND 1
INITIAL INVESTMENT	$ 64,402
COST CAPITALIZED subsequent to acquisition	0
TOTAL	64,402
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	192,029
COST CAPITALIZED subsequent to acquisition	2,220
TOTAL	194,249
PERSONAL PROPERTY	0
Gross real estate asset, Total	258,651
Accumulated depreciation	4,771
Encumbrances	$ 0
Colorado Springs, CO | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	13
LAND 1
INITIAL INVESTMENT	$ 25,718
COST CAPITALIZED subsequent to acquisition	1,346
TOTAL	27,064
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	261,585
COST CAPITALIZED subsequent to acquisition	28,675
TOTAL	290,260
PERSONAL PROPERTY	142
Gross real estate asset, Total	317,466
Accumulated depreciation	40,363
Encumbrances	$ 0
San Antonio, TX
Summary of real estate properties
NUMBER OF PROPERTIES | property		3
San Antonio, TX | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	8
LAND 1
INITIAL INVESTMENT	$ 20,698
COST CAPITALIZED subsequent to acquisition	10
TOTAL	20,708
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	198,719
COST CAPITALIZED subsequent to acquisition	3,556
TOTAL	202,275
PERSONAL PROPERTY	1
Gross real estate asset, Total	222,984
Accumulated depreciation	11,654
Encumbrances	$ 0
Chicago, IL | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	11
LAND 1
INITIAL INVESTMENT	$ 12,811
COST CAPITALIZED subsequent to acquisition	1,090
TOTAL	13,901
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	118,426
COST CAPITALIZED subsequent to acquisition	70,325
TOTAL	188,751
PERSONAL PROPERTY	317
Gross real estate asset, Total	202,969
Accumulated depreciation	60,624
Encumbrances	$ 0
Other (51 markets) | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	210
LAND 1
INITIAL INVESTMENT	$ 315,986
COST CAPITALIZED subsequent to acquisition	10,276
TOTAL	326,262
BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1
INITIAL INVESTMENT	3,324,552
COST CAPITALIZED subsequent to acquisition	205,043
TOTAL	3,529,595
PERSONAL PROPERTY	1,223
Gross real estate asset, Total	3,857,080
Accumulated depreciation	457,572
Encumbrances	$ 23,728

Schedule III - Real Estate an_3

Schedule III - Real Estate and Accumulated Depreciation - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) property	Dec. 31, 2021 USD ($)
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Federal income tax purposes	$ 13,000,000
Issuance costs	5,977	$ 1,813
Mortgage Notes Payable | Mortgage Notes
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Unamortized premium	486	1,720
Unaccreted discount	38	83
Issuance costs	$ 323	$ 651
Minimum | Buildings and improvements
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	3 years
Minimum | Lease intangibles
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	1 year 2 months 12 days
Minimum | Personal Property
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	3 years
Minimum | Land improvements
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	2 years
Maximum | Buildings and improvements
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	49 years
Maximum | Lease intangibles
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	99 years
Maximum | Personal Property
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	20 years
Maximum | Land improvements
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	39 years
Asset Held-for-sale
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Number of real estate assets held for sale | property	1
Amount of ​assets ​held for ​sale	$ 18,900

Schedule III - Real Estate an_4

Schedule III - Real Estate and Accumulated Depreciation - Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of Carrying Amount of Real Estate Investments [Roll Forward]
Beginning Balance, Total Property	$ 5,104,942	$ 4,670,226	$ 4,359,993
Retirement/dispositions
Ending Balance, Total Property	14,076,475	5,104,942	4,670,226
Reconciliation of Real Estate Accumulated Depreciation [Roll Forward]
Beginning Balance, Accumulated Depreciation	1,338,743	1,249,679	1,121,102
Retirement/dispositions
Ending Balance, Accumulated Depreciation	1,645,271	1,338,743	1,249,679
Real estate acquired
Additions during the period
Total Property	9,780,070	374,912	430,205
Retirement/dispositions
TOTAL PROPERTY	(1,098,702)	(247,880)	(222,680)
Ending Balance, Total Property	13,752,172
Additions during the period
ACCUMULATED DEPRECIATION	241,285	7,668	8,313
Retirement/dispositions
Accumulated Depreciation	(140,696)	(110,479)	(58,654)
Ending Balance, Accumulated Depreciation	1,638,800
Other improvements
Additions during the period
Total Property	219,783	103,035	80,462
Additions during the period
ACCUMULATED DEPRECIATION	205,703	191,875	178,636
Land held for development
Additions during the period
Total Property	49,416	2,021	2,579
Additions during the period
ACCUMULATED DEPRECIATION	0	0	282
Construction in progress
Additions during the period
Total Property	31,586	3,974	0
Retirement/dispositions
Ending Balance, Total Property	35,560
Additions during the period
ACCUMULATED DEPRECIATION	0	0
Retirement/dispositions
Ending Balance, Accumulated Depreciation	0
Investment in financing receivables, net
Additions during the period
Total Property		186,745	0
Total Property Reclassified	(66,509)
Additions during the period
ACCUMULATED DEPRECIATION	0	0	0
Financing lease right-of-use assets
Additions during the period
Total Property	52,249	11,909	19,667
Retirement/dispositions
Ending Balance, Total Property	83,824
Additions during the period
ACCUMULATED DEPRECIATION	0	0	0
Retirement/dispositions
Ending Balance, Accumulated Depreciation	0
Corporate Properties
Additions during the period
Total Property	3,640	0	0
Additions during the period
ACCUMULATED DEPRECIATION	$ 236	$ 0	$ 0

Schedule IV - Mortgage Loans _2

Schedule IV - Mortgage Loans on Real Estate Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Prior Liens	$ 0
Face Amount	104,331
Carrying Amount	100,085
Accrued interest receivable	758
Deferred fee	(1,200)
Carrying Amount, Net	99,643
Principal Amount of Loans Subject to Delinquent Principal or Interest	0
SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward]
Balance as of the beginning of the year	0	$ 0	$ 0
Additions:
Fair value real estate notes assumed	74,819	0	0
New real estate notes	23,325	0	0
Capitalized interest	1,499	0	0
Accretion of fees and other items	0	0	0
Deductions:
Collection of real estate loans	0	0	0
Deferred fees and other items	0	0	0
Balance as of the end of the year	$ 99,643	$ 0	$ 0
Texas | Medical Real Estate, Maturing in December 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	7%
Prior Liens	$ 0
Face Amount	31,150
Carrying Amount	30,552
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Texas | Property 1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	8%
Prior Liens	$ 0
Face Amount	54,119
Carrying Amount	51,052
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Florida | Medical Real Estate Maturing in February 2026
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	6%
Prior Liens	$ 0
Face Amount	13,062
Carrying Amount	12,988
Principal Amount of Loans Subject to Delinquent Principal or Interest	0
Construction loan, maximum	$ 65,000
North Carolina | Property 2
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	8%
Prior Liens	$ 0
Face Amount	6,000
Carrying Amount	5,493
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0